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bacteroides infection
DatadnCPHosntiate S.S.a new solution
•  I.M. injection or I.V. infusion 
achieves prompt and high peak 
serum levels of active clindamycin
•  well tolerated locally and sys- 
temically following I.M. injection 
or I.V. infusion
U pjohn
prescribing information on page 474
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Parental dosage and administration (IV or IM)
Adults: 600 mg/day in 2 equal doses.
Moderately severe infections: 600-1200 mg/day in 2, 3 or 4 equal
doses.
Severe infections: 1200-2700 mg/day in 2, 3, or 4 equal doses. 
NOTE: For more serious infections, these doses may have to be 
increased. In life-threatening situations, doses of as much as 
4.8g daily have been given intravenously to adults.
Children: (Over 1 month of age)
10-15 mg/kg/day in 3 or 4 equal doses.
Moderately severe infections: 15-25 mg/kg/day in 3 or 4 equal doses. 
Severe infections: 25-40 mg/kg/day in 3 or 4 equal doses.
NOTE: In severe infections it is recommended that children be 
given no less than 300 mg/day regardless of body weight.
Dalacin C Phosphate Sterile Solution should not be given un­
diluted intravenously; always administer in an infusion. See 
product monograph supplied with each package for complete 
dosage information and infusion rates.
Cautions: Generally well tolerated. Known and usual antibiotic 
administration route side effects have been reported. Pain at the 
injection site, induration and sterile abscess have been reported 
following intramuscular injection. Thrombophlebitis, erythema, 
swelling and pain at the infusion site have been observed following 
intravenous infusion.
Warning: Some cases of severe and persistent diarrhea have been 
reported during or after therapy with clindamycin. This diarrhea 
has been occasionally associated with blood and mucus in the stools 
and has at times resulted in acute colitis. When endoscopy has been 
performed, some of these cases have shown pseudomembrane for­
mation.
If significant diarrhea occurs during therapy, this drug should be 
discontinued or, if necessary, continued only with close observation. 
Significant diarrhea occurring up toseveral weeks post-therapy should 
be managed as if antibiotic-associated.
If colitis is suspected, endoscopy is recommended. Mild cases showing 
minimal mucosal changes may respond to simple drug discontin­
uance. Moderate to severe cases, including those showing ulceration 
or pseudomembrane formation, should be managed with fluid, elec­
trolyte, and protein supplementation as indicated. Corticoid retention 
enemas and systemic corticoids may be of help in persistent cases. 
Anticholinergics and antiperistaltic agents may worsen the condition. 
Other causes of colitis should be considered.
Abnormalities in liver function tests have been reported occasionally. 
Usual antibiotic side-eflects-rash, urticaria, pruritus, fever, leukocy­
tosis, nausea, diarrhea, changes in blood pressure, shortness of breath 
and bad or bitter taste in mouth have been reported.
Not indicated in patients who have demonstrated sensitivity to clin­
damycin or lincomycin. Safety in infants below 30 days of age or 
in pregnant women not established. Use with caution in patients 
with a history of asthma and other allergies. As with other antibiotics, 
periodic liver function tests and blood counts should be performed 
during prolonged therapy.
Detailed information available upon request.
A vai lability:
Dalacin C Phosphate Sterile Solution-Each ml contains clindamy- 
cin-2-phosphate equivalent to clindamycin base 150 mg in 2 ml and 
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GLIMPSES OF SURGICAL HISTORY: 
L FOR LIBRARIES
DAVID A. E. SHEPHARD
The medical LIBRARY has long been im­
portant to surgeons: its value to surgeons 
is evident, for example, in the instructions 
of the Company of Barber-Surgeons in Lon­
don in 1557 “that the two Masters of Ana­
tomy should have the keys of the Lyberary 
and of the Insvrments therein’’. Moreover, 
one of the great medical librarians, John 
Shaw Billings, was a surgeon, and the 
world’s largest medical library, the National 
Library of Medicine in Bethesda, is the 
descendant of Billings' Army Medical Lib­
rary. Many other surgeons have been great 
bibliophiles —  Harvey Cushing is one exam­
ple —  but how have surgeons’ nonsurgical 
colleagues contributed to this aspect of 
surgical history?
The Babylonians (c. 3000 BC), who 
made clay tablets, and the later Egyptians, 
who recorded medical information on 
papyri, were the unknown antecedents of 
latter-day bibliophiles. Surgical knowledge 
was recorded laboriously by hand by the 
Greeks, the Arabians and the scribes of 
Europe, many of whom were monks. Then 
came Caxton’s printing press and the Re­
naissance, and the world opened like the 
leaves of a book. In these ways the library 
became the mark of a cultured man and 
the special library the pride of professions: 
thus by 1638 the Barber-Surgeons was one 
group among many that possessed its own 
fine library.
Medical libraries then grew apace. Pro­
fessional colleges of physicians collected 
great books and useful journals; new hos­
pitals, medical schools and other medical 
institutions required good libraries; and 
philanthropic organizations and individuals 
also created great medical libraries. Nor 
must one forget physicians themselves, like 
the revered William Osier, medical biblio­
phile par excellence, whose collection 
reached McGill University as a bequest.
Whether a collection of tablets of clay, 
a stack of books and journals, or a pile of 
computer print-outs, the medical library is 
a window through which one can truly 
observe the unfolding of surgical history.
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Q U I L L  O N  S C A L P E L  This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
TOTAL PARENTERAL NUTRITION AT HOME
It is appropriate that this issue of the 
Journal contains— in addition to my com­
ments on total parenteral nutrition in the 
home—a paper on nutritional management 
for patients with external gastrointestinal 
fistulas (page 505), and another on the use 
of chemically defined diets in patients under­
going anorectal operations (page 511), for 
if the technical aspects of gastrointestinal 
surgery are to reach fruition in the rehabili­
tation of the patient to an acceptable life 
style, advances in our understanding of arti­
ficial nutritional sources will have to 
parallel success in the operating room.
Resection of more than 70% of the 
small bowel results in serious malabsorption, 
and prolonged survival is infrequent if less 
than 60 cm of small bowel remains. In pa­
tients in whom less than 70% of the small 
bowel has been resected, survival is com­
plicated by serious malnutrition and inability 
to work. Often the need to take frequent 
small meals and disability from severe 
diarrhea make normal existence and social 
activities impossible. Ini such patients the 
intravenous administration of nutrients can 
support life and improve nutrition, but to 
permit social rehabilitation this procedure 
must be performed at home intermittently 
so as to leave time for other activities.
This regimen of total parenteral nutrition 
has now been achieved1-3 and we have re­
ported the survival of nine patients, one for 
over 5 years, with complete social rehabili­
tation.6
For total parenteral nutrition to be under­
taken at home two main problems have to 
be solved. First, in providing access to the 
vascular system one must ensure patency for 
prolonged periods, freedom from infection 
and injury to the vascular system, and mini­
mal care. Initially arteriovenous shunts were 
proposed but these have been unsuccessful
because they do not remain patent. The use 
of arteriovenous fistulas, however, has been 
successful in individual patients, but they 
require daily needling and careful technique 
to prevent trauma and hematoma formation. 
The most successful method has relied on 
the use of Silastic tubing.-' 4-6 Broviac, Cole 
and Scribner7 have proposed use of a 
Dacron cuff to anchor the catheter at the 
skin margin and prevent ascending infection, 
but we have not used a cuff and have found 
no appreciable infection; furthermore, the 
cuff hinders removal of the catheter 
if replacement is necessary. The catheter is 
kept patent with a “heparin lock” . We have 
found that these catheters can remain in 
place for longer than 40 months without 
complication. In four patients the system 
has functioned for longer than 30 months; 
in one patient who died of incidental severe 
pneumococcal pneumonia, the vena cava 
was unaffected by the presence of a catheter 
left in place for 34 months. We also found 
that the mean survival for uncomplicated 
catheterization in nine patients was 23.6 
months.
Second, the feeding schedule requires that 
the infusion continue for 10 to 12 hours 
overnight while the patient is asleep; the 
patient disconnects himself from the infu­
sion apparatus during the day. Two problems 
have to be overcome: avoidance of air 
embolism when the container with the infu­
sion fluid empties and prevention of ex­
cessive pressure with consequent rupture of 
the line at the connections. To prevent air 
embolism we provide all nutrients in plastic 
bags so that when the bag empties air does 
not enter. Broviac and Scribner4 used a 
bottle container and an alarm to stop the 
infusion and wake the patient when the 
bottle was empty, but this more cumbersome 
technique relies on an electrical mechanism 
and disturbs the patient. To prevent the
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build-up of undue pressure in the line (as 
may develop if the patient obstructs the line 
when turning over in bed) and consequent 
rupture at connections, we apply simple 
pneumatic pressure by means of a constant- 
pressure device to cuffs surrounding the in­
fusion bags; this avoids the use of the elec­
trical system that is required when a pump 
is used, which allows pressure to build up 
unless an alarm wakes the patient. Pneu­
matic pressure infusion does not require 
electricity so it is useful on camping trips 
and visits to remote areas where electricity 
may not be readily available.
The nutrients are supplied through a 
central pharmacy in batches lasting 1 
month.8 The nutrient requirement averages 
35 kCal/kg/d with 1 g/kg/d of amino acids. 
The distribution of calories averages 31% 
lipid, 14% protein and 56% glucose in 3 
litres of fluid. The final glucose concentra­
tion is about 10% so the infusion can be 
discontinued suddenly without inducing 
hypoglycemia. The importance of this is that 
it allows the patient to infuse variably and 
to discontinue the infusion abruptly if re­
quired. It also obviates the need for careful 
pumping.
The details of the regimen have been 
published elsewhere;1' 8 it has maintained 
normal concentrations of all nutrients over 
several years of observation.6 All electro­
lytes are supplied and all known vitamins are 
included; our studies have shown that very 
small amounts of vitamin A and D (2500 
IU /d  and 250 IU./d respectively) are re­
quired to maintain normal concentrations 
and, in fact, a higher input may induce 
hypercalcemia. Trace elements (Zn, Cu, Cr, 
Mn, Se, I and Fe) also are provided. Finally 
we found that the essential fatty acid re­
quirement seems higher than is commonly 
accepted. Dose-response curves for our pa­
tients have indicated that about 50 g /d  of 
Intralipid is required to normalize the ratio 
of linoleate to oleate in red-cell-membrane 
phospholipid.9
Our patients have maintained ideal body 
weight, have normal concentrations of elec­
trolytes, most vitamins and trace metals, and 
a normal lipoprotein pattern. Socially they 
can function as active and useful members 
of society, working a full day or attending 
university. They can undertake leisure-time
activities such as camping and travelling 
abroad. While costs are high, total parenteral 
nutrition at home avoids even more expen­
sive hospitalization and allows patients to 
live a useful life.
K. N. Je e j e e b h o y , MD, FRCP[C]
Professor of medicine,
University of Toronto,
Toronto, ON.
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MEDICAL WRITING: 
PROBLEMS AND SOLUTIONS
Elsewhere in the journal (page 557) an 
announcement lists the name of the author 
of the winning entry for the Davis & Geek 
Surgical Essay Award. The editorial board 
congratulates Dr. J. B. Pietsch of Montreal 
on his winning entry, but the board also 
recognizes the exceptional work of his five 
colleagues, and commends them for their 
contributions, prepared during busy resi­
dency programs. The essay competition, 
made possible through the generosity of
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Davis & Geek, permitted only one winner to 
be declared; yet each of the six authors in 
submitting a manuscript achieved something 
worth while. Such creativity on the part of 
busy residents is worthy of note. Medical 
writing is rarely easy for physicians, and 
some of the problems that face physician- 
authors merit comment.
Surgeons are trained to operate; they are 
not (more’s the pity) trained to write. Indeed, 
this can be said of all physicians for no 
Canadian medical school or residency cur­
riculum includes instruction in medical and 
scientific writing —  which makes the entries 
for the Davis & Geek award the more com­
mendable. As to whether lack of formal 
instruction in writing is a serious fault of our 
system of medical education, each physician 
is entitled to his or her individual opinion. 
Some physicians may well consider such in­
struction “bunk”, while others might take 
the opposing view and share the opinion of 
Gregg,1 who held that “the common level 
of medical and scientific writing . . . consti­
tutes the most serious internal limitation to 
medical education and research”. Or some 
might share a middle view that medical 
writing skills are a necessary part of a well- 
rounded medical education. I subscribe to 
this third view because I believe not simply 
that any physician should take pride and 
pleasure in using words effectively — just 
as a surgeon prides himself on using his in­
struments effectively — but that good 
medical writing yields pragmatic benefits. 
The good author wastes less time than the 
poor one because his writing is organized; 
the good author is understood more readily 
than the poor one because his writing is 
clear; and the good author, whose writing is 
both concise and interesting, appeals more 
surely to the reader than does the poor 
author. Good writing enables an author to 
develop his power of thought; as Wood­
ford- has stressed, clear writing leads to 
sound thinking, and vice versa. And if one 
were to emphasize the pragmatic still more, 
one could say that good writing is important 
because well-written papers tend to be 
favoured by editors while poorly written 
papers are not.
Good medical writing, therefore, matters. 
But if physicians are never taught the basics 
of medical writing, how is the physician to
make the quantum leap from an untutored 
state to the state of being aware that he 
should write better, if not well? My sympa­
thies are entirely with the busy physician. 
Let me, therefore, suggest how a physician 
might learn to write better.
First, the physician-author should realize 
that he is not expected to attain the literary 
standard of a Nobel or Pulitzer laureate. His 
task is to recognize the few principles of 
good scientific writing —  accuracy, brevity, 
clarity, directness, effectiveness and variety 
in particular —  and then to apply these 
principles to his own writing.
Second, the physician—author must con­
vince himself that applying these principles 
will make his work more effective in the 
long run; it will facilitate communication 
with his patients and colleagues. This con­
viction will grow only if the author can 
demonstrate to himself that the cardinal 
principles of good writing work.
Third, because all skills need to be taught 
before an individual can learn them for him­
self, the physician-author must seek a 
teacher —  either a teacher in the flesh or a 
teacher in the form of any of numerous 
instruction manuals. The former, though not 
easy to find, has the advantage of stimulating 
interest and enthusiasm through direct ex­
change between student and teacher. One 
way of finding such teaching is to attend 
workshops on medical writing. Success of 
these workshops has clearly demonstrated 
their value and need, and, in view of the 
neglect of the teaching of medical writing in 
medical curricula, university authorities 
should consider this form of teaching more 
closely. Books also teach and there is no 
lack of books on general writing and on 
medical writing. Any physician who wishes 
to write well must learn from books, and 
each physician must decide which reference 
and instructional books suit him the best 
and then learn to use them.
But books, valuable as they are, are no 
more valuable than an anatomy text or an 
operating manual on its own is to the sur­
gical resident. More is required. The student 
of writing, like the student of surgery, must 
observe and even copy the “masters”. So a 
fourth step for the physician-author must be 
to read good writing, both by physicians as 
medical authors and by general authors of
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accepted excellence. And physicians can 
write well; Roland3 has gathered some 
models in an instructive anthology. Some 
physicians, too, have written well but not in 
the medical field: the names of Conan 
Doyle, A. J. Cronin and Somerset Maugham 
in prose and John Keats and William Carlos 
Williams in poetry are but a few among 
many. Wide reading of good writers is essen­
tial. Nor should one neglect good journalists, 
reading of whom keeps one’s writing 
modern.
A final step must be to write, as the six 
candidates for the Davis & Geek award have 
done: as Epictetus advised, if you want to 
be a writer, write. But you must write 
only if you have something to say —  and 
can be critical of your efforts. Experimenta­
tion and flexibility are needed; no one ap­
proach is necessarily the best. Do not be 
afraid to show your writing to your col­
leagues, preferably before submitting any­
thing to journals; editors offer opinions read­
ily enough, and it is better to have comments 
from informed colleagues first. Learning to 
write is a lifelong task; it is not ended after 
initial instruction any more than one’s 
education in surgery finishes with the com­
pletion of a residency. One must practice 
the art of writing, knowing that not even the
greatest authors are ever satisfied with their 
final drafts.
These five suggestions are personal ones; 
each physician-author must test them for 
himself and modify them as he wishes. I offer 
them knowing that good writing opens a 
door to communication with one’s colleagues 
that is important as well as rewarding. 
Writing well is a step to understanding the 
language that we too often neglect; our 
language is, after all, an instrument honed 
for a fine purpose, just as the surgeon’s 
knife is. Language is part of ourselves and is 
worth cultivating, and it is in this context 
that the editorial board salutes the efforts 
of the six candidates for the Davis & Geek 
Surgical Essay Award and the help of Davis 
& Geek in stimulating interest among these 
candidates.
D. A. E. Shephard, MB, FRCP[C]
Scientific editor,
Canadian Medical Association Journal.
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SELF-ASSESSMENT
SESAP II QUESTION
Items 41-43
A 57-year-old woman with an obstructing carcinoma of the esophagus is given total 
parenteral hyperalimentation while she is receiving preoperative irradiation. Three days 
later the patient is lethargic, and her behavior is strange. Her urine output has increased 
to 3000 ml/24 hr.
41. Which of the following would be most useful in determining the nature of this 
patient’s problem?
(A) Measurement of serum electrolytes
(B) Lumbar puncture
(C) Determination of the urine/serum creatinine ratio
(D) Liver function studies
(E) Measurement of blood glucose
42. The most likely diagnosis is
(A) congestive heart failure from fluid overload
(B) hypernatremia
(C) cerebral edema
(D) diabetes mellitus
(E) hyperosmolar, nonketotic coma
43. The most reasonable immediate therapy would be
(A) administration of digitalis and diuretics
(B) administration of glucocorticoids
(C) termination of all glucose infusions
(D) administration of insulin and continued hyperalimentation
(E) administration of insulin and 5 per cent dextrose in water
For each question select the one answer that is BEST from those noted above.
For the critique of Items 41-43 see page 558 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II Sylla­
bus: Surgical Education and Self-assessment Program No. 2.)
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LECTURES
ROYAL COLLEGE LECTURE, 1976 
PREOPERATiVE LEFT VENTRICULAR EJECTION FRACTION 
AND SURVIVAL AFTER CORONARY ARTERY SURGERY*
PIERRE GRONDIN, MD, G. PATRICK DONZEAU-GOUGE, MD, 
OLIVER BICAL, MD and JACQUES LESPERANCE, MD
A preoperative ejection fraction (EF) of less than 
0.30 slightly increases the immediate risk of 
myocardial revascularization. This risk can be 
greatly reduced by better myocardial protection 
and complete revascularization of the coronary 
lesions during surgery. Poor ventricular function, 
however, greatly influences the patient's long­
term survival, especially when the EF is less 
than 0.30.
In patients with coronary artery disease, in 
whom there are clinical and angiographic indica­
tions of an aortocoronary shunt and the EF, when 
measured in the right anterior oblique plane, is 
equal to or greater than 0.30, surgery may be 
performed with an acceptable surgical risk 
(3.9%) and satisfactory long-term (4 -to 5-yr) 
survival (85%).
When the EF is less than 0.30 it is necessary 
(before refusing operation) to conduct additional 
studies of ventricular function such as biplane 
ventriculography, ventriculography following the 
administration of nitroglycerin, epinephrine or 
after an artificially induced extrasystole. Isotope 
studies may also be considered, as they can 
reveal the presence of viable myocardial cells 
in the hypo- or akinetic segments.
Une mauvaise fraction d'ejection preoperative 
(FE <0.30) augmente un peu le risque immediat 
de la revascularisation myocardique. Ce risque 
peut etre beaucoup diminue par une meilleure 
protection myocardique et une revascularisation 
complete des lesions coronariennes lors de ('in­
tervention. Toutefois, une mauvaise fonction
Apres entente entre les Annales du College royal 
et le Journal canadien de chirurgie il a ete decide 
de publier simultanement les versions franchise et 
anglaise de la conference du College royal pre­
sentee par le docteur Grondin. Le texte frangais 
se trouve dans la livraison d’octobre 1976 des 
Annales.
*From the departments of surgery and radio­
logy, Montreal Heart Institute, Montreal, PQ.
Presented at the annual meeting of the Royal Col­
lege of Physicians and Surgeons of Canada, Quebec 
City, PQ, Jan. 22, 1976. Supported by the
Jean-Louis Levesque Foundation.
Reprint requests to: Dr. Pierre Grondin, Montreal 
Heart Institute, 5000 Belanger St. E, Montreal, 
PQ HIT 1C8.
ventriculaire influence beaucoup la survie a long 
terme des operes surtout lorsque la fraction 
d’ejection est inferieure a 0.30.
Chez les coronariens lorsqu'il y a des indica­
tions cliniques et angiographiques de pontage 
aortocoronarien et que la FE mesuree dans le 
plan oblique anterieur droit est elage ou supe- 
rieure a 0.30, la chirurgie peut leur etre offerte 
avec un risque operatoire acceptable (3.9%) et 
une survie a long terme (4 a 5 ans) satisfaisante 
(85%).
Cependant lorsque la FE est inferieure a 0.30, 
il faut avant de refuser la chirurgie effectuer 
des etudes complementaires de la fonction ven­
triculaire telles la ventriculographie en deux 
plans, la ventriculographie apres administration 
de nitroglycerine, d'epinephrine ou apres une 
extrasystole artificiellement induite. Des etudes 
a I'aide d’isotopes sont aussi a considerer car 
elles peuvent deceler la presence de cellules 
myocardiques viables dans les zones hypo- ou 
akinetiques.
D ir e c t  myocardial revascularization with 
aortocoronary bypass grafts will certainly be 
praised as one of the most spectacular ad­
vances in medicine in the second half of the 
20th century.1 Surgical revascularization 
from its beginning has been submitted to 
rigid critical evaluation, which is an essen­
tial part of all real scientific progress, and 
after 9 years of clinical experience with this 
procedure even the most sceptical recognize 
an enhancement in the quality of life for 
most operated patients.2'4
It was first established that aortocoronary 
grafts were capable of eradicating or alle­
viating angina, the most distressing symptom 
of coronary artery disease. Angiographic 
studies have demonstrated that these con­
duits actually delivered oxygenated blood to 
the myocardium beyond the obstructed 
coronary arteries and that 80% of these 
grafts were patent after 3 years.5 More 
sophisticated studies have permitted meas­
urement of the exact quantity of oxygenated 
blood per minute supplied to the ischemic 
myocardium and have shown a direct rela­
tion between peroperative graft flow, and
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short- and long-term permeability.6’ 7
However, this type of myocardial revas­
cularization, although it can benefit most 
patients with organic coronary artery dis­
ease, has two important limiting factors: a 
poor distal arterial run-off8’ 9 and altered 
left ventricular function.10 With respect to 
the distal arterial bed, it was recognized early 
in the clinical application of aortocoronary 
grafts that the arteriosclerotic lesions were 
located mostly in the proximal third of the 
main coronary branches and that 90% of 
the patients had a distal run-off suitable for 
short- and long-term graft permeability. 
Patients with diffuse distal involvement of 
the coronary arteries are few and frequently 
suffer from other serious illness such as 
diabetes, arterial hypertension, or familial 
or acquired dyslipidemia.
The alteration of left ventricular function 
can follow either ischemic destruction of 
myocardial fibres and their replacement by 
fibrous tissue, ischemic paralysis of viable 
myocardial cells, or a combination of these 
two mechanisms. Deterioration of ventricular 
function is related to coronary arterial 
lesions but, because of the extreme variability 
of the collateral circulation, identical invol­
vement of the coronary arterial tree may 
have varying repercussions on left ventri­
cular function in different patients. There­
fore, in the preoperative evaluation of a 
patient with coronary artery disease, both 
factors should be assessed individually.
In this presentation, we discuss the 
methods of evaluating left ventricular func­
tion and the importance of its alteration on 
the indications for and the results of coro­
nary artery surgery. This study should per­
mit identification of the type of patient 
suitable for myocardial revascularization, 
and at what stage of the disease bypass sur­
gery can be performed. It should also relate 
the risks and benefits of this procedure to 
the different levels of left ventricular dys­
function. In this study, we tried to answer 
three questions. First, what is the influence 
of ventricular function on operative morta­
lity? Second, what is the effect of ventricular 
function on long-term survival in the oper­
ated patients? Third, at what level of altera­
tion does the ejection fraction (EF) become 
significant in its influence on the operative 
risk and long-term survival?
Methods and Patients
Evaluation of Left Ventricular Function:
Ejection Fraction
There are several methods of evaluating 
left ventricular performance in the labora­
tory. The techniques currently used are 
determination of cardiac index, left ventri­
cular end-diastolic pressure and the ejection 
fraction (EF). Most agree that measurement 
of the EF, is, among the easily determinable 
parameters, the most reliable and useful 
method of assessing organic or functional 
alterations in left ventricular contraction.11 
This is the method we have used. The EF 
is obtained from a study of the left ventri­
culogram and is calculated according to the 
following formula:
end-diastolic volume — end systolic volumeEr —------------------ -——----—------ --------------------
end-diastolic volume
Ventriculography is performed using pre­
formed catheters introduced through a per­
cutaneous puncture of the femoral artery. 1 ~  
A Viamonte-Hobbs mechanical injector is 
used to introduce 40 to 60 ml of contrast 
medium (Renografin 76%) at 20 ml/s. The 
ventriculogram is obtained in a right ante­
rior oblique (RAO) plane of 30° at 90 
frames/s using a 15-cm (6-inch) Picker 
image intensifier. With a Tagarno projector 
ventricular contours are drawn on the same 
sheet of paper at the end of systole and of 
diastole and including trabeculations and 
papillary muscles. Ventricular volumes 
(ml/m- of surface area) are obtained ac­
cording to the method of Sandler and 
Dodge.1:1 In our laboratory normal EF is 
0.66 ±  0.15.
Patients
We studied two groups of patients under­
going single or multiple aortocoronary by­
pass grafts. For the sake of simplicity we 
have excluded patients in whom an addi­
tional procedure was performed simultane­
ously (e.g., prosthetic valve replacement, 
resection of a ventricular aneurysm).
Group 1 comprised 191 patients operated 
upon during 1971. In these patients we 
evaluated the influence of preoperative left 
ventricular function first on the operative 
risk and second on survival after 4 to 5 
years. Group 2 comprised 308 patients
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V
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undergoing the same surgical procedure 
during 1974. In this group because of inade­
quate follow-up, only the effect of the EF 
on operative mortality was correlated.
R e su lts
Influence of Left Ventricular Function
on the Operative Mortality
Operative mortality, as defined by the 
American College of Surgeons, is mortality 
occurring within 30 days of the operative 
procedure and relating to it. In group 1 
(1971), 14 of the 191 patients died (oper­
ative mortality, 7.3%). In group 2 (1974) 
only 9 of 308 patients have died (operative 
mortality, 2.9%) (Fig. 1). In group 1, the 
mean EF of the patients who died is not 
statistically different from the EF in those 
who survived (0.51 for the deceased and 
0.55 for the survivors). In group 2, the 
mean EF of the patients who died from the 
procedure is actually slightly greater (0.57) 
than that of the survivors (0.56). If we com­
bine the patients of groups 1 and 2 in whom 
an accurate preoperative EF was obtained, 
the mean EF of the 17 patients who died is 
0.54, while the EF of the 382 survivors is 
0.56. This is not statistically significant.
It is more interesting to study the opera­
tive risk in patients grouped according to 
their level of EF (Table I). When the 
patients are divided according to an 
EF of 0.60 the mortality is 4.2% for 
patients with an EF greater than 0.60 and 
4.3% for patients with a value of less than 
0.60. The same applies to an EF of 0.40: the 
operative mortality of patients with an EF 
greater than 0.40 is 4.1% and for patients 
with a value of less than 0.40 it is 5.5% . 
This difference has no statistical significance. 
However, if we use 0.30 as the dividing 
level, patients having an EF greater than 
0.30 have an operative mortality of 3.9%, 
while patients with an EF less than 0.30 
have a much higher mortality at 15.4%. It 
is permissible then to conclude that as far 
as operative mortality is concerned, the EF 
has no predictive value unless it is less than 
0.30.
There are striking differences in the 
operative risk between patients in group 1 
and those in group 2. Early in the experi­
ence with aortocoronary bypass, the ad-
350 — P atien ts o p erated
308
| 2.9
1974
*.2=5.209
P< 0.025
Fig. lj—Early mortality after aortocoronary 
bypass in groups 1 and 2.
TABLE I.—Predictive Value of P reoperative 
E jection Fraction on Operative M ortality 
(1971 and 1974)
Ejection
fraction
No. of 
patients
No. of 
deaths
Operative
mortality,
07 /0
> 0.60 167 7 4.2
< 0.60 232 10 4.3
> 0.40 363 15 4.1
< 0.40 36 2 5.5
> 0.30 386 15 3.9
<  0.30 13 2 15.4
verse role of poor ventricular function was 
stressed in the literature.14’ 15 This explains 
why we have been rather conservative in 
our surgical indications in patients with poor 
ventricular function, so much so that only 
16 patients in group 1 and 20 in group 2 
with an EF of less than 0.30 underwent 
operation. However, other centres16- 17 con­
test the importance of ventricular function 
on operative mortality. Since 1972 particular 
interest has been paid to methods of myo­
cardial protection during open-heart sur­
gery.18- 19 Like others we have modified our 
methods of perfusion in an attempt to mini­
mize peroperative myocardial bohemia. The 
mean arterial perfusion presst re during by­
pass was increased from 40 to 60, to 80 to 
110 mm Hg while hypothermia previously
4848235353534823535323484823232353484848532323232353232323532348485323232353534848532353
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performed at — 1 to 0°C was lowered to 
— 6 to — 4°C. Periods of aortic cross­
clamping were limited to 15 minutes and 
induced ventricular fibrillation, whose ill 
effects on subendocardial myocardial oxyge­
nation are now better known, was avoided. 
With experience we have achieved more 
complete revascularization of the myocar­
dium by increasing the number of grafts in 
each patient, from 1.5 grafts per patient in 
1971 to 2.8 in 1974. We believe that these 
improvements in surgical technique are 
mainly responsible for the decrease in oper­
ative mortality, from 7.3% in 1971 to 2.9% 
in 1974; this difference has statistical signifi­
cance (P <  0.025). It is of interest that, in 
1974, there were no operative deaths among 
26 patients operated upon with an EF less 
than 0.40.
We do not imply that that the EF has no 
influence on the operative risk but that this 
influence is of little importance. With metic­
ulous surgical technique, especially in regard 
to myocardial protection and complete re­
vascularization, we can offer to patients 
with poor ventricular function a quite ac­
ceptable operative risk. This is in accord­
ance with the recent work of Kay and 
Zubiate20 who, in 1973 and 1974, operated 
upon 59 patients with an EF of less than 
0.30 with only four deaths (operative morta­
lity, /%). However, Kay and Zubiate 
measured the EF of the left ventricle after 
an injection of the dye in the right ventricle, 
which may alter the measurement because 
of a less precise definition of ventricular 
contours.
Influence of Left Ventricular Function
on Long-Term Survival
A precise retrospective evaluation of the 
preoperative systolic EF was possible in only 
151 of the 191 patients in group 1; in 40 no 
exact measurement of the EF was made 
because the angiographic examination was 
done in other centres, or because of 
numerous extrasystoles at the time of the 
ventricular injection, or because of inade­
quacy of the angiograms. Among these 151 
patients, 9 died in the operative period and 
4 died after discharge from obvious non­
cardiac causes such as accidental death (2), 
carcinoma of the lung (1) and carcinoma of 
the digestive tract (1). This left us with 138
patients for the survival study. Among 
them, only 12 died of a cardiac condition 
over a 4- to 5-year period (late mortality, 
8.4%) after an average survival of 48 to 60 
months. In other words, the rate of late 
deaths was 2.1% for each year of follow­
up.
A comparative study of patients who died 
late and of survivors showed that the only 
significant difference between them was their 
preoperative ventricular function as ex­
pressed by the systolic EF. As outlined in 
Table II the mean age is similar in both
TABLE II.—P redictive Value of Preoperative 
E jection F raction on Late Deaths in Group 
1 (138 Patients)
Late Survivors
deaths in 1975
No. (and %) of
patients..................  12 (8.4)
Preoperative EF . . . .  0.45
Age, yr (mean)..........  52
Perfusion temperature,
°C (mean)..............  — 1
No. of grafts (mean). 1.5
NS = not statistically significant.
groups, perfusion techniques were performed 
in the same period and both groups received 
the same number of grafts per patient. How­
ever, the mean EF of patients who died is 
0.45 compared with 0.55 for the survivors 
(P <  0.01).
The role of the preoperative EF on long­
term survival can also be illustrated graph­
ically (Fig. 2).
Fig. 2.—Predictive value of preoperative ejection 
fraction (EF) on long-term survival of 151 patients 
in group 1.
126 (91.6)
0.55 (P < 0.01) 
49.7 (NS)
-  1 (NS)
1.8 (NS)
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Critical Level of the Ejection Fraction
We tried to outline the critical level of the 
EF with respect to its effect on long-term 
survival in our operated patients. We ana­
lyzed survival using three different levels of 
EF.
Ejection fraction of 0.50.—In 99 patients 
with an EF greater than 0.50 the 4- to 5-year 
survival was 94% , but in 39 patients in 
whom the EF was less than 0.50 the survival 
was only 85%. This difference is not statis­
tically significant.
Ejection fraction of 0.35.— Of 128 pa­
tients with a value greater than 0.35, 93% 
survived, while the 4- to 5-year survival in 10 
patients having a preoperative EF of less 
than 0.35 was only 70%. Statistically this 
difference is of marginal significance. Chi- 
square analysis shows that the P value is 
0.05 < P < 0.10.
Ejection fraction of 0.30.— Of 134 pa­
tient with a value greater than 0.30, 92.5% 
survived, while of 4 patients with an EF of 
less than 0.30 only 50% survived. This dif­
ference, in spite of the small number of pa­
tients is statistically significant (P <  0.025) 
(Fig. 3).
D iscussion
The decision to offer or refuse a patient 
operation is difficult in “marginal” situa­
tions. It is important to know, on the one 
hand, the natural history of the disease and, 
on the other hand, the precise value of the 
parameters used.
It has been learned over the past 10 years 
that the natural history of coronary artery 
disease is greatly influenced by two factors: 
the severity of the coronary lesion and the 
alteration of ventricular function. With 
respect to coronary artery lesions, there is a 
notable difference in the clinical course 
depending upon the involvement of one, 
two or three main trunks. A report of 590 
patients studied angiographically and hemo- 
dynamically, but not operated upon, by the 
Cleveland Clinic group,21 established a 5- 
year mortality of 9 to 35% depending upon 
the involvement of one to three arteries. 
These observations were made for patients 
in whom the EF was normal or near normal 
(i.e., ^  0.50). However, the same study
100 h—
0
92.5%
7.5%
=  Survivors
I Late death patients
EF >0.30 n = 134 EF <0.30 n= 4
x2-  5324 
P< 0.025
Fig. 3.—Predictive value of preoperative EF of 
9.30 on long-term survival of 138 patients in sur­
vival study in group 1.
established that when there is substantial 
alteration of ventricular function (EF < 
0.30) the 5-year mortality reaches 60% 
with involvement of one main artery and 
90% when all three main coronary branches 
are affected. These findings suggest that, 
when ventricular function is altered, coro­
nary artery disease can be compared to 
malignant neoplasms, in which an aggressive 
therapeutic approach is justified.
The same conclusion can be reached by 
comparison of results and survival in pa­
tients receiving conservative treatment and 
surgical treatment.22 Our survival curves at 
the Montreal Heart Institute are similar to 
those of other centres and deserve serious 
consideration (Fig. 4). Survival of our pa­
tients operated upon in 1971 (group 1) is 
85% after 4 to 5 years, with an operative 
mortality of 7.3%. If this initial mortality is 
reduced (as in group 2) to 2.9% , it is logical 
to forecast a 4- to 5-year survival in the 
order of 89%. Comparison of our results 
(patients receiving surgical treatment) with 
those of the Cleveland Clinic (patients re­
ceiving conservative treatment) indicate that 
survival is better for the surgical group 
even though the observation period is rela-
53532300532348530248532348535348530248534853024853485348534853485348535348234823485323485348234848534823
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Fig. 4 .—Survival (%) after coronary artery sur­gery in groups 1 (actual) and 2 (projected).
tively short and even though both medical 
and surgical groups are never entirely 
similar.
Our study demonstrated that when the 
EF is equal to or greater than 0.30, the 
operative risk is acceptable (3.9%) and 4- 
to 5-year survival is satisfactory (92.5%). 
The therapeutic decision becomes more dif­
ficult when the EF is less than 0.30 and 
when clinical and angiographic indications 
for myocardial revascularization persist. 
This situation, however, is rare, because the 
majority of patients with an EF of less than 
0.30 have usually gone beyond the clinical 
indications for bypass in the sense that they 
have little or no anginal pains and that their 
clinical picture is of cardiac failure.
However, such patients, though few, do 
exist and we believe that their ventricular 
function must be studied in more detail 
before operation is refused. Vogel, Cornish 
and McFadden23 established that the EF 
measured simultaneously in RAO and in 
left anterior oblique projection is usually 
10 to 12% greater than the EF measured 
only in the RAO projection. Moreover, when 
conventional ventriculography shows one or 
more akinetic or hypokinetic segments, no 
one can state that these segments represent 
fibrous tissue or relatively normal myocar­
dial fibres impaired in their contraction by 
ischemia. Studies by Bourassa and col­
leagues24 reproducing those done in Bos­
ton,11 Cleveland,4 Milwaukee14 and else­
where have established that, in many cases, 
hypokinesia and even akinesia disappear or 
improve after revascularization.
Recently, several methods have been used 
to identify areas in which myocardial revas­
cularization may improve ventricular func­
tion. These areas have been referred to as 
“the contractile reserve of the myocar­
dium”.2’1 This contractile reserve can be 
evaluated by repeating ventriculography 
after administration of nitroglycerin20 or 
epinephrine27 or after artificial induction of 
extrasystole. This type of evaluation during 
post-extrasystolic ventricular contraction is 
particularly useful.28
It has also been possible, with intravenous 
injection of thallium-20120 or intracoronary 
injection of technetium-99 and iodine-131,30 
to establish that these hypo- or akinetic 
segments do at times contain viable myo­
cardial fibres.
These complementary studies31 are par­
ticularly useful when the EF is around 0.30 
and should be performed before refusing 
operation to a patient still having angio­
graphic and clinical indications for revas­
cularization. Postoperative improvement in 
ventricular contraction can be predicted 
when there is at least a 10% increase of the 
EF after administration of nitroglycerin, 
epinephrine or after an extrasystole.31 The 
value of this prediction can be reinforced if 
perfusion of the ventricular walls with radio­
active substances shows the presence of the 
viable myocardial cells.
Conclusions
A poor preoperative EF increases only 
slightly the immediate surgical risk of myo­
cardial revascularization. This increase in 
surgical risk can be markedly reduced by 
better myocardial protection and more com­
plete correction of the coronary artery 
lesions at the time of operation. However, 
in cases of altered ventricular function 
long-term survival is poor especially when 
the EF is less than 0.30.
In patients with coronary artery disease 
when there are clinical and angiographic 
indications for myocardial revascularization, 
if the EF measured in the RAO projection 
is equal to or greater than 0.30, surgery can 
be offered with an acceptable operative risk 
(3.9%) and an adequate 4- to 5-year sur­vival (85%).
However, when the EF is less than 0.30, 
ventricular function should be evaluated by 
complementary methods such as biplane 
ventriculography, ventriculography after ad­
ministration of nitroglycerin, epinephrine or
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after an artificially induced extrasystole 
before operation is refused. Isotopic studies 
capable of revealing the presence of viable 
myocardial fibres in hypo- or akinetic seg­
ments should also be done.
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THE DONALD BALFOUR LECTURE, 1976 
SURGICAL JUDGEMENT: AN EXAMINATION OF OBJECTIVES
AND LIMITATIONS
SIR RODNEY SMITH, MS, DSc(Hon), PRCS(Eng), FRACS(Hon), 
FRCS(Edin) (Hon), FACS(Hon), FRCS[C] (Hon), FRCSI(Hon)
M r. D e a n , This is not my first visit to 
Canada, but it has been, for me, easily the 
most memorable. I have, in Quebec, just 
been accorded the great distinction of be­
coming a Fellow of the Canadian College. 
Today, I am allowed the privilege of giving 
a Donald Balfour Lecture, a very great 
honour which I accept with gratitude and 
welcome, not only because it gives me much 
personal pleasure to address you, but also 
because it gives us the opportunity, you and 
I, to remember together with affection as 
well as admiration a very great surgeon and 
a very great man.
I recall very well the first occasion on 
which I met Donald Balfour. It was in 1948, 
during my first visit to the North American 
continent, and he showed me great personal 
kindness as well as the wisdom, wit, charm 
and courtesy for which he was so well 
known. Such men are rare. They stick in 
the memory and their sayings, distilled from 
the acquired wisdom and experience of many 
years in this great profession of ours, illu­
minate the studies of those who seek to 
follow in their footsteps.
Some years before that, in the 1930s, as 
a young surgeon at St. Thomas’s Hospital in 
London I was influenced on more than one 
occasion by another memorable surgeon, 
admittedly of a very different pattern, an 
emphatic, extrovert consultant named Philip 
Henry Mitchiner, whose aphorisms were at 
times both pungent and original, and not 
always repeatable. On one occasion, I recall, 
“Mitch” (for so he was known to all) having 
expressed the opinion that an obscure acute 
abdomen was due to nothing more remark­
able than acute appendicitis presenting in 
an unusual manner, proved himself right by 
removing a gangrenous appendix. Later 
Mitch rendered an account, in guineas of 
course, 100 guineas or £105, and the pa-
* Delivered at the Toronto General Hospital, To­
ronto, ON, Jan. 26, 1976.
Reprint requests to: Sir Rodney Smith, 149 Harley 
St., London, W .l, England.
tient’s husband complained to the family 
doctor that this seemed a big fee for an 
operation which had taken only some 10 to 
15 minutes. Mitch’s reply to the embarrassed 
physician was “He has a point. I’ll send him 
another account and only charge him a fiver 
for the operation” and he kept his word. 
The re-worded account read:
“To knowing what to do £100
To doing it £ 5
Total £105 
or, if you prefer it, 100 guineas.”
Knowing what to do!
Surgical judgement. “Mitch” had saved 
this lady’s life not so much by performing 
an operation skilfully as by taking the right 
decision.
Good judgement is easy to recognize 
when a surgeon has it, just as one can easily 
recognize style in a skier, a tennis player, a 
violinist, but try to define either and you 
are at once in difficulties. Good judgement 
is certainly not just something that is ac­
quired solely with advancing years, a syn­
thesis of experience and a retentive memory, 
for we all of us know of junior colleagues 
whose judgement appears impeccable from 
very early on in their surgical careers. What 
is the secret? Part of it lies, of course, in an 
attitude of mind which is always evident 
among good doctors, that of constantly 
thinking about treating patients rather than 
diseases. How, for instance, would you 
answer the question “What’s the best way 
to treat a duodenal ulcer?” other than by 
saying “First tell me about the patient”, for 
who would claim that one would give the 
same opinion in the case of a happily 
married, contented university librarian as one 
would if the patient were a big-business 
tycoon, full of stress, gin and nicotine and 
just embarking on his second divorce. There 
is more to surgical judgement, though, than 
the mere exercise of humanitarian principles 
and most of it rests, not upon some myste­
rious instinctive quality denied to lesser 
mortals but on the conscious application of
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thought and logic and a deliberate assessment 
in each individual case of precise objectives 
and limitations.
In developing this argument, I shall put 
forward certain examples, mainly from upper 
abdominal surgery, in which my own par­
ticular interests lie, but these could equally 
well be culled from patients with urological, 
orthopedic or neurosurgical problems for the 
whole of the human body and all systems 
within it obey the same rules of basic 
science.
Let us take first, as a starting point, the 
problem posed by patients with cancer, a 
major responsibility of all surgeons. When 
a patient with cancer seeks our help, what 
precisely should be our aim? The answer 
“To cure him, of course”, is really 
not likely to get us very far. Let us be 
very basic and very simple about such a 
problem and start by agreeing, as surely we 
must, that all of us are going to die and, 
travelling in the same direction through life, 
each one of us does indeed “nightly pitch his 
moving tent a day’s march nearer home”. 
When a patient has a serious ailment such 
as a cancer and seeks our help what we are 
trying to do, surely, is to see that he does 
not, on this journey, take some short cut 
that he would rather avoid, and also that the 
terrain over which he travels shall be as 
smooth and as agreeable as possible.
Now, no one will deny that in some cases 
of neoplastic disease the patient, after treat­
ment, may live out his normal span without 
recurrence. We should not, however, base 
our treatment on the premise that this is 
probable. The saying is a reasonably apt 
one that “a physician can sometimes parry 
the scythe of death but has no power over 
the sand in the hour-glass” or, if you wish 
to alter this metaphor slightly, we may say 
that where cancer is concerned we can often 
parry the sword-thrust of the adversary but 
seldom disarm him. Let us accept that our 
first objective should be the survival of the 
patient; the aim after that is not immortality 
(either for the patient, or the reputation of 
the surgeon!) but a period of survival which 
he would not otherwise have. Let us call this 
X more years. Our second objective should 
surely be the quality of this survival. If we 
call this Y, then what we hope to offer the 
patient is some factor which we may express 
as X X Y, X being the length of survival
and Y the quality of survival. We would do 
well to remember not only that if the patient 
dies X =  0 and X X Y =  0 but also that 
if, in ridding a patient of his cancer, we 
produce a situation which is physically in­
tolerable then even if X, the length of sur­
vival, is 5 years or 10 years, if Y, the quality 
of survival must be recorded as zero, then 
X X Y =  0 and what we have achieved 
is precisely nil. The often quoted advice of 
the Arabian physician and philosopher, 
Avicenna, is worth remembering: “The cure 
of a disease must never be worse than the 
disease itself.” In many cases, of course, the 
two objectives, to lengthen the period of 
survival of the patient and to give him an 
acceptable quality of survival, do not con­
flict, but in a minority these two aims do 
conflict, and it is unlikely that we can be 
sure of doing our best for a patient unless 
we do sometimes accept that we have to 
face this difficulty.
Consider, for a moment, the patient with 
increasing dysphagia due to a cancer of the 
esophagus. A Japanese surgeon of my ac­
quaintance claims better results from eso­
phageal resection than other surgeons. He 
advocates a two-stage procedure. At the 
first operation the cancer is removed but no 
anastomosis attempted. The patient is left 
with a hole in the neck where the cervical 
esophagus is brought to the surface and a 
hole in the abdomen where he has a gastro­
stomy, through which he is fed and he is 
told “Come back in a year’s time and, if 
you’re not by then dying of a recurrence or 
metastases I ’ll perform the second stage and 
join the ends together for you.” Now, of 
course, those patients who complete the 
course and are finally allowed the privilege 
of an anastomosis are a highly selected 
group in that all patients with the more 
aggressive malignancies are automatically 
excluded and never appear in the final statis­
tics, so it is not difficult to understand the 
good long range results in the ultimate sur­
vivors. Well, every man must decide for 
himself, but I believe that many would share 
with me the opinion that such a program 
concentrates far too much attention upon 
figures which provide comfort for the self- 
regard of the surgeon and far too little upon 
the restoration of comfort to his patients, 
many of whom have not long to live.
Then again, some surgeons are so im-
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pressed with the excellent functional results 
obtained by colonic replacement after eso­
phageal resection, as compared with other 
methods of restoring continuity, and they 
may be right in the basic truth of this, that 
they will happily employ this type of recon­
struction after resection of a cancer even 
though prepared to admit that the incidence 
of relatively minor, but troublesome, com­
plications, such as a temporary fistula, is 
high and that the period in hospital after 
surgery is therefore on the average a good 
deal longer than after other simpler tech­
niques.
My own philosophy is different from 
either of these two examples. I believe that 
the most important limitation in the treat­
ment of a cancer of the esophagus is the 
biologic nature of the tumour. Prognosis is, 
in general, very poor and we are deluding 
ourselves if we pretend that what we are 
really trying to achieve is a high proportion 
of long-term survivors. Our objective, if we 
accept this, becomes clearer. It is to perform 
as simple an operation as possible which will 
restore swallowing to normal and have the 
patient home again as quickly as we can. 
Prolonged survival thereafter is a bonus to 
be accepted with gratitude, but we have no 
right to expect it. In the case of a resectable 
cancer this means, for me, a one-stage oper­
ation of the Ivor Lewis type, though I accept 
that in the hands of the experienced a total 
thoracic esophagectomy as practised by 
McKeown may well slightly improve the 
long-term outlook without adding to the 
operative risk or add to the time in hospital.
Now what of cancer of the pancreas, a 
particular interest of mine, and on the in­
crease at the present time, in Britain cer­
tainly and in some other countries. Some 
surgeons ignore technical difficulties and, 
in the absence of metastases, perform a 
resection whenever possible, even being 
prepared in so doing to resect a segment of 
the portal vein and replace it with a graft. 
Others believe the prognosis in all patients 
with a cancer of this kind to be so poor 
that palliative surgery only should be con­
sidered.
Both, in my view, are wrong. If we 
consider first cancer of the head of the 
pancreas or periampullary region, we must 
remember that we are dealing with a group 
of tumours which, although they have fea­
tures in common, have fundamental biolo­
gical differences. At the most benign end 
of the scale the rare primary carcinoma of 
the duodenum causes obstructive jaundice 
when it involves and occludes the ampulla 
of Vater. Secondly, carcinoma of the am­
pulla of Vater itself often presents as a 
hard scirrhus nodule of tumour replacing 
the ampulla and usually obstructing both 
bile duct and pancreatic duct. This is the 
tumour which on a barium meal will often 
show the typical “reverse three” deformity 
of the duodenal mucosa which is so diag­
nostic. Thirdly, a primary carcinoma of the 
terminal common bile duct in the groove 
between the head of the pancreas and the 
duodenum is far from rare and, fourthly, a 
carcinoma arising in the head of the pan­
creas itself and early obstructing the bile duct 
produces a clinical picture very similar to 
that produced by the other three.
In considering the appropriateness or 
otherwise of performing a radical excision 
for a cancer in this area it is important to 
realize that results depend very much upon 
which of these tumours we are dealing with 
and that this is true not only of the opera­
tive hazard but also of the long-term survival 
rates. First, as regards hazard, the operative 
risk when performing a pancreatoduodenec­
tomy for a carcinoma of the pancreas is 
much higher than the operative risk when 
the tumour is ampullary, duodenal or biliary 
in origin (Table I). Similarly the long-term 
results (Table II) show that if a successful
TABLE I.—P ancreatoduodenectomy: T he
Operative R isk
Location Number Deaths
Mortality
(%)
Head of pancreas. 44 9 20.5
Terminal bile duct 60 5 8.3
Ampulla of Vater. 120 3 2.5
Total............. 224 17 7.6
TABLE II.—Long-Term Survival After
R esection
3-year 5-year
Type of survival survival
tumour rate (%) rate (%)
Carcinoma of head of
pancreas.................... 10 6
Carcinoma of terminal
common bile d u c t... 36 19
Ampullary carcinoma. 50 35
Vk
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pancreatoduodenectomy has been performed 
the expectation of a reasonable long-term 
survival is very much better if the tumour 
has been ampullary rather than pancreatic. 
The combination of a high operative hazard 
with a low expectation of useful survival in 
pancreatic carcinoma has been responsible 
for the suggestion by some surgeons that 
radical pancreatoduodenectomy should be 
reserved for tumours in the periampullary 
region and that carcinoma of the head of the 
pancreas should be treated routinely by a 
palliative operation only, all idea of resection 
being rejected. I have some sympathy with 
this view but there are several arguments 
against it. Firstly, when the abdomen is 
explored in a case of this kind it is not 
always easy to be quite certain what type 
of tumour is present. For instance, it is not 
uncommon for an ampullary tumour, ob­
structing the pancreatic duct as well as the 
bile duct, to produce a zone of obstructive 
pancreatitis which may be mistaken for a 
bulky carcinoma of the head of the pan­
creas itself. Secondly, it is all very well to 
say in an individual case “Let us perform 
a palliative operation,” but if this is our 
declared objective it is clearly necessary to 
define exactly what it is we aim to palliate. 
Jaundice, it is true, and the terrible itching 
that sometimes accompanies it can be re­
lieved with a biliary short-circuiting pro­
cedure and duodenal obstruction by a gas­
trojejunostomy but this takes no account of 
pancreatic pain and I have little doubt that 
if a resectable tumour is not resected, solely 
on the grounds that its classification within 
this group makes a long-term survival un­
likely, a surgeon may later regret this deci­
sion if his patient lives on with severe in­
tractable pain which is difficult or even 
impossible to control by the normal use of 
analgesic drugs. This aspect of the problem 
has, I think, been altered a little by the 
possibility of treating some tumours of this 
kind by means of cytotoxic agents delivered 
via the celiac, artery. This can certainly have 
an important effect upon pain if not upon 
long-term survival. In spite of this, my own 
inclinations at the moment lean towards the 
resection of tumours in this group wherever 
resection is possible without major technical 
difficulty. However, I am far from being 
positive upon this point. Indeed, to be posi­
tive far too often means being mistaken at
the top of one’s voice and I regard this as 
one of the debatable aspects of surgery for 
pancreatic carcinoma. As to the functional 
results of pancreatoduodenectomy, it is 
wrong to believe that problems of pancreatic 
insufficiency, either endocrine or exocrine, 
are common. If as part of the operation the 
pancreatic duct is successfully anastomosed 
to the jejunum steatorrhea does not occur 
and it is a small minority of patients who 
after a pancreatoduodenectomy require pan­
creatic extracts by mouth to control such a 
complication. This, of course, does not apply 
to patients submitted to total pancreatectomy 
to which I would now like to refer.
Total Pancreatectomy
Various surgeons, depressed by the rela­
tively poor results of pancreatoduodenectomy 
in the group we have been discussing, have 
suggested that the results of partial excision 
of an organ containing a cancer ought to be 
improved by substituting total removal, and 
they have developed this thought by suggest­
ing that in cases of cancer of the head of 
the pancreas the operation of total pancrea­
tectomy should be substituted for pancrea­
toduodenectomy. Similar arguments have 
been put forward from time to time suggest­
ing that for cancer of the breast the so- 
called super-radical operation ought to be 
performed and for carcinoma of the sto­
mach, even a limited carcinoma of the 
pylorus, total gastrectomy should be pre­
ferred to a less drastic excision. With regard 
to the pancreas an additional persuasive 
twist is sometimes provided by the observa­
tion that a danger point after a standard 
pancreatoduodenectomy is the pancreato­
jejunal anastomosis and that this is elimin­
ated if total pancreatectomy is performed. 
In my view we should reject any assumption 
based on the premise that the bigger the 
operation for cancer the longer the period 
of survival is likely to be. In fact, as we all 
know, the reverse may be the case. Total 
pancreatectomy as opposed to pancreato­
duodenectomy has a higher mortality rate, 
no higher long-term survival rate and pro­
duces metabolic problems which are no­
where near as simply controlled as some ad­
vocates of this operation would have us 
believe. As to the argument that total pan­
createctomy should be preferred to a stand-
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ard Whipple procedure because it avoids the 
danger of a leaking pancreatojejunal anasto­
mosis, it is my belief that a better solution 
to this problem is to learn how to perform 
a pancreatojejunal anastomosis so that it 
doesn’t leak.
Thus, in my view, in the majority of 
cases of cancer of the pancreas, to be more 
radical means to be less successful in help­
ing the patient.
I would like to talk next about cancer of 
the liver. Few would feel that disseminated 
cancer offers a useful field for excisional 
surgery, though the possibilities of infusion 
with cytotoxic chemicals or arterial ligation 
and of a combination of the two are inter­
esting and, in some ways, encouraging. The 
large, single malignant tumour, however, is 
a different matter. Here there is no doubt 
that for some patients partial resection of the 
liver holds out a genuine chance of survival 
in good health for a number of years and 
therefore becomes a reasonable objective. 
Indeed my old chief, Gordon-Taylor, per­
formed this type of operation on several 
occasions in the 1920s and 1930s. In those 
days, however, the technique of resection 
was comparatively crude. A wedge-shaped 
section of the liver was excised, without 
regard to the detailed anatomy of the organ, 
hemostasis during the operation being con­
trolled by the pressure exerted by the hands 
of the operator and his assistants, and later 
made permanent by a series of large inter­
locking mattress sutures. This technique 
enabled the operation to be completed with­
out killing the patient but was too often 
followed by serious and sometimes fatal 
complications, such as secondary hemor­
rhage, biliary fistula, subphrenic abscess, 
necrosis and anerobic infection of the liver 
and the like. Nowadays partial hepatectomy 
implies an anatomical dissection with due 
regard to the detailed architecture of the 
liver and is a much safer procedure. The 
division of the liver into recognizable seg­
ments and, in particular, the division of the 
liver into two quite distinct right and left 
halves, has been demonstrated for years. 
Indeed the injection-corrosion technique, 
which allows a most beautiful visualization 
of the vascular architecture and biliary sys­
tem in the liver, is based upon work which 
was well known and understood back in the 
days of the Hunter brothers. The demon­
stration of the right and left halves of the 
liver, of course, goes back earlier than that: 
Glisson showed that milk injected up one 
hepatic duct will not come down the other 
hepatic duct, and he deduced from this that 
the duct system in the right half of the liver 
must be separate from that in the left.
Involvement even of the major part of 
the liver in a malignant process can be 
treated by hepatic lobectomy or subtotal 
hepatectomy with profit to the patient. 
Figs. 1 and 2 illustrate this point. I am 
going to interpose a story of Mr. Dickson 
Wright whose name will be known to some 
of you, and indeed this story too for all I 
know. Its relevance will be apparent. It was 
about 1955, I think, that examining in the 
English FRCS he showed a young gentle­
man in his Clinical a patient with a very 
large malignant hepatic mass and said to 
him: “My boy, tell me something about 
hepatectomy”. Playing for time the candidate 
said: “Yes, sir, do you mean partial or 
total?” to which Mr. Dickson Wright instant­
ly replied: “Partial, of course: total is for 
the Mastership examination.” This naturally 
raised a laugh at the time, but Mr. Dickson 
Wright was merely slightly ahead of the 
field. Total removal and replacement of the 
liver at that time was not considered pos­
sible. But, of course, the world is moving 
so fast these days that a'man who says that 
something cannot be done is usually inter­
rupted by somebody doing it. Nowadays, it 
is possible to remove the liver and replace 
it by a liver transplant and I cannot leave 
the subject of cancer of the liver without 
referring to opinions based upon the con­
cept that primary carcinoma in the liver, 
originating in liver cells, bile ducts or the 
supporting stroma, should perhaps be treated 
by total removal of the malignant liver and 
a hepatic transplant.
This belief is, I think, misconceived. Let 
us stick to objectives and limitations. The 
limitation is obvious. A large malignant 
hepatic mass offers only a small chance of 
prolonged survival so the quality of life 
offered is all-important. In the case illus­
trated in Figs. 1 and 2 less than 10% of the 
liver was retained when subtotal resection 
was performed, but from this small fragment 
a new liver regenerated and the patient, a 
small boy, developed normally, went back 
to school and during the period of his sur-
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Fig. 1.—Primary malignant tumour of liver treated by subtotal hepatectomy. (a) Preoperative 
photograph of patient, (b) Six months after operation, (c) Eighteen months after operation.
vival lived a normal life. The point is that 
in this patient with massive involvement of 
the liver, it proved possible to give him not 
only 7 years of life but 6V2 years of good 
health, not a precarious survival on im- 
muran and antibiotics. There are others like 
him. If I have a similar case tomorrow this 
is the type of surgery I would plan for 
my patient.
Let us now leave the complicated sub­
ject of patients who have cancer. The same 
logic applies in making decisions about pa­
tients with much simpler ailments, such as 
gallstones, diverticular disease of the colon 
or an uterine fibroid, yet so many surgeons 
get in an unnecessary tangle in seeking an 
answer to the questions “to operate, or not 
to operate”. I well remember one candidate 
in the final FRCS examination who had 
been very unwilling to offer any positive 
opinion who, when I finally pressed him
“do please at least tell me —  do you advise 
me to operate on this patient or do you 
advise me not to operate on him?” replied 
“Oh sir, to do either would be an imperti­
nence.” Surely if medical treatment is inap­
propriate the objectives of a surgeon are to 
preserve life and eliminate symptoms and the 
limitations are age and the fitness of the 
patient and the operative risk. Let us see 
how we might apply these very simple 
principles to a patient who has, say, gall­
stones. In the case of a patient with cancer, 
far too often we are necessarily confined 
to a consideration of what help can be given 
over a period of a few years, perhaps months 
only. The patient with gallstones is different, 
for surely we are hoping to cure him in the 
sense that we are aiming to leave his ex­
pected life-span unaffected —  but the same 
rules of objectives and limitations apply and 
it is my opinion that if these rules are applied
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Fig. 2.—Primary malignant tumour of liver 
treated by subtotal hepatectomy. (a) Resected liver, 
(b) Cut surface of resected liver, (c) Photomicro­
graph of tumour, a malignant mixed-cell hepatic 
tumour.
with logic one is led inexorably towards an 
active rather than a passive policy in the 
majority of cases.
As regards limitations, these may, firstly, 
be technical, but surely the purely technical 
difficulties associated with surgery for gall­
stones should not loom too large provided
one does not accept avoidable embarrass­
ments, such as may be encountered in at­
tempting to perform a cholecystectomy 1 
week after the onset of an attack of acute 
cholecystitis when an inflammatory mass has 
already formed around the gallbladder. 
Secondly, one is, as always, constrained by 
the age and fitness of each patient, but re­
member that when considering whether or 
not to intervene surgically, one is not com­
paring the hazards of an operation with NIL 
but with the hazards of refusing to operate 
upon the patient. One must plan to accept, 
on behalf of the patient, the lesser of two 
risks, whichever it may be.
Looked at in this light, it becomes easier 
to make up one’s mind about some of the 
commoner debatable issues in the surgery 
of gallstones, such as, for instance, what 
advice to give a fit, middle-aged person with 
asymptomatic stones. The argument that 
many patients in this group will live out 
their normal life span and never have any 
trouble, so that we should advise against 
surgery, is a superficial one. I believe that 
such patients should be advised to undergo 
cholecystectomy, not because the risks of 
trouble without surgery are high; the risks 
in many cases may be small, but not as 
small as the risks of a cholecystectomy.
What of the patient with acute cholecys­
titis? An operation or nonoperative treat­
ment? I believe that unless an inflammatory 
mass around the gallbladder has already 
formed, early operation is advisable, not 
because the risks of conservative treatment 
are high but because they are higher than the 
complications of cholecystectomy. This argu­
ment holds good even if we apply it to the 
older and more seriously ill patients, for not 
only do the risks of an operation rise as we 
consider increasingly aged and increasingly 
ill patients, but the risks of withholding sur­
gery rise still more steeply. In the very aged 
one should beware of advising against an 
operation even if an inflammatory mass can 
already be palpated, but here, as the limita­
tion of technical difficulty rises one should 
not overlook the logic that one’s objective 
may be different from that in the case of a 
younger patient. Here, survival may be the 
sole objective and that is why in the very 
aged a timely cholecystostomy remains in 
some cases a logical operation.
I cannot leave this area of surgery with-
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out a quotation from Lord Moynihan, still 
an appropriate comment today. He said 
“The hazards of surgery for gallstones are 
not to be compared with the hazards of delay 
in surgery for gallstones!”
I shall come back, in a few moments, to 
clinical surgery, but as a short detour, it has 
always seemed to me that the arguments I 
have been asking you to accept apply also to 
some of the ethical problems which abound 
in the context of modern surgical research. 
How much, for instance, should one be 
allowed to improvise and experiment in 
order to acquire knowledge which will help 
one to treat not the patient immediately be­
fore one but future patients? Surely all of 
us have at times been worried by this problem 
in one guise or another. I must admit, my­
self, to being conservative in this area. At 
a moment of decision I do not believe that 
a doctor can treat more than one patient at 
a time and that therefore if one says to one­
self “What is my objective?” it must be “to 
be guided in the treatment of this patient 
solely by knowledge and conscience and 
to place the acquisition of knowledge to the 
advancement of medical science second to 
that and not above it”.
Harmless experimentation, such as let us 
say the taking of blood for chemical analysis 
to acquire knowledge unconnected with the 
treatment of the patient from whom the 
blood is taken, is entirely permissible pro­
vided that where our examination of object­
ives tells me that this is nothing whatever 
to do with the treatment of the patient, we 
tell the patient so and make it clear to him 
that he is the one who is making the contrib­
ution to science and that he could refuse 
to do so if he wished. If in doubt, ask your­
self the questions “Am I doing this for him, 
or is he doing it for me?”
As a final clinical example I would men­
tion the patient with chronic pancreatitis, a 
terrible disease, about which more confused 
nonsense is written than almost any other. 
Yet if we consider objectives and limitations 
it is not all that difficult to make logical 
decisions. What are our objectives? To cure 
it? Surely not. Chronic pancreatitis is in­
curable in the sense that the pancreas how­
ever treated will never return to normal. 
What then? Surely to eliminate unacceptable
symptoms, in particular intractable pain. 
How can we do this? There are only a 
limited number of things we can do to the 
pancreas, excise it or part of it, drain its duct 
system if this is obstructed, combine the 
two in some way, or denervate it, though the 
results of this are unimpressive. A study of 
the pathology present should tell us which 
type of surgery would be the most logical. 
For instance to drain a small, unobstructed 
duct system is unlikely to succeed. The 
limitations are technical difficulties, age and 
physical condition of the patient and, most 
important, the moral and psychological 
robustness of the patient, for whilst an intel­
ligently planned operation may be extremely 
successful in a patient of good moral 
fibre who can and does give up alcohol and 
has resisted hard drugs knowing of the 
danger, a patient whose personality has 
largely disintegrated through the impact of 
alcohol, chronic pain and addiction to nar­
cotics is unlikely to be helped by any treat­
ment, medical or surgical.
Mr. Dean, this lecture appears to have 
travelled in a circle and we have arrived 
back very nearly at our starting point. Thus 
it is that I end as I began by suggesting that 
in assessing objectives and limitations it is 
an unprofitable exercise for a surgeon to 
take important decisions about disease 
without first finding out all he can about 
each individual patient to whom the disease 
is attached. A good understanding of 
pathology is, of course, essential but so also 
is an understanding of the reaction, both 
physical and psychological, of each patient 
to his own illness. The accurate assessment 
of the relative importance of the many 
factors which then have to be taken into 
account is not always easy and the surgeon 
who wishes to become better at this aspect 
of medicine will soon find that to knowledge, 
experience and a good memory must be 
added not only logic but also compassion 
and humanity. All these are compounded 
in that characteristic which allows a surgeon, 
often when faced apparently with inadequate 
information on which to base an important 
decision, to do the right thing more often 
than do his colleagues. We have a name for 
the capacity to do this. It is “Surgical Judge­
ment” —  and this is when we came in.
- J ft
<
J
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NUTRITIONAL MANAGEMENT OF EXTERNAL GASTROINTESTINAL FISTULAS*
MERVYN DEITEL, MD, FRCS[C], FACS, FICSt
From July 1969 to December 1975, 86 patients 
with 100 fistulas required one or a combination 
of three modern nutritional aids: central intra­
venous hyperalimentation; the peripheral intra­
venous, lipid-amino acid-carbohydrate system; 
and elemental, nutritionally complete liquid 
diets. Of the fistulas, 81 closed spontaneously, 
and in 11 operative closure was attempted; 89 
fistulas healed. Eight patients died (9.3%). Before 
1969, in an earlier comparable group of patients 
who had not received such nutrition, the morta­
lity was 40.0%.
Fistula drainage and sepsis were controlled. 
Abscesses were drained. Skin was protected. 
The most successful way of identifying the na­
ture and origin of a fistula was by instillation of 
radiopaque liquid into the external opening. 
Prolonged fistula drainage occurred with distal 
bowel narrowing and inflammation; previous 
irradiation to the area; underlying granulomatous 
bowel disease; bowel adjacent to skin; and 
foreign bodies in the fistulous tract. Operative 
closure (resection) was necessary only for distal 
obstruction and wide breakdown or complete 
disruption of an anastomosis. Patients who did 
require operation were in a better nutritional 
state to withstand operation after receiving spe­
cialized nutritional support. Adequate calories 
and amino acids afforded healing and secretory 
and mechanical rest for the gastrointestinal tract.
Entre juillet 1969 et decembre 1975, 86 patients 
presentant au total 100 fistules ont necessity un 
ou I'association de trois nouveaux modes de re­
alimentation: I’hyperalimentation intraveineuse 
centrale, le systeme lipide-acide amine—glucide 
administre par voie intraveineuse peripherique, 
et les regimes elementaires liquides, nutritive- 
ment complets. Ouatre-vingt-une fistules se sont 
refermees spontanement alors que la refection 
chirurgicaie a ete tentee dans 11 cas; 89 fistules 
ont gueri. Huit patients sont decedes (9.3%). 
Avant 1969, chez un groupe de patients compa-
*From the department of surgery, University of Toronto and St. Joseph’s Hospital, Toronto, ON.
Presented at the annual meeting of the Royal College of Physicians and Surgeons of Canada, Quebec City, PQ, Jan. 21, 1976.
tAssistant professor, department of surgery, Uni­versity of Toronto.
Reprint requests to: Dr. M. Deitel, St. Joseph’s Hospital, 30 The Queensway, Toronto, ON M6R 1B5.
rabies qui n’avaient pas regu un tel apport nutri- 
tif, on avait observe un taux de mortalite de 
40.0%.
L'ecoulement de la fistule et la septicemie 
ont ete controles. Les abces ont ete draines. La 
peau a ete protegee. La fagon la plus efficace 
d’identifier la nature et I'origine d’une fistule a 
consiste a installe un opacifiant liquide dans 
I'ouverture exterieure. Un drainage fistulaire 
prolonge a ete associe au retrecissement et a 
('inflammation de I'extremite distaie de I’intes- 
tin, a I'irradiation prealable de la region affectee, 
a une affection granulomateuse de I’intestin, a 
la proximite de I'intestin avec la peau, et a la 
presence de corps etrangers dans la fistule. La 
fermeture chirurgicaie (resection) a ete neces- 
saire seulement dans les cas d’obstruction dis­
tale ou de rupture etendue ou complete d'une 
anastomose. Les patients qui ont necessity une 
intervention etaient en meilleur etat nutritif pour 
supporter I’operation apres avoir regu une reali­
mentation specialisee. Un apport adequat en ca­
lories et en acides amines a permis la guerison 
et procure un repos des fonctions mecaniques 
et secretaires du tractus gastro-intestinal.
I n  July 1969, St. Joseph’s Hospital, Toronto, 
introduced a program of specialized nutri­
tional support for patients with major cli­
nical nutritional problems; in 19.3% the 
indication was external gastrointestinal fis­
tula. This paper describes the methods of 
nutrition used and the results obtained from 
a prospective study of patients with external 
gastrointestinal fistula and from a retro­
spective study designed to compare these 
patients and patients treated with routine 
intravenous fluids or oral diet, or both, before July 1969.
Patients and Methods
Specialized Nutritional Support
Since July 1969, 86 patients had 100 
external fistulas requiring one or a com­
bination of three modem nutritional aids; 
central intravenous hyperalimentation was 
used in 81 patients (followed by the other 
methods in 43 patients), the peripheral lipid 
system was used in 14 patients, and ele­
mental diets were used in 40 patients (following the other methods in 38).
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TABLE I.—F eatures of the T hree M ethods of 
Specialized N utrition
Central intravenous hyperalimentation 
Advantages:
Safe with an organized skilled approach9' 15 
Disadvantages:
Problems of insertion and prolonged maintenance 
of aseptic central venous catheter5- 9 
Possible development of hyperosmolality6' 8
Lipid system 
Advantages:
M ay be given peripherally —  no significant peri­
pheral phlebitis
Avoids hazards of caval catheters 
Safe —  requires no special technique 
Isotonic — cannot cause hypertonic complications 
No side effects noted 
Disadvantages:
Changing flow rates must be regulated13 
Restricted forearm movement
Elemental diets 
Advantages:
Patients will adjust to preferred flavours 
Allows intravenous hyperalimentation to be 
stopped earlier1' 14 
Disadvantages:
Often unpalatable even with flavouring14 
When given by fine nasogastric tube, could as­
pirate unless head of bed elevated 
Diarrhea if given too quickly 
Hypertonic dehydration if not enough water 
given
Less effective in high small-bowel fistulas1' 16
Intravenous hyperalimentation.— Patients 
treated by intravenous hyperalimentation1' 5 
received 2000 to 3000 nonprotein Cal/d 
plus 100 to 150 g of amino acids, infused 
continuously through a catheter inserted cen­
trally by subclavicular subclavian puncture. 
A small constant infusion pump gave a flow 
rate of glucose of about 500 mg/min.6-8 
Strict aseptic protocol was maintained.!) 
Serum electrolytes, blood urea nitrogen and 
blood sugar concentrations were monitored. 
Patients also received 10% soybean oil 
emulsion (Intralipid) (500 ml) by peripheral 
vein two or three times a week to supply 
essential fatty acids.10"12
Lipid system .—Patients treated by the 
lipid system13 received a simultaneous in­
fusion of Intralipid (3 g/kg body weight) 
and 3.5% synthetic amino acids (Vamin) 
in 5% glucose or fructose, through separate 
intravenous lines, with both lines united 
terminally by a Y-connector to a steel needle 
in a peripheral vein. The iso-osmolal soybean 
oil emulsion (pH, 7.4) prevented peripheral 
phlebitis. Electrolytes, vitamins and heparin 
were added to the amino acid-carbohydrate 
solution. This method supplied more than
2000 nonprotein Cal/d (17% carbohy­
drate) and 125 to 150 g of amino acids 
daily.
Elemental diets.—These are nutritionally 
complete, predigested bulk-free liquid diets 
containing simple sugars and balanced amino 
acids, and stimulate no substantial secretion 
of digestive enzymes.14 When flavours were 
accepted orally, which occurred in over 
90% of patients with the aid of a taste 
panel,14 the diet was taken as frequent sips 
to prevent abdominal cramps and diarrhea. 
Otherwise, the diet was administered through 
a no. 8 nasogastric tube with a constant 
pump;7 the head of the bed was elevated 
to avoid aspiration. (Occasionally the diet 
was given through a gastrostomy or jejuno- 
stomy tube.)
Table I 1- 5- 6’ 8- 9- 13-16 outlines advan­
tages and disadvantages of each of the three 
methods.
S t u d y  G r o u p s
The patients were divided into two groups. 
Group 1 comprised 30 patients with 32 
major fistulas who were treated from July 
1965 to June 1969, before specialized 
nutritional support was introduced. They 
were studied retrospectively. Only fistulas 
that had been recorded under “Diagnosis”, 
“Operation” or “Complications” on the pa­
tient’s discharge sheet were included.
Group 2 (in the period from July 1969 
to December 1975) consisted of 86 patients 
with 100 external gastrointestinal fistulas 
who required specialized nutritional support.
TABLE II.—Sites of Origin of F istulas
Site of fistula
Patient group
1* 2*
(» =  30) (n  =  86)
Esophageal and eso­
phagogastric ............... 7 10
Gastric.............................. 1 5
Gastroduodenal............. — 2
Gastrojejunal................. — 5
Duodenal......................... 3 11
Pancreatic....................... 1 10
Biliary.............................. 1 4
Jejunal.............................. 5 11
"Ileal.................................. 7 9
Ileocolic and cecal......... — 13
Colonic and colorectal.. 7 17
Rectovaginal.................. — 3
T otal........................ 32 100
*Group 1, July 1965 to June 1969; group 2, July 1969 
to December 1975.
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TABLE III.—Results of T reatment TABLE IV.—Major Causes of F istula
Patient group
(n =  30) (»  =  86)
No. of fistulas................ 32 100
Spontaneous closure 
No. of fistulas/no. of 
patients.................... 11/11 81/71*
% of fistulas.............. 34.4 81.0
Attempted operative 
closure
No. of fistulas/no. of 
patients..................... 10/9 11/9
% of fistulas.............. 31.3 11.0
Successful operative 
closure
No. of fistulas/no. of 
patients.................... 8/7 8/7
Overall successful 
closure
No. of fistulas/no. of 
patients.................... 19/18 89/78
% of fistulas.............. 59.4 89.0
Average duration of 
treatment in « 
survivors (d).............. 79.8 39.1
Mortality
No. of patients.......... 12 8
% ................................. 40.0 9.3
*In 2 patients, spontaneous closure of jejunal fistulas 
occurred after more than 200 days.
This group, studied prospectively, included 
18 patients transferred from other hospitals 
for treatment of postoperative fistulas.
Sites of origin of fistulas (Table II) were 
comparable in both groups. In group 1, there 
were 16 males and 14 females, aged 29 to 
89 years (mean, 54 yr). In group 2, there 
were 51 males and 35 females, aged 6 to 
88 years (mean, 54 yr).
R esults
The results are set forth in Table III. The 
average duration of treatment in survivors 
decreased by 50% from 79.8 days in group 
1 to 39.1 days in group 2. Furthermore, 
with improved infusates (crystalline, bal­
anced amino acids; addition of lipid; formul­
ation of trace element additives) the duration 
of treatment decreased during the study 
years of group 2. The mortality also de­
creased between 1969 and 1975.
Fistulas occurred most often in malnour­
ished patients. There was more than one 
cause in each patient, but the major cause 
is set out in Table IV. It is interesting that
Cause No. of fistulas
Suture-line breakdown.............  42
Trauma during operation........  14
Abscess and infection...............  15
Abdominal trauma.................... 9
Inflammatory bowel disease... 5
Previous irradiation.................. 4
Miscellaneous............................. 11
100
56% directly resulted from an operation — 
42% were due to suture-line breakdown 
and 14% followed trauma at operation, 
usually lysis of adhesions.
Factors that contributed to prolonged fis­
tula drainage were: (a) narrowing, irritabili­
ty, inflammation or abscess involving bowel 
distal to the fistula; (b) previous irradiation 
to the area; (c) underlying granulomatous 
bowel disease; (d) bowel immediately ad­
jacent to skin with a very short fistulous 
tract; (e) metallic mercury (from a ruptured 
balloon of a long intestinal tube) in the fis­
tulous tract; and (f) reactive foreign bodies, 
such as buried heavy silk sutures.
Fistulas could be demonstrated by methy­
lene blue swallow, upper gastrointestinal 
radiographs or by radiographs with enema- 
liquid contrast medium. The most successful 
way of identifying the nature and origin of 
the fistula was by installation of radiopaque 
liquid down a tube in the external opening.
Our only indications for surgical inter­
vention (i.e., resection of the involved bowel 
with anastomosis if possible) were distal 
bowel obstruction or wide breakdown or 
complete disruption of an anastomosis. 
Prolonged fistula drainage was not an indica­
tion for operation, as demonstrated by the 
two patients in group 2, in whom jejunal 
fistulas closed spontaneously after more 
than 200 days; their intra-abdominal con­
dition was such that operation would surely 
have resulted in death; today these patients 
are alive and well.
Discussion
Comparison with previous reports in the 
literature (Table V 17'22) shows a decrease 
in the mortality of 39 to 45% before the use 
of these nutritional aids17'20 to 28% with 
elemental diets21 and 6.45% with intra­
venous hyperalimentation.22 Our series
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TABLE V.—Mortality in Published Series
Authors
Dates 
of study
No. of 
fistulas
Mortality,
%
Edmunds, Williams and Welch (I960)17....................... ..........  1946 - 59 157 44
Chapman, Foran and Dunphy (1964)18........................ ..........  1953 - 63 56 45
Halversen, Hogle and Richards (1969)19...................... ..........  1945 - 69 55 40
Lorenzo and Beal (1969)20.............................................. ..........  1959 - 68 18 39
Voitk and associates (1973)21......................................... ..........  Not stated 36 28
MacFayden, Dudrick and Ruberg (1973)22 ................. ..........  1970 - 72 78 6.45
Deitel (present series)...................................................... ..........  1965 - 69 32 40
1969 - 75 100 9.3
likewise showed a similar decrease from 
40% to 9.3% .
Although we emphasize the importance 
of nutrition, fistula drainage and pooling 
(and thus digestion of the tract and skin) 
were controlled effectively by suction cathe­
ters. With heavy secretions, a single lumen 
tube or a sump tube was attached to an 
Emerson or Stedman pump. When drainage 
was small, intermittent Gomco sucdon was 
adequate. The tubes, which were often 
multi-eyed, were changed as frequently as 
necessary. As a well-defined tract formed 
about the tube, the tube was pulled back so 
that the tip would not impinge on the bowel 
and prevent the fistula from closing, and a 
narrower tube was inserted.
For lesser drainage, an ileostomy bag was 
applied. Occasionally, patients were placed 
prone on a Stryker bed or split mattress. 
Skin was protected with karya gum powder, 
karya and glycerin, aluminum paste, tinc­
ture of benzoin, heat lamps or cod liver o il-  
zinc oxide (Desitin) cream. In our experi­
ence, liberal amounts of Desitin provided 
the most effective protective barrier.
We controlled generalized sepsis with 
appropriate antibiotics, and drained local 
abscesses. The debilitated patients were 
placed on pulsating air mattresses to avoid 
decubitus ulcers and were mobilized as much 
as possible to promote anabolism. Large 
granulating wound defects were managed by 
porcine graft or amniotic membrane dress­
ings,23 and ultimately with split-thickness 
skin grafts.
Most fistulas were treated initially with 
central intravenous hyperalimentation, while 
electrolyte and fluid balance were restored. 
By adding water to the hyperalimentation 
solution, adequate fluid replacement was 
achieved.1’ 4 At the same time, adequate 
calories and amino acids for protein syn­
thesis were supplied, while suppression of
gastrointestinal secretions caused a rapid 
decrease in fistula output.22’ 24 29 Meas­
ured fistula output decreased most rapidly 
with intravenous hyperalimentation, and 
was usually less than 50% within 48 hours. 
Those patients who eventually required 
operation were in a better nutritional state 
to withstand the procedure. Catheter sepsis 
(Escherichia coli) developed in only one pa­
tient and from his intra-abdominal E. coli 
abscess; the infection resolved promptly on 
removal of the catheter and drainage of the 
abscess.
Positive nitrogen balance is more evident 
with central intravenous hyperalimentation 
of hypertonic glucose than with the peri­
pheral lipid system.30’ 31 More calories can 
be administered with the hypertonic carbo­
hydrate infusion with less fluid intake and 
less positive water balance. Extensive fistulas 
were controlled most successfully and healed 
most rapidly, at least initially, with central 
intravenous hyperalimentation.
It was our observation that fistulas (espe­
cially proximal and mid-small bowel) healed 
more rapidly with intravenous hyperalimen­
tation than with the elemental diets.1’ 14- 16 
However, many potential dangers of the 
former were avoided by switching to an 
elemental diet when fistulas were almost 
completely healed. When an elemental diet 
was substituted, the fistula sometimes re­
opened, with nonerosive drainage but with 
substantial volume and nutritional loss in 
upper small-bowel fistulas;16 if the elemental 
diet was continued the fistula healed slowly, 
but if intravenous hyperalimentation was 
resumed, drainage ceased immediately and 
the fistula healed. In one patient who 
received an elemental diet through a jejuno- 
stomy tube, marked hyperosmolar dehydra­
tion developed, which responded to adequate 
addition of water and supplemental intra­
venous infusion.14
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Where intravenous hyperalimentation is 
difficult to institute, for example, in patients 
with a tracheostomy or close to a burn scar, 
the peripheral lipid system is advantageous. 
It may also be applied to the confused, fid­
gety patient, who may pull out and infect, 
or break off, a central venous catheter. This 
method may be used without specialized 
care at any hospital and may be set up by 
an intravenous team nurse. However, the 
changing flow rates of the two lines must 
be regulated at intervals, even though the 
system does not require the degree of 
constancy of flow necessary with the hyper­
tonic central system. In our series the lipid 
system was useful in patients who were not 
sufficiently malnourished to require intra­
venous hyperalimentation.
A conventional oral diet increases the 
volume and concentration of digestive exo­
crine pancreatic and gastrointestinal secre­
tions.16’ 24 The erosive enzymes when 
passing outside the bowel through a fistula 
digest the surrounding tissues, including the 
immature collagen that is attempting to heal 
the tract and surrounding skin. Furthermore, 
proteins, especially enzymes, are lost with 
the drainage, which further increases deple­
tion, and food residue may be trapped in 
the fistulous tract. The hospital full-fluid 
diet provokes considerable enzyme secretion 
and yields substantial residue (e.g., we see 
emerging cereal particles and surrounding 
reddened skin, especially with small-bowel 
fistulas) and the usual clear fluid diet (which 
is protein deficient) provides only 826 
kCal/d.32 However, the modern nutritional 
aids used in this series provide secretory and 
mechanical rest for the gastrointestinal tract, 
as well as positive nitrogen balance with 
tissue synthesis and healing.1- 26
Our surgeons have observed that nutri­
tional build-up before major gastrointestinal 
operations has permitted operations to be 
performed on previously unacceptable mal­
nourished candidates. These methods, used 
after multiple, difficult or sometimes unreli­
able anastomoses, to provide bowel rest and 
nutritional support, appear to have pre­
vented fistulas from occurring.
I thank Drs. V. M. Kaminsky, P. Anand and 
C. Degani for assistance with compilation of data 
and care of many of these patients, and the depart­
ments of laboratories and pharmacy for their 
valuable cooperation.
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low-residue elem ental diet
'Flexical' elemental diet is ideally tormulated to provide for 
the pre and post-operative nutritional management of 
patients undergoing bowel surgery.
Clinical investigations1 demonstrated that patients fed 
Flexical four days and received standard cleansing 
procedures prior to colon surgery exhibited a cleaner bowel, 
maintained positive nitrogen balance and lost less weight, 
than those managed on clear fluids alone.
Flexical is ideally formulated to provide pre-digested protein 
of excellent protein quality, MCT* Oil as a fat component 
and balanced vitamin and mineral levels... to help patients 
overcome the trauma of surgery.
Flexical is supplied in powder form and is available in 
four flavors 454 g (1 lb) cans.
Full information, handbooks and educational wall charts are available from your 
M ead Johnson representative.
’Data on file. Medical Department. Mead Johnson Canada 
*T,M. Authorized User
F t - 1003 I PMAC l Unit of Bristol-Myers Pharmaceutical Group Division of Bristol-Myers Canada Limited 
Candiac. Quebec
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THE CHEMICALLY DEFINED DIET AND ANORECTAL PROCEDURES*
PHILIP H. GORDON, MD, FRCS[C]
Current indications for the use of a chemically 
defined diet are constantly expanding. Its use 
is recommended after such procedures as 
sphincteroplasty, postanal repair, skin grafting 
following excision of a neoplasm or hidradenitis 
suppurativa, repair of rectovaginal fistula and 
hemorrhoidectomy. The use of such diets to 
avoid colostomy in special anorectal procedures 
is described.
Les indications actuelles des regimes alimen- 
taires a composition chimiquement definie 
s'etendent continuellement. Leur emploi est 
suggere apres des interventions telles que la 
sphincteroplastie, la refection chirurgicale post- 
anale, la greffe cutanee consecutive a 1’excision 
d’un neoplasme ou d’une hidradenite suppu­
rative necrosante, la refection d'une fistule rec- 
tovaginale et I’hemorroidectomie. On decrit (’uti­
lisation de ces regimes alimentaires dans le but 
d'eviter la colostomie dans certaines interven­
tions ano-rectales.
Since the introduction of hyperalimentation 
(i.e., administration of essential nutrients 
intravenously or orally) the indications for 
its use have expanded greatly. Current indi­
cations for use of a chemically defined diet
*From the department of surgery, Jewish General 
Hospital, Montreal, PQ.
Reprint requests to: Dr. P. H. Gordon, Depart­
ment of surgery, Jewish General Hospital, 3755 
Cote Ste. Catherine, Montreal, PQ H3T 1E2.
are numerous,1'3 including preoperative 
bqyvel preparation, treatment of malabsorp­
tion problems of the short-bowel syndrome, 
postoperative feeding of patients unable to 
tolerate conventional food, management of 
gastrointestinal fistulas, treatment of patients 
with excessive ileostomy drainage and with 
exacerbation of inflammatory bowel disease, 
use in patients receiving chemotherapy and 
radiation therapy and in cases of severe 
trauma.
A  chemically defined diet may also help 
to eliminate bowel movements during the 
healing period in patients undergoing certain 
anorectal operations, as illustrated in this 
paper by two case reports.
The diet used was Flexical (Mead 
Johnson). It is a low-residue complete nutri­
tional food, containing all known essential 
vitamins and minerals. It has been used as 
the sole source of nutrition by patients need­
ing a well-absorbed, low-bulk diet. It may 
be fed either orally or administered by tube. 
The exact composition of the diet has been 
published previously.3
Case Reports
Case 1 .—A 54-year-old woman had increas­
ing perianal irritation associated with rectal 
bleeding. A well-demarcated, erythematous, 
minimally elevated plaque with a scaling sur­
face, extending in a 6-cm radius, affected the 
anus and labia majora. Rectal palpation dis-
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closed a polyp, which was excised; the polyp 
was reported to be a villous adenoma. Biopsy 
of the skin lesion revealed Paget’s disease. 
Further investigations failed to discover any 
underlying carcinoma. After vigorous mech­
anical and antibiotic bowel preparation, the 
lesion was excised and a split-thickness skin 
graft placed circumferentially around the anus. 
Postoperatively the chemically defined diet was 
administered orally at one-quarter strength 
(providing 625 Cal/d) and was gradually in­
creased to full strength (2000 Cal/d). The 
patient also received a binding agent, dipheno­
xylate hydrochloride (Lomotil), and an anal­
gesic (codeine). The skin grafting was entirely 
successful. Nine months later a recurrence of 
the lesion was managed in a similar fashion 
with complete success.
Case 2.—A 58-year-old woman with a his­
tory of five operations for anal incontinence 
was found, through physical examination and 
electromyography, to have severe scarring of a 
quadrant of the sphincter. The rest of the 
sphincter muscle functioned adequately and 
there was no evidence of a primary neurogenic 
deficiency. After vigorous mechanical and 
antibiotic bowel preparation, a sphincteroplasty 
was performed. Postoperatively the patient 
received Flexical as in Case 1; the diet was 
continued for 23 days, during which time no 
formed stools were passed except for a pellet 
that escaped in the sitz bath on three occa­
sions. However, the diet was effective in pre­
venting regular bowel movements.
D iscussion
Nutritionists and physiologists have long 
sought to develop a nutritionally complete 
chemically defined diet, composed of known, 
discrete, easily synthesized components, that 
would support normal life while eliminating 
the need for digestion and excretion. In pa­
tients undergoing certain anorectal opera­
tions, when excretion of feces must be avoid­
ed and where a diverting colostomy would 
be considered desirable or even mandatory, 
chemically defined diets may be useful.
Various studies2-4a have established that 
chemically defined diets drastically reduce 
the amount and number of evacuations. For 
example, Winitz and colleagues found that, 
in human volunteers, stool volume and fre­
quency decreased to as little as 50 g q6d. 
Deitel and Syed!) found that stool is eventu­
ally reduced to a tiny, soft (due to lack of 
indigestible residue), dark (due to iron) 
evacuation about once every 6 days.
In addition these diets have demonstrated
their ability to maintain or even greatly im­
prove the nutritional status of patients under 
various circumstances; they may reverse the 
development of cachexia, induce a positive 
nitrogen balance and enable a patient to 
regain lost strength.3- 4- 10' 43
Indications for Possible Use of the
Chemically Defined Diet
The problems concerned with the care 
of the perineum following operative inter­
vention on the perineal skin or the sphincter 
mechanism are well known. In the past a 
diverting colostomy was considered neces­
sary before applying a graft in the perianal 
region, because sepsis might prevent the graft 
from “taking” satisfactorily, or when repair­
ing a sphincter defect, to allow the repair 
sufficient time to heal securely before the 
patient had a bowel movement. In Case 1 
use of a chemically defined diet combined 
with binding agents allowed a totally circum­
ferential perianal skin graft to heal success­
fully.
Parks14 described a procedure for patients 
who have undergone postanal repair, aimed 
at regaining sphincteric control, the result 
of which could be facilitated by the use of a 
chemically defined diet. His repair acts as 
an obstruction to defecation so that strain­
ing in the postoperative period would result 
in tearing of the stitches. To avoid this, one 
can create either a temporary colostomy or 
induce diarrhea with magnesium sulfate to 
avoid straining during evacuation. Parks used 
the latter method; he gave magnesium sul­
fate before the operation and for 12 days 
after. Diarrhea is effective in preventing 
breakdown of the repair, but avoiding mo­
tions altogether by use of a chemically de­
fined diet would decrease the straining fur­
ther, and might produce even better results 
than those reported by Parks.
Squamous-cell carcinomas of the anal 
margin distal to but not involving the den­
tate line are generally treated by wide local 
excision. These areas are often skin grafted 
and once again use of a chemically defined 
diet can allow the graft to heal.
Injury to the anal-sphincter mechanism 
may arise from many causes; the most com­
mon are fistula repairs and obstetrical in­
juries.1,1 For patients who have undergone 
repair, some surgeons15- 16 advise confine­
ment of the bowel action for several days.
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However, this would result in an initial hard 
stool which, when passed, might damage the 
repair. Other surgeons,17- 18 including Haw­
ley (personal communication, 1974), have 
recommended a temporary colostomy.17- 19 
Again, use of a chemically defined diet for 
2 to 3 weeks would obviate the need for 
such a diversion.
For patients with extensive involvement 
by hidradenitis suppurativa of the perianal 
region and buttocks, temporary diverting 
sigmoid colostomy together with radical ex­
cision of all the diseased tissue has been 
recommended.19'- 1 Excision may be fol­
lowed immediately or ofter an interval of 
several days by skin grafting. However, the 
use of a chemically defined diet may avoid 
the need for the diverting colostomy. The 
administration of such a diet may eliminate 
the constant and continued contamination 
with feces, allow some healing and thus de­
lay the need for radical surgery.
After repair of rectovaginal fistulas, 
regardless of the type of procedure, the use 
of a chemically defined diet may decrease 
the chance of a breakdown of the repair.
In patients admitted for hemorrhoidec­
tomy, the low-residue diet has been recom­
mended for preoperative preparation without 
chemical or mechanical assistance.22 A 3- 
day preparation with the low-residue diet 
was considered qualitatively better than 
enemas and cathartics and postoperatively 
the level of discomfort was reduced because 
there was no residue to eliminate. This 
effectively delayed the first bowel movement 
until after some primary tissue repair had 
occurred, resulting in less pain and bleed­
ing. Additionally less time was spent by 
hospital staff in attending patients in pain. 
Low-residue diets for this indication, how­
ever, must await further evaluation.
Constipating drugs were administered to 
our patients, in addition to the chemically 
defined diet, but the indications for their 
use are not quite so clear. Depending on the 
patient’s previous bowel function one might 
determine the actual amount of such medica­
tion to use — in a patient with infrequent 
bowel movement, smaller doses would be 
suggested whereas in patients with frequent 
bowel movements, larger doses might be 
more appropriate.
I thank Mrs. R. Michaels for typing this 
manuscript and Miss T. M. N. Nguyen for her 
help in the administration of the diet.
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D IR E C T IV E S  A U X  C O N T R IB U A N T S
Toute communication initiate doit etre adres- 
see au Coredacteurs, CP 8650, Ottawa, ON 
K1G 0G8 sous la mention: "Le journal cana- 
dien de chirurgie".
Manuscrits. Les texts originaux des articles 
et des autres communications y compris un 
nombre limite de rapports sur des cas spe- 
ciaux doivent etre rediges en double exem- 
plaire, en frangais ou anglais, et accompagnes 
d’une lettre demandant leur publication dans 
le Journal. Veuillez les dactylographier sur une 
seule face d’une feuille normal avec double 
interligne et grandes marges.
Illustrations. Les illustrations telles que des 
photographies d’appareils cliniques, des ra- 
diographies, des photomicrographies, des gra- 
phiques et des digrammes doivent etre four- 
nies sous la forme d’epreuves sur papier glace 
sans montage, les bordures intactes, d’un format 
ne depassant pas 12 x 17 cm. Chaque illustra­
tion doit etre munie d’une legende dactylo- 
graphiee sur une page separee du texte de 
Particle. S’il s’agit d’une photomicrographie, 
expliquez le contraste et l’echelle de Pagran- 
dissement. Les lettres qui servent a identifier 
les elements d’une illustration doivent etre d’u­
ne dimension suffisante afin de demeurer visi­
bles lorsque les necessites de l’impression im- 
posent une reduction de l’image fournie. II 
ne„ a^uf Pas <lu’on puisse identifier un patient 
grace a une illustration a moins qu’il n’y ait 
expressement consenti par ecrit; faute de per­
mission les-traits de sa physionomie doivent 
etre obliteres. Les illustrations en couleur ne 
seront publiees qu’aux frais de leur auteur. 
Si 1 illustration provient d’une autre source que 
celle de 1’auteur, il convient d’obtenir tant de 
P auteur que de l’editeur de l’ouvrage dont elle 
est tiree, 1’autorisation de s’en servir aux fins 
de la publication.
Tables. II faut en les etablissant se conformer 
au format rectangulaire du Journal et les 
rediger sur des feuilles separees du texte, une 
table par feuille.
References. Celles-ci doivent etre citees dans 
le texte au moyen d’un chiffre et groupees 
dans l’ordre a la fin de votre article en vous 
conformant a la maniere de faire adoptee par 
ce Journal. Les references a des periodiques 
doivent etre conformes a celles qu’adopte 
VIndex Medicus.
Un resume qui ne doit pas depasser 125 mots 
doit accompagner chaque article sur une page 
separee.
Une epreuve en placard sera adressee a Tau- 
teur de Particle avant sa parution; on ne peut 
autoriser que de legeres retouches. Ce n’est 
qu’au moment de restituer ces epreuves d’au- 
teur au Journal qu’il y aura lieu de passer 
commande de reimpression.
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A RANDOMIZED CONTROLLED TRIAL OF HOME CARE: 
CLINICAL OUTCOME FOR FIVE SURGICAL PROCEDURES*
LOWELL W. GERSON, PhDf and JOHN F. COLLINS, MB, ChB, FRCP(Edin)*
The clinical function of patients receiving home 
care after five surgical procedures was assessed. 
Hospital patients who normally would have 
received minimal nursing care at the end of 
their hospital stay were randomly assigned to 
an experimental home-care group or a control 
group who were discharged from hospital after 
the normal length of stay. Comparisons of “ un­
toward events” (discomfort, infection, delayed 
healing, or complications) are reported for the 
two groups in five surgical categories (varicose- 
vein stripping, herniorrhaphy, cholecystectomy, 
anal and rectal operations and abdominal hys­
terectomy) where the home-care program oper­
ated efficiently. No apparent differences in the 
rates of untoward events were noted between 
hospital and home-care groups. It is concluded 
that home care should be considered for reasons 
other than clinical function, such as socio­
economic functioning, the wishes of the patient, 
or more efficient use of hospital space.
On a evalue I'etat clinique de patients ayant 
recu des soins a domicile a la suite de cinq 
interventions chirurgicales. Des patients hospi­
talises, qui auraient normalement recu des soins 
infirmiers minimaux a la fin de leur sejour a 
Ihopital, ont ete assignes au hasard a un groupe 
experimental recevant des soins a domicile, ou 
a un groupe temoin qui regut son conge de 
I’hopital apres la duree normale du sejour. Une 
comparaison des “evenements defavorables" 
(inconfort, infection, guerison retardee, ou com­
plications) est presentee pour les deux groupes, 
pour cinq categories chirurgicales (phlebecto- 
mie, herniorrhaphie, cholesystectomie, opera­
tions anales et rectales, et hysterectomie abdo- 
minale) ou le programme de soins a domicile 
s'est avere efficace. Aucune difference appa- 
rente dans le taux d'evenements defavorables 
n'a ete observee entre le groupe hospitalise et
^Supported by National Health Grant 601-21-1, 
Health and Welfare, Canada.
tAssociate professor of medical sociology, depart­
ment of community medicine, Memorial Univer­
sity of Newfoundland, St. John’s, NF; currently, 
associate professor, department of clinical epide­
miology and biostatistics, McMaster University, 
Hamilton, ON.
tMedical director of St. John’s Home Care Pro­
gram, St. John’s, NF.
Reprint requests to: Dr. L.W. Gerson, Depart­
ment of epidemiology and biostatistics, McMaster 
University Medical Centre, 1200 Main St. W, 
Hamilton, ON L8S 4J9.
le groupe de soins a domicile. On conclut que 
les soins a domicile devraient etre retenus pour 
des raisons autres que I'etat clinique du patient, 
telles que le fonctionnement socio-economique, 
les desirs du patient ou une meilleure utilisa­
tion de I'espace hospitalier.
O n e  current aim in health care is to reduce 
the use of the hospital. Home care can 
achieve this. Evaluation of home care gen­
erally considers its economic advantages or 
patient attitudes and satisfaction, but clinical 
dimensions are rarely reported. This paper 
compares the clinical outcome for five sur­
gical procedures in which patients were 
randomly assigned either to remain in hos­
pital the traditional length of time or to 
receive part of their postoperative care at 
home.
The principal question is: Are there dif­
ferences in the incidence of untoward events 
(symptomatic discomfort, infection, delay in 
healing, operative complications) between 
patients transferred to home care and pa­
tients with the same diagnosis who remain 
in hospital for the “normal” time?
To answer this and other questions, three 
active-treatment hospitals in a city of ap­
proximately 100 000 people (metropolitan 
area, 140000) established an experimental 
home-care program. Before the start of the 
program home care was not available in the 
community, and the hospitals were oper­
ating at capacity with lengthy waiting lists.
B ackground and P a r tic ipa tin g
P erso n n el
The home-care program was intended to 
provide a substitute for in-hospital treatment. 
Patients transferred to the program were to 
receive services only for the period in which 
normally they would have been in hospital. 
The following services were provided free 
for home-care patients: home nursing, home 
making, physiotherapy, transportation, 
drugs and medical and surgical supplies. All 
except the last three are typical home-care 
services.
Attending physicians ordered required 
services for patients they transferred to home 
care. Home physiotherapy was provided by
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part-time physiotherapists employed by the 
program. All other services were supplied on 
a contract basis by city agencies. The pro­
gram employed a nurse-coordinator, a part- 
time medical director and a secretary. The 
nurse-coordinator arranged all home-care 
services and monitored continuity of care. 
The medical director was responsible for the 
quality of medical care and evaluation of 
the patient’s physical function at the end 
of the experimental period.
Each of the three participating hospitals 
employed a nurse as liaison officer between 
hospital staff and the program’s nurse-coor­
dinator. Hospital liaison nurses located 
potential study patients (through the ad­
mitting department and ward records), ex­
plained the program to them and obtained 
informed consent. They consulted with 
medical staff to ensure that as many patients 
as possible in the home-care group were dis­
charged to home care at the earliest date.
Before the trial started, medical advisory 
committees in each participating hospital 
were required to endorse the study. Meetings 
were held with various groups of physicians 
to obtain approval of the project in principle 
and individual agreement to participate. The 
medical director described services to be 
provided and identified reasons for selecting 
only certain categories of patients. The ex­
perimental nature of the project was also 
emphasized. Letters were sent to all staff 
members at the three hospitals and presenta­
tions were made at quarterly staff meetings. 
At the end of the contact period, over 95% 
of staff physicians and surgeons at the hos­
pitals agreed to cooperate, some with re­
servation.
M ethods
Determination of Categories
A preliminary study identified the cate­
gories of hospital patients most suited to 
home care. The principal criteria of suitabili­
ty were relatively low levels of technical 
nursing and clinical monitoring during the 
latter part of the hospital stay. MacDonell’s 
“level of care assessment return”,1- - which 
assigns scores (based on time and nursing 
effort required) to each of 55 nursing tasks 
in three areas (clinical monitoring, technical 
nursing and basic nursing), was used to
determine the categories. A group of local 
health experts reviewed the form to decide 
the level of care that could safely be pro­
vided at home. The method of selecting 
diagnostic categories has been reported else­
where^ but is described here briefly.
Each day for 4 months, head nurses on all 
wards, except obstetrics and psychiatry, com­
pleted a return for each patient; 71 041 as­
sessments (i.e., patient days) were completed. 
The average daily total of nursing-care points 
received by patients in each diagnostic 
category was calculated. Profiles of care 
were developed by plotting daily averages of 
care against time spent in hospital. Diagnos­
tic categories in which the median level of 
care for clinical monitoring and technical 
nursing fell below 15 points, at some point 
well in advance of the usual discharge date, 
were selected for the main study. This sur­
vey also enabled us to determine normal 
lengths of hospital stay.
Eligible Patients
Eligibility for inclusion in the program 
was determined by means of the following 
criteria.
1. The patient’s diagnosis had to be one 
of those included in the program.
2. There should be no major secondary 
diagnoses or complications (i.e., ones that 
would extend the length of hospital stay).
3. The patient had to reside in the catch­
ment area served by the program (roughly 
equivalent to the St. John’s metropolitan 
boundary).
4. The patient’s home had to meet mini­
mum standards of safety (heat and hot 
water).
5. The patient had to be willing to 
cooperate in the research program. This 
involved acceptance of (a) random assign­
ment to experimental or control group, (b) 
initial and follow-up interviews and (c) evalu­
ation by the medical director.
Patients who satisfied these criteria were 
placed in the study population and randomly 
assigned on a 2:1 basis to the experimental 
(home care) or control (normal hospital stay) 
groups.
Data Collection
The presence of untoward events was 
determined in two ways. First, the medical
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TABLE I.—Average Length of Postoperative I n-Hospital Care in D ays
Procedure
Group
Varicose-vein
str ip p in g H erniorrh aphy
Chole­
cystectom y
A n a l a n d  rectal 
operations
A b d o m in a l
hysterectom y
1 No. of patients 
Mean stay
15 9 20 15 32
( ±  S D) . . . . 5.1 ±  1.49 4.4 dh 2.24 6.1 ±  2.25 6.5 ±  5.64 7.8 ±  3.67
2 and 3 No. of patients 
Mean stay
24 41 67 24 60
( ±  S D) . . . . 7.6 ±  1.53 7.1 ±  1.98 9.0 ±  4.01 8.1 db 4.09 9.3 ±  4.48
director interviewed each patient shortly 
after termination of home care in the ex­
perimental group and after hospital discharge 
in the control group. Second, 3 weeks after 
discharge, a follow-up assessment, including 
specific questions on symptom occurrence, 
was conducted in the patient’s home by 
trained interviewers. The timing of the 
evaluations was planned to ensure that pa­
tients in both groups would be at the same 
point of convalescence.
M aterial
The Study Population
The experiment lasted 13 months. The 
study population comprised 583 patients 
who fulfilled all requirements for admission 
to the program. Of these patients 399 were 
randomly assigned to the experimental group 
and 184 served as controls. However, some 
patients who were originally assigned to the 
experimental group were not placed on home 
care by their physician. Thus, three rather 
than two groups emerged: the experimental 
group who received home care (group 1), 
the experimental group who were discharged 
without request for home care (group 2) and 
the control group (group 3). No statistically 
significant differences were identified when 
the three groups were compared using the 
usual demographic, social and physical- 
status characteristics.4' 5 The average age 
of the 196 men and 387 women in the study 
was 44 years. The average of 10 years’ 
education is what would be expected for 
these age groups in this setting.
T he Surgical P ro cedures
Eleven surgical and two medical catego­
ries were originally identified as possible 
home-care groups. Home-care patients in 
8 of the 13 categories did not have an ap­
preciably shorter average hospital stay than 
their controls. Here home care was an addi­
tional service. The analysis in this report 
will be restricted to the five surgical pro­
cedures in which home care appeared to 
operate efficiently —  excision and ligation 
of varicose veins, inguinal and femoral her­
niorrhaphy (unobstructed), cholecystectomy, 
surgery for anal and rectal fistula and pilo­
nidal cysts, and abdominal hysterectomy. 
Slightly over half the patients in this study 
had one of the five operations. The mean 
length of stay for these patients is set forth 
in Table I. Control (group 3) and those 
designated experimental but not referred to 
home care (group 2) had the same average 
length of stay and thus are combined in the 
table.
R e su lts
Untoward Postoperative Sequelae
First follow-up interview.—The medical 
director’s assessment of clinical function in 
home-care patients and control patients is 
presented in Table II. (He was not able to 
assess patients who were allocated to home 
care but not receiving service.) The medical 
director was neither a surgeon, nor, in the 
strictest sense, “blind” to the patient’s group 
assignment. Moreover, no strict criteria were 
developed for the definition of an untoward 
event.
Abdominal hysterectomy had the highest 
rate of physician - discovered untoward 
events; the overall infection rate for groups 
1 and 3 was 12.7%. Some complication was 
experienced by 23.6% of patients in both 
groups. Symptomatic discomfort was re­
ported by 16.4%. Delayed healing occurred 
in 9.1% . The location of treatment, home 
or hospital, had no significant effect on the 
rate of events.
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TABLE II.— Frequency of Physician-D iscovered Untoward Events 
for Each Procedure in Groups 1 and 3
Procedure
Varicose-vein
stripping Herniorrhaphy Cholecystectomy
Anal and rectal 
operations
Abdominal
hysterectomy Jk. '
Type of event
Group 1 3
= 15 n = 10
1
n = 9
3
n — 19
1 3 
n = 20 n = 32
1 3 
n = 15 n = 6
1 3 
n = 32 n = 23
Infection........ ............  2 0 0 0 3 2 1 0 2 5 l -
•#
Delay in 
healing........ ...........  0 0 0 0 1 1 0 0 4 1
Complications ............  2 0 0 2 3 6 2 1 7 6 f
Symptomatic 
discomfort.. ...........  2 2 0 0 1 7 3 0 5 4
Herniorrhaphy had the fewest untoward 
events. Only 2 of 19 patients in group 3 
experienced complications. Echeverri and 
colleagues6 reported two complications, one 
each in their experimental and control group, 
in 29 patients who had undergone hernior­
rhaphy. There were no statistically significant 
differences between the groups for any un­
toward events of the five treatment cate­
gories.
Second follow-up interview.—Patients’ 
self-reporting of symptoms in each of the 
five categories under consideration is 
presented in Table III. Interviewers ques­
tioned all patients about the presence of each 
of 15 symptoms. Table III indicates the 
number of patients who responded positively 
to each direct question.
The frequency with which patients re­
ported symptoms on direct enquiry was con-
TABLE III.—Frequency of Interviewer-Discovered Symptoms for Each Procedure 
in Groups 1, 2 and 3
Procedure
V iiricose-vein
stripping H erniorrhaphy Cholecystectomy
A n a l and  rectal 
operations
A bdom inal
hysterectomy
1 2 3 1 2 3 1 2 3 1 2 3 1 2 3
Discharge from 
wound........... 3 3 0 0 i 2 6 14 8 9 4 4* 17 22 16
Pain................... 10 9 7 7 8 11 11 18 20 8 10 3 26 21 12*
Fever................. 0 0 0 0 0 0 1 3 3 1 0 0 6 1 2
Bleeding............ 0 0 0 0 1 0 0 4 2 4 3 3 9 9 4
Nausea/ 
vomiting....... 1 2 2 1 1 1 4 10 8 0 1 0 8 6 5
Trouble 
urinating....... 1 1 1 0 1 1 1 3 1 0 0 0 13 14 10
Constipation/ 
diarrhea........ 2 3 2 2 3 2 8 12 7 1 4 1 13 14 8
Sleeplessness .. . 5 5 2 3 5 4 4 10 i i 6 5 2 14 16 9
Weakness/ 
tiredness........ 10 9 9 5 17 11 14 29 25 6 12 4 27 32 20
Headache/ 
dizziness........ 1 1 5* 2 3 2 4 9 8 1 1 2 12 15 8
Aching............... 9 7 5 4 4 10* i i 17 17 7 12 2 8 12 7
Lack of
appetite........ 0 3 i 0 4 0 6 11 11 0 5* 0 13 13 10
Swelling/
stiffness......... 9 9 7 4 13 9 9 13 13 3 5 1 12 19 11
Discolouration.. 6 7 3 0 1 3 2 2 2 1 1 0 3 4 1
Low spirits....... 2 5 4 2 2 4 8 12 21 3 4 1 18 16 9
*
A  '
*Chi square significant P <  .05.
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siderably higher than rates observed by the 
medical director. However, ranking of un­
toward events for each procedure was 
unchanged; the highest rate in both physician 
and interviewer enquiry was in patients who 
had abdominal hysterectomy, followed by 
cholecystectomy. Rates for anal and rectal 
fistula and varicose-vein stripping were 
similar. Herniorrhaphy had the lowest rate. 
Chi square tests were performed between 
home-care and hospital groups for each 
reported symptom. Seventy tests showed no 
statistically significant difference and five 
were significant at the 5 % level. Five signif­
icant tests of 75 could be expected by chance 
alone. Thus, we could conclude that there 
was no difference among groups with respect 
to self-reported symptoms.
D iscussion
The purpose of this study was to deter­
mine if a group of patients who usually 
receive low levels of nursing care at the end 
of their hospital stay could safely be treated 
at home. The results of the clinical evalua­
tion for five surgical procedures in which 
home care saved hospital days indicated no 
differences between groups in the rates of 
physician- or interviewer-discovered un­
toward events.
The scale of this trial produced problems 
in execution —  half of the patients assigned 
to the experimental group were not referred 
for home-care service. While it would have 
been naive to expect total cooperation, we 
did not anticipate such a large attrition rate. 
This raised a serious question regarding the 
comparability of groups. Although there may 
have been some bias by the attending physi­
cians in deciding who should receive home 
care, when the three groups were compared,
they proved similar. Systematic bias in physi­
cian and surgeon referral patterns should 
have been reflected in the results. One might 
expect that “better risks” would be sent 
home and marginal patients kept in hospital. 
If biased selection was operating, patients in 
group 2 should have had a higher rate of 
untoward events than those in group 1. 
Since they did not and since the two groups 
were essentially similar in demographic 
characteristics, we can conclude that syste­
matic bias was not operating in the attending 
physicians’ selection of patients in the ex­
perimental group for home care.
Because home care offered neither ad­
vantage nor disadvantage, the decision as to 
whether patients should be treated at home 
or in hospital after the five operations under 
study should be made for reasons other than 
clinical function, such as the patients’ phy- 
chosocial functioning, their wishes, or for 
more effective use of scarce hospital 
facilities.
We wish to thank Dr. Eugene Vayda for his 
many helpful comments and suggestions.
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SPONTANEOUS RUPTURE OF LIVER IN PATIENT 
ON ORAL CONTRACEPTIVES*
S. P. DIXIT MB, FRCS(Eng), FRCS[C], FACS, FICS, M. DIETRICH, M D, FRCP[C]t 
and G. M. J. FENTON, MB, ChB
Hemoperitoneum as a result of spontaneous rup­
ture of the liver occurred in a 28-year-old woman 
who had been taking oral contraceptives for 7 
years. The hemorrhage occurred between a 
benign tumour and the liver and was treated by 
left hepatic lobectomy. The pathologic aspects 
of this tumour are discussed and the current 
literature is reviewed. Conservative excision 
compatible with hemostasis is the recommended 
treatment.
Un hemoperitoine consecutif a la rupture spon- 
tanee du foie est survenu chez une femme de 
28 ans qui avait ete sous contraceptifs oraux 
pendant 7 ans. L'hemorragie est apparue entre 
une tumeur benigne et le foie et le traitement a 
consiste a faire une lobectomie hepatique gau­
che. Les aspects pathologiques de cette tumeur 
sont discutes et la litterature la plus recente est 
passee en revue. Le traitement recommande 
consiste a faire une excision conservatrice, com­
patible avec I'hemostase.
Oral contraceptives carry a definite, though 
small, risk to health. Relatively common 
problems include deep venous thrombosis, 
pulmonary embolism and cerebrovascular 
accident. Rare problems relate to impair­
ment of liver function —  jaundice, Budd- 
Chiari syndrome and tumour-like lesions —  
which may result in hemorrhage. One such 
problem is illustrated in the following case 
report.
Case R eport
A 28-year-old woman who had been taking 
oral contraceptives (Oracon, Mead Johnson) 
for 7 years experienced sudden severe pain in 
the left lower thorax. On admission she was 
dyspneic and apprehensive. There were no ab­
dominal complaints. Her pulse was 100 beats/ 
min and regular, blood pressure was 110/70 
mm Hg. Results of examination of chest, 
abdomen and cardiovascular system were
*From the Woodstock General Hospital, Wood- 
stock, ON.
tPresent address: Grace Hospital, Windsor, ON 
N9A 5C6.
Reprint requests to: Dr. S. P. Dixit, Department 
of surgery, Woodstock General Hospital, 270 
Riddell St., Woodstock, ON N4S 6N6.
within normal limits. Her hemoglobin concen­
tration was 14.2 g/dl and the leukocyte count 
was 9.8 x 10!'//. A presumptive diagnosis of 
pulmonary embolism was made. The patient 
was heparinized and treated conservatively. 
Next day a pleural rub was audible on the left 
side and the pain was controlled only by ad­
ministration of meperidine hydrochloride 
(Demerol, 100 mg pm). After 48 hours her 
pulse rate increased to 120/min and systolic 
blood pressure decreased to 60 mm Hg. Her 
hemoglobin concentration had decreased to 
7.8 g/dl and the leukocyte count was 26.5 x 
10!V/. A chest radiograph appeared normal. 
The physical findings comprised peritoneal 
irritation, an epigastric mass (slightly to the 
left), abdominal distension and inaudible 
bowel sounds. The diagnosis was revised to 
hemoperitoneum of nontraumatic origin. Intra­
venous infusion was started and protamine 
sulfate (50 mg) was administered.
At laparotomy 2100 ml of blood was found 
in the peritoneal cavity. A tumour (size, 13 x 
8 x 4  cm) was found on the inferior surface 
of the left lobe of the liver with blood clots in 
the left upper quadrant and some bleeding 
dissection between the normal liver and the 
lesion. The tumour, which was enclosed in a 
yellowish-brown “capsule”, could be separated 
from the liver, but this was followed by more 
bleeding from the raw surface of the liver. 
After ligation of the left hepatic radicles to the 
right of the ligamentum teres and the left 
hepatic vein, a left hepatic lobectomy was per­
formed. Individual bleeding points on the cut 
surface were ligated and a large Hemovac 
suction drain was inserted. During the opera­
tion the patient received blood (3000 ml), 
low-molecular-weight Dextran (500 ml) and 
Ringer’s lactate solution (1000 ml). Postopera- 
tively the patient required 1 unit of blood daily 
for 4 days because of bleeding from the cut 
hepatic surface. A hematoma formed beneath 
the scar; it was aspirated. The patient left 
hospital after 12 days and was advised to dis­
continue the oral contraceptives.
Liver scan subsequently disclosed regenera­
tion of the liver; follow-up liver function tests 
gave normal results.
Histologic features.—The tumour was com­
posed entirely of liver cells, without a capsule; 
it was delimited from the normal liver tissue 
by a layer of liver cells in which there was 
fatty degeneration and complete loss of the
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normal portal area-central vein relationship, 
with no normal bile ducts. Small bile lakes 
were common. The liver cells of the tumour, 
which contained vacuoles, were arranged in 
irregular cords; the sinusoidal architecture was 
difficult to find except at the periphery. Pro­
minent veins and venules were numerous in 
the zone just beneath the liver “capsule”. Ad­
jacent to the lesion but well removed from it 
the portal area and the central lobular area 
were normal architecturally and showed no 
fatty change in the hepatocytes. Bile ducts 
were present in normal numbers and distribu­
tion. No cholestasis was noted and the appear­
ance of the vasculature was unremarkable 
(Figs. 1 and 2).
Staining with trichrome, reticulin and 
periodic acid-Schiff accentuated the lack of 
sinusoidal and normal lobular architecture in 
the tumour, highlighted the zones of necrosis 
with associated hemorrhage and demonstrated 
the lack of glycogen in the tumour (Fig. 3).
D iscussion
Tumour-like malformation of the liver 
may present as (a) a palpable mass in the 
epigastrium or in the right or left hypochon-
Fig. 2.—Central zone of tumour showing marked 
fatty change. No portal vein area-hepatic vein 
architecture is evident. Small bile lake is seen 
(hematoxylin and eosin, x 100).
Fig. 3.—Margin of liver and lesion showing 
recent hemorrhage in lesion and normal adjacent 
liver tissue (period acid-Schiff stain, x 100).
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drium, with or without pain; (b) an inci­
dental finding during cholecystectomy or 
other abdominal procedure on a young 
woman who has been taking ovarian hor­
mones; and (c) hemoperitoneum.
Review of the literature disclosed that 
hepatic lesions are reported in women 
between 22 and 48 years of age taking oral 
contraceptives, or a combination of estrogen 
and progesterone, for 6 months or more. The 
lesion is more common on the right side. 
Two cases of bilateral tumours have been 
reported;1’ 2 in one the lesion from the 
right side was removed, biopsy taken from 
the left-lobe tumour, oral contraceptives dis­
continued and the patient’s progress follow­
ed with liver scans. The lesion regressed 
spontaneously. One third of the patients 
with hemoperitoneum died, compared with 
no deaths in those in whom the tumour was 
resected electively. Patients found to have 
a lesion at the time of another abdominal 
operation were later investigated and oper­
ated upon.
Aids to Diagnosis and Treatment
Lesions of the epigastrium or right or left 
hypochondrium, found during physical 
examination, should be investigated by liver 
scan, hepatic arteriography and estimation 
of a-fetoproteins. Liver function tests are 
seldom helpful. Liver scan may show a 
focal defect, but this does not differentiate 
benign and malignant lesions. If the lesion 
is malignant celiac arteriography will show 
dilated hepatic arteries and typical irregular 
tumour “blush” . Benign lesions usually have 
clearly defined margins with peripheral arte­
rial supply; the arteries run parallel and 
towards the centre.3 There is absence of the 
laking effect and shunting. Portal vein inva­
sion is not seen.
If a tumour is noted at the time of an­
other abdominal operation and no other 
lesion is found in the abdomen, exci- 
sional biopsy of the lesion should be per­
formed, if the patient’s condition allows. If 
the tumour is submitted for frozen section 
the result may be unreliable due to the rarity 
of the lesion. Needle biopsy should be 
avoided if the lesion is obviously vascular.
With respect to hemoperitoneum, the 
most helpful signs are rigidity, guarding, 
hypotension tachycardia, low hemoglobin
concentration and raised leukocyte count 
(>  20.0 x 101'//). A peritoneal tap may be 
helpful.
The treatment in the elective cases should 
be excision of the tumour. Enough blood 
should be available for this procedure. It is 
not necessary to perform a formal lobectomy 
but the lesion must be excised completely.
Pathologic Appearance of Tumour
In all reported cases the gross appear­
ance of the tumour was similar. In size, the 
tumour was 4 to 15 cm in diameter and 
appeared usually on the under surface of the 
liver. The tumour was always encapsulated, 
except at its point of attachment to the liver; 
blood clots were usually found between the 
liver and the lesion. Descriptions of the 
microscopic appearance have varied. Baum 
and associates4 agreed with Edmondson5 
and reported atypical hepatic cells arranged 
in cords, no portal tracts or central veins, 
few biliary ducts and no peliosis hepatis. 
Contostavlos6 reported peliosis hepatis as 
did O’Sullivan and Wilding,7 who stressed 
the vascularity of the lesion. Frederick, 
Howard and Spatola8 described thrombosis 
of the hepatic vein, which is considered one 
of the main features of the lesion. Horvath, 
Kovacs and Ross*' described a tumour com­
posed of well-differentiated hepatoma cells, 
but the outcome of their case is uncertain. 
No reports mentioned fatty change, which 
was the most predominant feature of the 
lesion we describe. In rats, fatty change and 
necrosis have been described after the ad­
ministration of stilbestrol.10 However, our 
patient did not receive stilbestrol at any 
stage.
O’Sullivan and Wilding7 considered the 
lesion to be a hamartoma, whose growth 
was stimulated by the steroid contraceptive. 
Except for one case, the common factor has 
been the ingestion of oral contraceptive for 
6 months to 10 years. The oncogenic po­
tential of estrogens is well known, giving 
rise to clear cell carcinoma of the vagina 
and cervix. Androgenic anabolic steroids are 
associated with hepatocellular carcinoma, 
while the estrogenic steroids stimulate the 
growth of hepatic adenomas. A review of 
the literature on the relation between the 
liver and female sex hormones, especially 
oral contraceptives, makes no mention of
ft
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the development of benign hepatomas.11 It 
is quite possible that the thrombosis, as in 
Budd-Chiari syndrome, is caused by steroids 
acting on a congenital abnormality to pro­
duce the lesion; as thrombosis leads to necro­
sis and fatty change, the tumour separates 
and causes bleeding between itself and the 
liver surface.
If any woman of child-bearing age with 
evidence of spontaneous hemoperitoneum 
has been taking a combination of estrogen 
and progesterone for any reason, the pos­
sibility of spontaneous rupture of the liver 
should be kept in mind. If the hemoperi­
toneum is found to be due to a benign 
tumour the tumour should be excised to­
gether with the smallest amount of normal 
liver tissue necessary to achieve effective 
hemostasis.
We thank Dr. A. Enriquez for preparation 
of the microscopic slides, and Mrs. L. Matthews, 
RN and Mrs. J. M. Hood for their help in the 
preparation of this manuscript.
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ACUTE CARDIAC FAILURE: THE RELATION BETWEEN 
CORONARY FLOW AND CARDIAC FUNCTION*
W J KEON MD FRCS[C], G. C. TAICHMAN, PhD, Y. AKYUREKLI, M D, FRCS[C]
and B. V. KORECKY, MD, PhD
To study the effects of acute coronary hypoten­
sion on the working dog heart in situ, both 
coronary arteries were cannulated and perfused 
with oxygenated blood at controlled pressures 
(40 to 120 mm Hg). At a perfusion pressure of 
120 mm Hg, total coronary artery flow appeared 
to be sufficient (0.95 ±  0.08 ml/min*g) to main­
tain normal cardiac performance for a 2.5-hour 
observation period. During incremental decreases 
in coronary perfusion pressure, significant linear 
correlations were found between coronary flow 
and cardiac index (r =  0.84), left ventricular 
maximum dP/dt (r =  0.83), stroke index (r =  
0.82), stroke work (r =  0.83) and mean arterial 
pressure (r =  0.62). During simulated shock 
conditions (systolic arterial pressure, <  75 mm 
Hg), relative reductions in coronary flow ( —60.9 
±  4.0%) paralleled changes seen in cardiac 
function and persisted for 28 ±  4 min.
Pour etudier les effets de l'hypotension coro- 
narienne aigue sur le coeur de chien in situ, les 
deux coronaires sont cannulees et perfusees 
separement avec du sang oxygene a des niveaux 
de pression controles (40 a 120 mm Hg). A une 
pression de perfusion de 120 mm Hg, le debit 
coronarien total semble suffisant (0.95 —  0.08 
ml/min*g) pour assurer la performance cardia- 
que durant une periode d’observation de 2.5 
heures. La pression de perfusion coronarienne 
est diminuee de fagon progressive et on etablit 
des relations lineaires entre le debit coronarien 
et ['index cardiaque (r =  0.84), la dP/dt maximum 
(r =  0.83), I’index d'ejection systolique (r =  
0.83) et la pression arterielle moyenne (r =  0.62). 
Pendant des conditions de choc simule (pression 
arterielle systolique, <  75 mm Hg), la diminu­
tion relative du debit coronarien ( — 60.9 ±  4.0%) 
a ete suivie des changements de fonction car­
diaque observes et s'est maintenue pendant 
28 ±  4 minutes.
A n  intensive research program has improved 
the management of patients suffering from 
acute myocardial infarction.1 However, sta­
tistical surveys have shown that cardiogenic
*From the University of Ottawa cardiac unit, 
Ottawa Civic Hospital, Ottawa, ON.
Supported by the Ontario Heart Foundation.
Reprint requests to: Dr. W. J. Keon, University 
of Ottawa cardiac unit, Ottawa Civic Hospital, 
1053 Carling Ave., Ottawa, ON K1Y 4E9.
shock complicating one in every six patients 
hospitalized for acute myocardial infarc­
tion-’ 3 is associated with an 80 to 90% 
mortality. Our clinical experience has shown 
that direct revascularization of ischemic 
myocardium will improve prognosis in these 
patients,4'6 but further studies are necessary 
to define the correct timing for this pro­
cedure.
Although the onset of cardiogenic shock 
appears to be directly related to the total 
extent of damaged myocardium, irrespective 
of its temporal occurrence,7 the experi­
mental production of cardiogenic shock has 
been difficult.8 The creation of large areas 
of myocardial injury by various means9' 19 
has only occasionally produced shock-like 
states, variable in extent and duration. In 
the present experiment we have used a 
different approach. In situ working dog 
hearts on total coronary bypass were sub­
jected to controlled levels of coronary hypo­
tension. As a result, systemic hypotensive 
states developed for extended periods of 
time. As a potential experimental shock 
model, the preparation appears to be both 
technically feasible and reasonably repro­
ducible.
M eth o ds
Surgical
Short-term investigations were performed 
on mongrel dogs (weight, 21 to 50 kg). 
Animals were premedicated with atropine 
(4 mg, intramuscularly) and initially anesthe­
tized with Pentothal (20 mg/kg, intravenous­
ly). After tracheal intubation the animals 
were ventilated with a mixture of 70% 
oxygen and 30% nitrous oxide using a 
Harvard volume respirator. For the re­
mainder of the experiment, surgical anes­
thesia was maintained with 0.5 to 1.0% 
halothane.
A thoracotomy was performed through 
the fifth left intercostal space and the peri­
cardial sac was opened to the right of the 
phrenic nerve. The heart was cradled in the 
pericardium by suturing the edges of the 
thoracic wall.
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The three main coronary arteries were 
isolated by blunt dissection. The right coro­
nary artery was dissected close to its origin, 
while the left anterior descending and cir­
cumflex branches were isolated at the 
bifurcation of the left main coronary artery. 
After heparinization (2 mg/kg, intravenous­
ly), all three vessels were cannulated and 
perfused by an extracorporeal circuit. 
Throughout these experiments, pH, Po2 
and PcOm values were periodically measured 
(.Radiometer BMS-3) from the arterialized 
blood of the animal and the extracorporeal 
circuit, and appropriately adjusted by 
changing inspiratory carbon dioxide content 
on the respirator or by the administration of 
0.5% sodium bicarbonate. During these 
experiments, arterial pH values from the 
animal-extracorporeal circuit ranged from 
7.34 to 7.48, Po-j from 90 to 135 mm Hg 
and Pccu from 32 to 49 mm Hg.
Instrumentation
Fig. 1 is a simplified representation of the 
experimental design. Continuous lead II 
electrocardiographic monitoring was used 
to compute heart rate (HR) and served as a 
time reference signal for other measure­
ments. Fluid-filled vascular catheters in con­
junction with Statham transducers (P23Db) 
and Electronics for Medicine amplifiers 
(SGM-2) were used to measure various 
pressures referenced to the level of the right 
atrium. A catheter was introduced into the 
common carotid or the right brachial artery 
to measure arterial pressure (AP) from the 
ascending aorta. From the jugular veins, two 
flow-directed catheters (Edwards, model 
93-118-7F) monitored pressures in the right 
ventricle (RVP) and the pulmonary artery 
(PAP). Mean right and left atrial pres­
sures were measured by water manometry, 
while a Millar catheter-tip manometer 
system passed across the aortic valve meas­
ured left ventricular pressure (LVP). 
The natural frequency responses of 
these systems were as follows: AP, 28 Hz- 
LVP, 20 kHz; PAP, 10.5 Hz; and RVP, 25 
Hz. Mean pressures were achieved either by 
mechanical dampening or electronic filtering. 
A differentiating circuit was applied to the 
left ventricular pressure signal to compute 
the differentiated response (dP/dt).
Aortic root flow velocity was measured
aortic pressure; AF =  aortic root flow; CVP =  
central venous pressure (right atrial); CS =  coro­
nary sinus sample; RVP =  right ventricular 
pressure; LVP =  left ventricular pressure; MF 
=  mural force; LAP =  left atrial pressure; PAP 
=  pulmonary artery pressure; LCAF =  left coro­
nary artery flow; RAF =  right coronary artery 
flow.
by a circumferential Statham flow probe and 
calibrated by simultaneous determination of 
cardiac output via a thermodilution techni­
que in the pulmonary artery. Coronary 
venous samples were collected by catheter- 
izing the coronary sinus. An uncalibrated 
isometric Walton Brodie strain-gauge device 
was sutured onto the anterior left ventricular 
surface to monitor changes in epicardial 
mural force. Signals were either recorded 
directly (Beckman S-l 1 Dynograph) or 
stored on tape (Bell and Howell VR-3200) 
for later processing.
Extracorporeal Circuit
The circuit (Fig. 1) was primed with 
heparinized (3 mg/kg) fresh whole blood 
from donor dogs and 5:1 Hartman’s solu­
tion. During bypass, venous blood was col­
lected from the femoral veins into a reservoir 
whose height regulated the venous pressure. 
This blood was then oxygenated (Po.,, 100
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to 130 mm Hg) and heated to body temper­
ature (37 to 38°C) by an oxygenator (Har­
vey H200). Arterialized blood was returned 
to the animal through the cannulated coro­
nary arteries. The coronary perfusion pres­
sure was controlled by the height of a reser­
voir above the left atrium. Since separate 
right and left coronary reservoirs were used, 
pressures to either vasculatures could be 
altered individually or in unison. The right 
coronary reservoir fed the right coronary 
artery while the left reservoir supplied both 
the circumflex and the left anterior descend­
ing arteries. Flow to each coronary vessel 
was measured by extracorporeal flow probes 
(Biotronex). Tapered catheters (Travenol 
5M0287) were used as coronary cannulas 
whose unimpeded flows were minimally 600 
ml/min.
Experimental Protocol
Initially all animals were allowed to 
stabilize for at least 45 minutes. During this 
period the coronary perfusion pressure was 
maintained at 120 mm Hg. If consistent 
values could not be measured, then addi­
tional time was allotted for stabilization. At 
the end of this period, data were collected 
and used as control values for all subsequent 
maneuvers. In these experiments, the effects 
of coronary hypotension were examined both 
in terms of extent and duration. Hypotension 
was induced by step-wise decrements in the 
height of the coronary reservoirs while values 
were recorded at least 10 minutes after the 
pressure was changed. In order to assess all 
parameters at the peak of the heterometric 
autoregulatory curve (Frank-Starling rela­
tionship), the venous reservoir was adjusted 
during the stabilization period until no fur­
ther increase in mean arterial pressure was 
achieved. Once optimal loading conditions 
were established, no further adjustments 
were made.
R e s u l t s
In these experiments 3 to 6.5 hours were 
required from induction of anesthesia to the 
start of experimental hypotension. In the 
course of cannulating coronary vessels, the 
average ischemic time was 48 ±  17 seconds 
(mean ±  SEM). During these maneuvers 
and the initial perfusion period, systemic 
hypotension was minimized by an arterial
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TABLE I .—H emodynamic D ata (n  =  12)*
Parameter Measurement
Stabilization time (min)............... 68 ±  10
Heart rate (beats/min)................. 131 ±  11
Pressures (mm Hg)
Arterial
Mean.......................................  116 ±  8
Systolic.................................... 127 ± 1 1
Diastolic.................................. 94 ±  10
Right atrial (cm H20 ) ..............  7.1 ±  1.2
Pulmonary arterial (mean). . . .  16.1 ±  1.5
Left atrial (cm H 20 ) ................  18.8 ±  3.9
Left ventricular end-diastolic.. 1.22 ±  2.1
dP/dt, max (mm H g/s)...........  1911 ±  148
Cardiac index (ml/'min-kg).........  151 ±  9
Stroke index (ml/beat-kg)...........  1.12 ±  0.10
Stroke workf (mm Hg/beat-kg). 121 ±  14
Coronary flow, total
(ml/min-g).................................  0.95 ±  0.08
Left, right coronary flow ratio. . . 2.59 ±  0.31
*A11 values (mean ±  SEM) were taken at the end of 
the stabilization period.
(Stroke work = mean arterial pressure x stroke 
index.
support circuit. In addition arrhythmias that 
developed were treated by the administra­
tion of an intravenous 20-mg bolus of lido- 
caine. The stabilization period could not be 
completed in 4 of the 16 animals; we were 
not able to wean them from the arterial 
support. The control hemodynamic values 
of the remaining 12 animals are presented 
in Table I.
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CPP-mmHg 120 100 80 70 60 50 40 40* 40** 
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Fig. 2.—Hemodynamic effects of controlled 
coronary perfusion. Coronary perfusion pressure 
(CPP) was incrementally reduced while AP, LVP, 
derivative of LVP (dP/dt), aortic flow (AoF) and 
coronary blood flow (C B F ) were monitored. All 
records were made 10 minutes after CPP was 
altered. At CPP 40 mm Hg, additional records 
were taken at 20 minutes (*) and 30 minutes (**).
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Fig, 3a
Fig. 3b
Fig. 3.—Coronary pressure-flow relations ex­
pressed as (a) perfusion pressure (hydrostatic 
driving pressure) v. total coronary flow (ml/min) 
and (b) effective perfusion pressure (perfusion 
pressure —  left ventricular end-diastolic pressure) 
v. total coronary flow per gram of heart. In (a) 
open circles and square brackets represent mean 
±  SEM.
In three animals, the effects of prolonged 
coronary perfusion at 120 mm Hg were 
evaluated. Over a 2.5-hour observation 
period, the parameters, with the exception 
of total coronary flow, fluctuated by no more 
than 12% from initial control values. The 
total coronary flow steadily decreased during 
this period; the greatest reduction was 21%.
In the remaining nine animals the coro­
nary perfusion pressure was progressively 
reduced in 10 to 20-mm Hg steps until an 
arterial systolic pressure of 75 mm Hg or 
less was recorded (Fig. 2). In order to satisfy 
this criterion, the coronary perfusion pres­
sure had to be reduced by 59.3 ±  2.6%, 
which in turn caused the total coronary flow 
to decrease by 60.9 ±  4.0% (Figs. 3 and 
4a). Though all hemodynamic parameters 
were measured under optimal loading con­
ditions, the underperfusion of the heart 
limited its performance (Figs. 4b-f). When
A% PERFUSION PRESSURE
-100 -50
A% CARDIAC OUTPUT or INDEX
-100 -50
Fig. 4.—Relative reductions in coronary flow v. 
other hemodynamic parameters. In order to lower 
arterial systolic pressure to 75 mm Hg, a 59.2 ±  
2.6% (mean ±  SEM) reduction in perfusion 
pressure (a) was needed to reduce coronary flow 
by 60.9 ±  4.0% . Consequently cardiac output or 
index (b), maximum dP/dt (c), stroke index (d), 
stroke work (e) and mean arterial pressure (f) 
were reduced by 59.0 ±  5.4%, 52 5 ±  3 3% 
62.0 ±  4.2%, 74.8 ±  3.7% and 37.6 ±  3.7% 
respectively. For control values see Table I.
A
%
 C
O
R
O
N
AR
Y 
FL
O
W
 
A
%
 C
O
R
O
N
AR
Y 
FL
O
W
 
A
%
 C
O
R
O
N
A
R
Y
 F
LO
W
November 1976 THE CANADIAN JOURNAL OF SURGERY 535
A  % STROKE INDEX
-100 -5 0
<
-100 -5 0
ARTERIAL PRESSURE
<z
g8
<
pressure. (In addition, preloading pressures 
such as left ventricular end-diastolic and left atrial pressures increased as the perfu­
sion pressure was reduced.) Other para­meters measured did not significantly corre­
late with coronary flow.
At the final perfusion pressure the effects 
of protracted periods of coronary hypoten­
sion were studied. Consistently, all values 
measured did not change appreciably from 
the start of this period (Fig. 2); in fact, 
fibrillation with subsequent complete cir­
culatory collapse was usually abrupt in on­
set. In seven dogs allowed to die in this 
fashion, the mean survival time at the lowest 
perfusion level was 28 ±  4 minutes. Reper­
fusion at 120 mm Hg perfusion pressure in 
two animals who had sustained 30 minutes 
of severe ischemia resulted in a partial recovery; however, within 2 and 5 minutes, 
respectively, uncontrollable arrhythmias de­veloped.
At the completion of the experiment, hearts were examined macroscopically. In all 
animals studied a large, hemorrhagic, pale 
brown area was found across the wall of the pulmonary conus. Occasionally this area 
encompassed the basal portion of the sep­tum. The rest of the heart had scattered 
perivascular hemorrhages that were more 
prevalent in the hypotensive group than in the three control animals.
D iscussion
analyzed in detail at various hypotensive levels, linear correlations were found to exist (Fig. 5). In descending order of significance, they were cardiac index, maximum dP/dt, 
stroke index, stroke work and mean arterial
In a recent review, Feola and Glick8 
emphasized the problems encountered with 
animal experimentation in the study of car­
diogenic shock. In the majority of reports 
cited, the occurrence of the desired shock­
like state, associated with prolonged severe 
reduction in cardiac output and arterial 
pressure, was unpredictable in only a few 
experiments. In general, the preferred pro­
cedure has been the production of large areas of myocardial damage either by coro­nary artery ligation, 9-12 direct myocardial 
injury,18’ 14 coronary embolization15 17 or 
coronary thrombosis.18- 10 Although these 
insults may be analogous to the clinical events preceding cardiogenic shock, the presence of heterogenous flow patterns20 
and the subsequent development of a mixed population of normal to irreversibly damaged
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Fig. 5c
cells,-1 make precise mechanical, electrical 
and metabolic analysis difficult. This may, 
partly, account for the variable response.
As an alternative approach, the technique 
of separating and controlling the coronary 
vasculature from the rest of the circulation 
may represent a more practical solution.-- 
In the present experiment total coronary 
flow was monitored while the coronary per­
fusion pressure and left ventricular filling 
pressure were arbitrarily set. At a perfusion 
pressure of 120 mm Hg the hemodynamics
TOTAL CORONARY FLOW(ml/min-g)
Fig. 5d
TOTAL CORONARY FLOW(ml/mir>g)
Fig. 5e
Fig. 5.—Relation between total coronary flow 
(ml/min-kg) and various hemodynamic para­
meters: (a) cardiac index; (b) maximum dP/dt; 
(c) stroke index; (d ) stroke work; and (e) mean 
arterial pressure.
appeared to be within normal limits and 
remained so for 2.5 hours of observation. 
With the exception of coronary flow, the 
increased resistance monitored was pro­
bably a result of cellular edema. - :{
In the animals subjected to hypotensive 
coronary perfusion pressures, initial reduc­
tions evoked a mild autoregulatory re­
sponse;-4 however, over most of the range 
of pressures investigated, coronary flow 
became pressure-dependent and decreased 
linearly with the driving pressure. In a recent 
study with a similar preparation, Liedke, 
Hughes and Neely2- showed that when 
coronary flow is reduced, the balance 
between supply and demand can no longer 
be maintained and cardiac performance de­
creases. In the present experiments, signifi­
cant linear correlations were observed 
between coronary flow and the various in­
dices of mechanical cardiac performance. In 
addition, these reductions appeared to be 
equal in magnitude: a 60.9 ±  4.0% reduc-
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tion in coronary flow produced a similar 
reduction in cardiac index, stroke work and 
maximum dP/dt, and the balance was pre­
served. Although clearly detrimental to the 
rest of the animal, the reduction in mecha­
nical function may have certain advantages 
for the ischemic myocardium, and the con­
servation of chemical energy by the reduc­
tion of external work may be important in 
preserving myocardial integrity. In this way 
tissue necrosis may be delayed.23
In attempting to resolve the temporal 
limits and events of this shock-like state, we 
have observed that cardiac function re­
mained unchanged, albeit hypodynamic, for 
28 ± 4 minutes; reperfusion at this point 
appears to indicate the loss of myocardial 
integrity.
As an experimental model of cardiogenic 
shock, the present results indicate that a 
severe hypodynamic state can be achieved 
quickly and repetitively so as to permit the 
study of pathophysiologic and therapeutic 
experiments. In these initial experiments, 
the effects of a uniform reduction in total 
coronary flow was evaluated; however, the 
separate manipulation of individual coronary 
flows can easily be accommodated so as to 
parallel more closely the clinical situation. 
In subsequent studies we hope to examine 
this type of intervention in an effort to re­
solve the extent and temporal limitations 
of acute reductions in myocardial flow and 
to create an animal model to parallel our 
clinical experience with emergency revas­
cularization surgery.4"6
We thank K. Sheldrick and the personnel of 
the department of research, Ottawa Civic Hos­
pital, for their technical assistance.
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SAGITTAL HEMIPATELLECTOMY IN THE TREATMENT OF 
CHONDROMALACIA PATELLAE*
JAMES D. SULLIVAN, MD, FRCS[C]
A study of the preoperative assessment, surgical 
technique and follow-up in 17 surgical procedures 
(16 patients) indicates that sagittal hemipatellec- 
tomy is an acceptable alternative form of sur­
gical treatment in patients with chronic painful 
chondromalacia patellae. The study series com­
prised 16 patients (mean age, 21 years) in whom 
the duration of symptoms averaged 5 years, 2 
months. In all patients the procedure relieved 
the pain and permitted a return to their accus­
tomed work and exercise routine within 3 to 6 
months after operation. The duration of follow­
up is still too short to permit evaluation of 
possible late complications of this procedure.
Une etude de (’evaluation preoperatoire, de la 
technique chirurgicale et de 1'evolution subse- 
quente de 17 interventions chirurgicales prati- 
quees chez 16 patients, indique que I'hemipa- 
tellectomie sagittate est une alternative 
chirurgicale acceptable chez les patients souf- 
frant de chondromalacie douloureuse chronique 
de la rotule. La serie etudiee comprend 16 pa­
tients (age moyen, 21 ans) chez qui la duree 
moyenne des symptomes etait de 5 ans et 2 
mois. Chez tous les patients', ^intervention a 
soulage la douleur et permis un retour a leur 
travail habituel et a leurs exercices courants, 
entre 3 et 6 mois apres I'operation. La duree de 
post-observation est encore trop courte pour 
permettre une evaluation des complications tar- 
dives possibles de cette operation.
T h e  term “chondromalacia patellae” first 
coined by Aleman1 in 1928 remains one of 
the more perplexing conditions for ortho­
pedic surgeons in regard to etiology and 
treatment. T raum a,-0 constitutional fac­
tors7!' and degenerative phenomena1 0-1 
have been suggested as having etiologic im­
portance, and treatments are likewise diver­
sified along either conservative1' 11 or 
surgical lines.5- 12' 15-17 We discuss herein 
certain mechanical and constitutional factors 
of relevance to the condition in young pa­
tients and conclude that sagittal hemipatel- 
lectomy is indicated for those with symp­
toms persisting longer than 18 months.
♦From the division of orthopedic surgery, St. 
Mary’s Hospital, Montreal, PQ.
Reprint requests to: Dr. J.D. Sullivan, Ste. 300, 
5300 Cote des Neiges Rd., Montreal, PQ H3T 1Y3.
Patients and Methods
1 studied the aspects of chondromalacia 
patellae in 16 patients whose ages ranged 
from 15 to 32 years (mean, 21 yr). Three 
patients were male, 13 were female. The 
duration of symptoms ranged from 15 years 
to 18 months (average, 5 yr, 2 mo). Follow­
up after operation ranged from 2 years to 
6 months (average, 1 yr, 2 mo) (Table 1). 
All patients were examined and operated 
upon under the direction of one surgeon. 
Hemipatellectomy was performed on 17 
knees — the left knee in 12 cases, the right 
knee in 5. The medial facet was excised in 
16 cases, the lateral facet in 1.
Preoperative Assessment
Criteria used in the preoperative evalua­
tion included:
1. Parapatellar and retropatellar pain 
usually of at least 18 months’ duration un­
response to conservative treatment — rest, 
analgesics, anti-inflammatory drugs, exer­
cise, change of activity and bracing.
2. Patellas stable to palpation, and 
stable collateral ligaments. Absence of 
marked intra-articular disease documented 
by history, plain roentgenograms and occa­
sionally contrast arthrography.
3. Clinical evidence of irritation along 
the borders of the patella and subjacent 
femoral condyle with similar pain symptoms 
elicited by palpation.
Patients included in the study were 
selected from those with a good history, 
skeletal maturity and a possible successful 
outcome through graded and progressive 
rehabilitation.
Postoperative Assessment
A point system was arbitrarily chosen to 
assess the results. A maximum of 5 points 
was allotted to each case as follows:
2 points if the preoperative movement 
was regained;
1 point if pain had disappeared;
1 point if the patient returned to former 
activities;
1 point if the patient was satisfied with
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TABLE I.—Summary of 16 Patients* Operated on for Sagittal Hemipatellectomy
Range of motion
Symptom Extension Flexion Follow-up
Patient Age Sex
duration,
yr Operationt 3 mo 6 mo 3 mo 6 mo Complication
Point
score
period, 
mo
1 15 M 3 X LMH Full Full 120° Full Occasional 
instability, 
requires brace
4 24
2 32 F 2 a LMH Full Full 110° Full Effusion for 
2 mo
4 24
3 18 F 8 LMH Full Full 60° Full None 5 18
4 15 F 2 LMH/
PTT
Full Full 90° Full Keloid scar 
formation
4 18
5 16 F 2 RMH Full Full 90° Full None 5 18
6 20 M m RLH Full Full 110° Full None 5 18
7 26 F 3 LMH/
LM
Full Full 70° Full None 4 12
8 24 F 4 LMH Full Full 70° Full None 5 12
9 15 F V/2 RMH Full Full 105° Full None 5 12
10 16 F m LMH Full Full 90° Full Superficial
infection
4 12
11 19 F 3 RMH Full Full 90° Full None 5 12
12 32 F 2 LMH Full Full 90° Full None 4 12
13 22 F 5 RMH Full Full 90° Full None 5 12
14 25 F m LMH Full Full 30° Full Extra-articular 
ankylosis re­
quired mani­
pulation
4 12
15 30 F 15 LMH Full Full 90° Full None 4 6
16 21 M IA LMH Full Full 110° Full None 5 6
17 19 F 6A LMH Full Full 90° Full None 4 6
*One of the 16 patients had two separate operative procedures and is listed as patient 5 and patient 10. 
+LMH = left medial hemipatellectomy; PTT = patellar tendon transfer; RMH = right medial hemi­
patellectomy; RLH = right lateral hemipatellectomy; LM = left meniscectomy.
the strength, dependability and appear­
ance of the knee.
If the patient scored 4 or better, the case 
was declared satisfactory, if less than 4, un­
satisfactory. In our series, eight patients 
scored 5 points and nine scored 4 points 
thus placing all patients in the satisfactory 
category.
History and Physical Signs
The pain pattern usually consisted of dis­
comfort around and under the patella, 
present during gentle, moderate, or strenu­
ous exercise when the knee joint was loaded 
in flexion or in full extension with a forceful 
quadriceps contraction. The knee might like­
wise be painful after prolonged exercise or 
even at night in bed. No true locking was 
noted but the patients usually complained 
of momentary “catching” of the patella or 
“giving way” of the knee. Effusions, usually 
small to moderate, were recorded. The lower 
extremities of each patient were examined 
in the standing, squatting, jumping and 
supine positions. With the patient standing, 
attention was directed to the appearance of
the patella (alta, baja or subluxata). A gen­
eral view of femoral or tibial rotation was 
also appreciated as well as the placement 
and contour of the tibial tubercle. Squatting 
or jumping indicated the side, site and timing 
of the pain felt by the patient. Examination 
of the patient in the supine position with the 
knee bent to 20° allowed access to the 
patella and in particular to its medial and 
lateral borders and subjacent femoral con­
dyle. In most instances the patient permitted 
gentle palpation along the borders. Palpa­
tion along the medial border elicited pain 
more often than palpation along the lateral 
side. Pain was elicited from pressure either 
under the patella or from the femoral con­
dylar ridge. The patella felt knobbly. Side- 
to-side patellar movement would likewise 
elicit pain as would downward pressure on 
the superior patellar pole while the patient 
was asked to do a full quadriceps contrac­
tion. When effusions were present the volume 
never exceeded 25 ml. “Tightness factors” 
about the knee according to criteria elabor­
ated by Nicholas7 were sought and success­
fully demonstrated in all but one patient.
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Plain radiographs, done in all cases, in­
cluded anteroposterior, lateral, tangential, 
skyline and tunnel views. No special in­
formation could be obtained from skyline 
views to indicate the degree of patellar 
malalignment or side of patellar cartilage 
disease. Arthrograms were not useful in 
visualizing defects in the patellar cartilage. 
Arthroscopy was not attempted.
Operative Techniques
The patient was anesthetized and a tourni­
quet applied around the thigh. The incision 
(usually medial patellar in this series) was 
made, with care being taken to leave a suit­
able tendinous cuff for reattachment of the 
components of the quadriceps muscle. The 
joint was opened and the findings, closely 
similar in all cases, included the following:
1. A varying amount of lysis of the re­
tropatellar cartilage was noted; the medial 
facets (both superior and inferior) were 
involved most commonly. The degenerative 
findings ranged from superficial fraying 
(area, 0.5 cm) to practically the entire 
medial half of the patella. Areas of cartilage 
softness and thinning could be detected and 
mapped out by introducing the tip of a 21- 
gauge needle into the suspected area under 
direct vision. On occasion, frank ulceration 
with bony eburnation was noted (Fig. 1).
2. Involvement of the subjacent femoral 
condyle (usually medial) with circumscribed 
areas of flattening, thinning and ulceration 
of the articular cartilage and injection of 
synovial vessels with mild to moderate 
pannus formation. In the one case of lateral
Fig. 1.—Preoperative view through medial ar- 
throtomy incision. Note "kissing lesions” involving 
medial patellar surface and underlying continuous 
portion of medial femoral condyle.
involvement (case 6), the findings were prac­
tically identical.
3. Minimal to mild effusion.
4. Intact ligamentous structures and 
menisci (in all but one case).
Once the extent of the lesion was identi­
fied, a sagittal hemipatellectomy was done 
subperiosteally using a reciprocating electric 
saw. The cut edge of the patella did not 
usually bleed, so bone wax was unnecessary. 
The synovium and capsule were closed under 
normal tension. In one patient (case 8), the 
vastus medialis was transferred medially and 
distally because of the high insertion of the 
muscle. The skin was approximated with 
subcuticular stitches and Steri-Strip band­
ages. A cylinder cast was applied in the early 
cases but with experience a modified Jones 
bandage was found to provide adequate 
splinting.
The resected specimen (Fig. 2) was photo­
graphed and sent for microscopic examina­
tion.
Fig. 2.—Resected specimen. Note thinning and 
pitting of medial edge.
R eh a bilitation
Splinting was continued for 5 weeks in the 
plaster cast but for only 2 weeks in the Jones 
bandage. Partial weight bearing was allowed 
with crutches as soon as the patient could 
maintain a strong quadriceps contraction and 
lift the straight knee on command. All pa­
tients were instructed in quadriceps exercises 
postoperatively; this proved useful to the 
rehabilitation process.
After the splinting period, patients were 
instructed in isometric and isotonic exercises 
in flexion and extension of the knee, and 
abduction and adduction of the hip. Partial
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weight bearing with crutches was usually 
continued for 2 to 3 weeks after removal of 
the splint until a normal gait pattern re­
turned and knee flexion progressed beyond 
90°; the crutches were then discarded and 
weight-resisting exercises were begun. These 
were done on a daily routine for 6 weeks, 
then three times daily for a further 6 weeks. 
Control radiographs were obtained in all 
cases including skyline views with the knee 
at 45° of flexion. These revealed that more 
than two thirds of the patella remained and 
kept its normal relationship with the under­
lying femur (Fig. 3).
Exercise Pattern
Twice daily, with weights on the foot 
progressing from 2.25 kg to 11.25 kg, the 
patient carried out a full range of movement 
exercises in extension, flexion, hip abduc­
tion and hip extension (25 times).
R esults
The most striking result noted in all 16 
patients was the absence of pain after oper­
ation and during convalescence, and later 
when preoperative activities that had pro­
duced pain had been resumed. Usually 3 
months after operation at least 90° of knee 
flexion had been regained and at 6 months, 
full range of motion had returned (Table I). 
All patients were able to function at their 
former levels of athletic and nonathletic 
activity. Among the athletic activities that 
could be resumed without pain were volley­
ball, basketball, jogging, highland dancing, 
hockey and skiing.
There were several minor complications. 
Transient patellar instability developed in 
one patient; this cleared up with rest, exer­
cise and temporary use of a patella-holding 
brace. Recurrent effusion in another patient 
required draining on three occasions. A third 
patient had a keloid scar infection and a 
fourth was troubled with a superficial wound 
infection which scarred on healing. Extra- 
articular ankylosis in another patient re­
quired knee manipulation tinder anesthesia 
4 months postoperatively. This procedure 
successfully restored normal movement to 
the knee. Two patients remembered specific 
trauma prior to the onset of symptoms.
Most patients did not believe that the 
appearance of the operated knee was much
Fig. 3.—(Top) Preoperative skyline view show­
ing changes in medial segment of right patella. 
(Bottom) Postoperative view in same patient 
following sagittal hemipatellectomy.
Fig. 4.—(Top) Postoperative view of right knee 
scar in patient standing. (Bottom) Postoperative 
view of scar in patient sitting.
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different from its fellow and were pleased 
with the cosmetic appearance of the scar 
(Fig. 4). Varying degrees of “barometric 
pain” were experienced in most cases in the 
area of surgery; this correlated closely to 
the type of discomfort felt preoperatively. 
Transient numbness over the prepatellar 
area was recorded in all cases.
D iscussion
The difficulty in treating patients with 
chondromalacia patellae effectively stems 
from the problems in providing an accurate 
diagnosis, demonstration of the location and 
construction of the patella and the relatively 
young age group in which the condition 
usually arises. Preoperative assessment is 
critical in all cases, particularly in differen­
tiating chondromalacia and subluxation of 
the patella. In all patients considered for 
hemipa'illectomy, manual subluxation must 
be e juded. Articular cartilagenous lesions 
in r J early stages are not seen on radio­
graphs and furthermore such lesions usually 
have no capacity for healing ad integrum. 
The constant asymmetrical frictional loading 
between opposing surfaces in the patello- 
femoral joint sometimes leads rapidly to a 
nutritional disorder within the cartilage 
matrix; this results in mechanical failure of 
cartilage with loss of elasticity, softening, 
Assuring and occasionally loose-body forma­
tion.18 Moreover, the problem may go even 
deeper than the cartilagenous surface and 
produce permanent changes in the sub­
chondral bone plate.11’ 19'21 Changes also 
occur on the femoral condylar ridges, which 
at times are more obvious than the patellar 
changes.12
In all but one of the patients there were 
signs of a “tight” patellofemoral joint as 
evidenced by limited movements of the 
patella in side-to-side displacement, mild 
fixed flexion of the knee, and little collateral 
ligament or rotational joint laxity. This did 
not, however, always correlate with “tight­
ness” in other areas in the same patient or 
with specific alterations in patellar locations 
(alta or baja). A tight patellofemoral joint 
added to specific and often repeated excur­
sions of the patella, as in squatting and 
jumping, appears to have been responsible 
for increased friction and initiation of pain­
ful symptoms. In such cases, conservative
treatment with quadriceps stretching exercises 
done in the prone position prove useful when 
started early. In the late stages of the disease, 
however, no exercise program appears to be 
of much value.
Outerbridge15 indicated how the increased 
convexity in the shape of the medial femoral 
condyle made it more prone to injury from 
patellar friction. Wiberg,22 using anatomic 
and radiographic methods, demonstrated 
how the medial patellar facet group is loaded 
more forcefully when the knee is flexed 
beyond 90°.
In this series, the medial patellofemoral 
joint was most often involved. The one case 
of lateral joint involvement was in a hockey 
player who had received a sudden direct 
blow to the lateral side of his patella. In 
fact, lateral patellar pain was so uncommon 
that this led me to conclude that in cases 
where it is the presenting complaint, patellar 
subluxation (loose patellofemoral joint) must 
be suspected rather than chondromalacia 
(tight patellofemoral joint).19
Surgical treatment for chondromalacia 
included a soft-tissue procedure to release 
the lateral retinaculum and decompress the 
patellofemoral joint,15 patellar tendon trans­
fer, patellar chondrectomy, patellaplasty,23 
patellectomy5 and excision of the femoral 
condylar ridge.12
Surgical hemipatellectomy for chondro­
malacia patellae was first described by 
Sacks.1'  Ten years later, O’Donoghue10 in 
a series of 60 patients showed good results 
using this procedure in patients suffering 
from a variety of ailments about the knee 
including chondromalacia.
Surgical hemipatellectomy in chondro­
malacia has a number of advantages. A part 
of the joint can be repaired without compro­
mising the whole. By excising the medial or 
lateral patellar facet or facets, the offending 
portion of the patella and friction from the 
femoral condylar ridge are removed; I 
believe that friction arising from the femoral 
condylar ridge is as responsible for the pain­
ful symptoms as the patella itself. Recovery 
is early and in many ways parallels recovery 
from meniscectomy. The scar is cosmetically 
acceptable and the actual surgery is simple, 
requiring a minimum of elaborate equip­
ment.
The procedure is contraindicated in more
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extensive chrondromalacia patellae if either 
a tibial tuberculoplasty (raising the tibial 
tubercle by means of a bone graft) 
or patellectomy can be considered. More­
over, the operation is contraindicated in 
patellar subluxation, collateral ligament laxi­
ty and poorly motivated patients.
It is still too early to predict; the full 
measure of recovery from the painful symp­
toms of chondromalacia offered by sagittal 
hemipatellectomy. Five questions must be 
answered: (a) will circulation to the rest of 
the patella be compromised? (b) will the 
hemipatellectomized patients continue to 
show and produce malacic cartilage? (c) 
will such an operation unfavourably uncover 
the femoral condyle and make it more vul­
nerable to injury? (d) will the general nutri­
tion of the patellofemoral joint be altered? 
and (e) will quadriceps atrophy ultimately 
develop?
Conclusions
This experience led me to draw three 
conclusions:
1. Chondromalacia patellae is an early 
degenerative lesion occurring predominantly 
in the medial portion of the patellofemoral 
joint; it may be progressive and lead to 
chronic symptoms.
2. Certain constitutional and activity 
related factors may be important in the 
cause of this syndrome.
3. Simple ablative surgery in the form 
of a sagittal hemipatellectomy helps to relieve 
chronic suffering.
My sincere thanks to Mrs. J. Champagne and 
Mrs. G. Rice for the preparation of this manu­
script.
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PROSTHETIC REPLACEMENT OF THE ANTERIOR CRUCIATE LIGAMENT IN DOGS*
K. SAIDI, MD, P. BEAUCHAMP, MD and C. A. LAURIN, MD, FRCS[C], FACS
Prosthetic cruciate ligaments are now used clinic­
ally. Long-term results are not yet available and 
for that reason an attempt has been made to 
reproduce the clinical situation in dogs. Post- 
traumatic osteoarthritis was inevitably noted 
following simple excision of the anterior cru­
ciate ligament in a control group of 10 animals. 
Different prosthetic materials were used and 
their breaking point was compared with that of 
normal anterior cruciate ligaments. The longest 
follow-up period was 6 months. Although some 
animals had no clinically demonstrable instabili­
ty, at autopsy all prosthetic ligaments were 
noted to have failed. The degree of post-trauma- 
tic osteoarthritis was directly related to the 
duration of follow-up. The causes of failure of 
the prosthetic ligament do not appear to be 
related to the method of anchorage to bone but 
rather to the type of prosthetic material used. 
Although the tensile strength may occasionally 
have been sufficient, the materials did not have 
the required elastic characteristics to meet the 
physiologic demands of a normal cruciate liga­
ment.
Des ligaments croises artificiels sont mainte- 
nant utilises en clinique. Les resultats a long 
terme ne sont pas encore connus, et pour cette 
raison on a tente de reproduire les memes con­
ditions cliniques chez le chien. Une osteoarthrite 
post-traumatique a ete inevitablement observee 
a la suite de I'excision simple du ligament croise 
anterieur chez un groupe temoin compose de 
10 animaux. Differents materiaux artificiels ont 
ete utilises et leurs points de rupture ont ete 
compares a ceux de ligaments croises ante- 
rieurs normaux. La plus longue periode d'ob- 
servation a ete de 6 mois. Bien que quelques 
animaux n'aient manifesto cliniquement aucun 
signe d'instabilite, on a observe a I’autopsie que 
tous les ligaments articifiels avaient echoues. 
Le degre d'osteorarthrite post-traumatique a ete 
directement relie a la duree de la periode d’ob- 
servation. Les causes de la defaillance des liga­
ments artificiels ne semblent pas etre reliees 
a la methode utilisee pour ancrer le ligament sur 
I'os mais semblent plutot attribuable aux mate­
riaux employes. Bien que la force de tension 
peut, a I'occasion avoir ete suffisante, les mate-
*Sponsored by Medical Research Council of Canada grant MA-1040.
Reprint requests to: Dr. C. A. Laurin, Director and chairman, Orthopedic surgery, University of Montreal, 3875 rue St-Urbain, Montreal, PQ 
H2W 1V1.
riaux ne possedaient pas les caracteristiques 
d'elasticite requises pour rencontrer les besoins 
physiologiques d'un ligament croise normal.
W h e n  Emery and Rostrup1 first reported 
their results of prosthetic replacement of the 
anterior cruciate ligament in dogs, two tech­
nical difficulties became evident. The first 
was anchorage at the tendon-bone junction; 
the second was related to the identification 
of an inert material that could successfully 
replace a cruciate ligament. This material 
should have the strength of that ligament 
and should also be able to withstand the in- 
vivo demands of a normal ligament for an 
indefinite period. Ideally, the prosthetic 
ligament should somehow benefit from a 
sensory protective mechanism, either by 
invasion of the ligament by host tissue, or 
by proprioceptive feedback at the tendon- 
bone junction.
Material and Methods
Four prosthetic materials —  Ti-Cron 
(Davis & Geek, Cyanamid of Canada Lim­
ited, Montreal), Tevdek (Deknatel, Inc., 
New York), Ethicon (Ethicon Inc., Somer­
ville, NJ) and braided wire —  were used to 
replace the anterior cruciate ligament.
The experiment was carried out on 50 
adult mongrel dogs; 10 others served as con­
trols. The animals were divided into four 
groups according to the four types of mate­
rials used to replace the anterior cruciate 
ligament —  Ti-Cron (group 1, 10 dogs), 
Tevdek (group 2, 10 dogs), Ethicon (group 
3, 10 dogs) and braided wire (group 4, 20 
dogs). The strength of the material was tested 
prior to insertion and multiple strands were 
used when necessary (Table I). A vertical 
force was applied to these ligaments until 
they tore. The rate of force application, 
though not recorded, was constant. We at­
tempted to reproduce the clinical circum­
stances associated with tearing of the cru­
ciate ligaments (though we were not 
necessarily successful in doing so). At au­
topsy, the ligaments noted to be in con­
tinuity were similarly tested for their 
breaking point. The animals were sacrificed 
at regular intervals; the longest follow-up
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TABLE I.—T ensile Strength of Prosthetic L igaments
Vol. 19
Group Prostheticmaterial
Breaking point, kg* 
In vitro In vivo Follow-up, wk
1 .............
00 X 6 29.25 9.90 3
00 X 6 16.65 20
00 X 10 40.50 16.65 24
2 ...............................
# 5 X 3 56.25 40.50 12
# 5 X 3 36.00 16
# 5 X 3 31.50 16
# 5 X 3 27.00 20
# 5 X 3 27.00 243 ..................................... 36.00 42.75 34 ............................. 123.75 117.00 2
Control....................... 78.75 Fresh
“Testing by application of vertical force.
was 6 months. Postoperative infections de­
veloped in 13 animals (3 in group 1, 3 in 
group 3 and 7 in group 4); these were ex­
cluded from the study so their results are 
not reported.
Surgical Technique
Test animals.—Two cavities were cu­
retted in the lateral femoral condyle and 
under the medial tibial plateau. The ends 
of the prosthetic anterior cruciate ligament 
were embedded in a bolus of cement that 
filled these two cavities. The knee was gently 
flexed to 45° to achieve the desired tension 
on the prosthetic ligament and the cement 
was then allowed to set. Finally, a cylinder 
cast was applied and left in place for 20 
days to favour healing of the surgical inci­
sion.
Control animals.—In the control group 
of animals, the anterior cruciate ligament 
was excised but not replaced; metallic clips 
were applied at the proximal and distal stubs 
of the ligament. Just as in the test animals, 
the limb was then immobilized for 20 days 
in a cylinder cast.
TABLE II,
Evaluation Technique
The in-vivo sagittal stability of the knees 
was assessed clinically and radiologically 
prior to sacrifice, under general anesthesia. 
Great care was taken to standardize the 
stress films; the knees were maintained at 
90° and a force of 6.75 kg was applied to 
verify anterior sagittal stability.
R esults
Clinical Evaluation
Most animals appeared to function nor­
mally 4 weeks after surgery. However, most 
knees were found to be unstable (Table II); 
this instability could be confirmed radio­
logically by the use of stress films. Effusion 
was clinically obvious in all animals with 
demonstrable ligamentous instability. With 
one exception, all animals had a normal 
range of motion.
Autopsy Findings
All prosthetic ligaments failed. Most were 
torn, usually at their femoral attachment, 
while a few had lengthened (Table II).
.—Results
Condition of prosthetic
„ . , , ligament at autopsy
. Period of Clinical ----------------------------- ------------------
Experimental group observation, mo instability Intact Elongated Torn
Group 1 (n = 7 )......................... 1 to 6 5 0 3 4
Group 2 (n = 10).....................  3 to 6 5 0 5 5
Group 3 (n = 7 ) ......................  3 to 6 7 0 0 7
Group 4 (n =  1 3 )....................  2 to 6 8 0 0 13
A
A
- l -
i
i
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All dogs with a follow-up period of more 
than 2 months had an effusion; synovial 
hypertrophy was usually obvious with occa­
sional cartilage erosions. Some areas of 
cartilage erosion were related to the free 
stub of the prosthetic ligament, and others 
to the ligamentous instability; this was partic­
ularly obvious over the posterior segment 
of the femoral condyles.
The tensile strength of ligaments that were 
in continuity did not always correspond to 
their preoperative or in-vitro tensile strength. 
Most ligaments were weaker after they had 
been in place for more than 2 months (Table
I).
There were gross and microscopic signs 
of post-traumatic osteoarthritis in the con­
trol group (confirming the findings of 
others-’4) though these were not as obvious 
in the animals that had been sacrificed 
earlier and in whom the ligament was still in 
continuity. The findings in the control group 
were comparable to those noted when pros­
thetic replacement had failed.
The cartilage over the cement-filled bolus 
was always normal and there appeared to 
be no interference with cartilage nutrition 
following the insertion of a subchondral 
cement bolus.
D iscussion
The possible clinical applications of pros­
thetic ligaments are numerous and the in­
dications for their use will likely broaden 
once the technical problems have been over­
come. Prosthetic cruciate ligaments could 
be used for acute or chronic lesions; the 
surgical repair of acute tears of the anterior 
cruciate ligament at their midsection has 
been most disappointing and has been dis­
carded by many.3 Similarly, the intra- 
articular, reconstructive repair of chronic 
cruciate-ligament instability has yielded un­
even results6 and many now rely on extra- 
articular tendon transfers or ligamentous 
reconstruction, or both.7 Another possible 
application of prosthetic cruciate ligaments 
may be related to total knee arthroplasty.
Severe flexion deformities are sometimes 
overcome by major bony resections with 
ensuing instability which could be overcome 
using prosthetic ligaments.
Attempts to restore stability probably 
failed because we were unable to reproduce 
the in-vivo characteristics of normal cruciate 
ligaments. The initial strength of the pros­
thetic ligaments was sometimes greater than 
that of normal cruciate ligaments but did 
not withstand the test of time. Lengthening 
or breakage, or both, with ensuing post- 
traumatic osteoarthritis always resulted.
Preliminary results following subsequent 
experimental work suggest that the length 
and the tension of normal cruciate ligaments 
vary during normal knee motion. These 
later experiments also suggest that normal 
cruciate ligaments have sufficient elasticity 
to accommodate changes in length and ten­
sion during physiologic function.
The causes of failure of the prosthetic 
ligaments used during these experiments are 
likely multiple. Cement anchorage appears 
adequate and there is no evidence of asso­
ciated damage to the overlying cartilage, but 
considerable caution is still indicated when 
using prosthetic ligaments in humans.
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HISTORY OF M EDICINE
PEDIATRIC SURGERY: OLD ART AND NEW SCIENCE*
JAMES S. SIMPSON, JR, MD, FRCS[C], FACSt
Pediatric surgery represents a transition for sur­
gical operations as magical, religious or social 
rituals; through surgery devised for adults and 
adapted for children; to surgery devised solely 
for children. This specialty is now established 
with training programs and methods of examin­
ing the competency of its trainees in Canada 
and many countries of the world.
La chirurgie pediatrique represente une tran­
sition dans ie domaine des interventions chirur- 
gicales qui, de ceremonies magiques, religieuses 
ou sociales a I'origine, en passant par I'epoque 
oil la chirurgie destinee aux adultes etait adap- 
tee aux enfants, a maintenant atteint le stade 
d'une chirurgie uniquement mise au point pour 
les enfants. Cette speciality est maintenant 
bien etablie au Canada et dans plusieurs pays 
du monde oil Ton compte des programmes de 
formation et des methodes servant a eprouver 
la competence des stagiaires.
K n o w in g  the stature of those who have 
presented this memorial lecture in previous 
years, I accept this responsibility with trep­
idation and humility, but also with extreme 
gratitude. All of us have known one or 
more individuals who have influenced our 
future. For me, such a person was my 
father, James Starr Simpson, who was sur- 
geon-in-chief at St. Joseph’s Hospital for 27 
years. I am ever grateful to him for the ex­
ample he set in his association with patients, 
as well as with friends and acquaintances. He 
approached people humbly yet warmly; he 
accepted them no matter what their station 
in life, and always felt a deep concern for 
their problems. He was a humane, loving 
individual; and when the situation demanded 
it he had the strength of character to be 
direct and forthright.
T h e  O r ig in s  o f  P edia tr ic  Su r g er y
“Pediatric surgery is constantly fascinat-
*Based on the 1975 James Starr Simpson Memo­rial Lecture, presented at the 20th annual clinic day, St. Joseph’s Hospital, Toronto, ON, Nov. 13, 
1975.
tPresident, Canadian Association of Pediatric Surgeons; staff surgeon, The Hospital for Sick Children, Toronto; assistant professor, department of surgery, University of Toronto.
Reprints requests to: Dr. J. S. Simpson, Ste. 421, 170 St. George St., Toronto, ON M5R 2M8.
ing and tremendously rewarding. It is broad 
enough to interest the worker, difficult 
enough to satisfy the ambitious, and new 
enough to stimulate the imagination.” 1 
There have been many changes in the sur­
gical management of newborn infants and 
children, particularly during the past 10 
years, and great advances in knowledge. 
But, in this world of rapid change, it is well 
to pause at times, reflect on the past and 
plan for the future.
Pediatric care has existed since time be­
gan, and the old writings make it clear that 
it has long included surgical procedures. 
However, pediatrics as a medical specialty 
did not come into existence much before 
the middle of the 19th century, and pediatric 
surgery—distinct from surgery practised for 
adults— came even later. Until pediatric 
medicine and surgery became distinct dis­
ciplines, the health of most infants and chil­
dren was considered the responsibility of 
the gods or nature; this type of neglect is 
still prevalent among some primitive so­
cieties. It was the practice in some earlier 
civilizations to destroy many infants, parti­
cularly the sickly. Today, however, parents 
are reluctant to have their children looked 
after by any but the most competent physi­
cians and other health-care workers.
It is debatable whether circumcision or 
trephination is the oldest surgical operation. 
Circumcision of Jewish males has been 
practised since the time of Abraham (about 
4000 years ago)—“Every man child among 
you shall be circumcised.” (Genesis 17: 10) 
— and was included under the hygiene code 
of the Mosaic Law. For generations other 
ancient cultures, notably in Africa, have ac­
cepted the operation as a puberty rite for 
males and, in some areas, females also. 
Among the Australian aborigines, circum­
cision, accompanied by subincision (slitting 
the penis) in males and introcision in fe­
males, apparently originated during the 
“Dreamtime”,- unknown centuries ago.
Trephination, which was performed until 
recently by primitive man,3 w&s practised 
during the New Stone Age, which started
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in the Near East about 9000 BC and con­
tinued in north-west Europe until about 
2000 BC. Excavated skulls of this era show 
that children, as well as adults, were sub­
jected to trephination.3- 4 Since few of these 
skulls had beeen fractured, the operation 
was probably carried out in an attempt to 
alleviate conditions that prehistoric man 
attributed to demonic possession.4 There is 
evidence that amputations, also, were per­
formed during the New Stone Age.5
R ecorded H istory of Pediatric
Surgery
The earliest known records of surgical 
operations are Egyptian petroglyphs (2500 
BC) depicting circumcision and surgery of 
the extremities and head,5 and the oldest 
known treatise on pediatrics (an Egyptian 
papyrus dating back to 1450 BC) consists 
of prescriptions and incantations for the 
protection of mothers and babies and the 
treatment of diseases of children.3 The first 
consistent body of pediatric doctrine, parti­
cularly on hygiene and nutrition, is in the 
Indian Susruta, compiled in the 5th century 
BC; it describes about 120 surgical instru­
ments.5 Probably most primitive societies 
practised mutilating ritual procedures — 
that “can have added little to the comfort 
of the child”;2 for example, operations such 
as infibulation, and the boring of holes for 
ear and nose rings, were practised in Europe 
during the “La Tene” period (500 BC to 
100 AD).5
Hippocrates (460-370 BC), considered to 
be the father of medicine and pediatrics, re­
peatedly referred to the special features of 
diseases as they occurred in children. How­
ever, physicians of his day were seldom con­
sulted concerning the health of infants and 
children. He described special problems in­
herent in pediatric head injuries, and gave 
advice concerning the treatment of hema­
tomas and fractures.6
In about 30 AD, Aulus Cornelius Celsus 
wrote his “De re Medica” —  which was, 
in fact, a compilation from the Greek.4 Cel­
sus (the first classical medical writer, whose 
work appeared in 14784) included in his 
writings a few passages mentioning disease 
in children. He stated that “children are 
required to be treated entirely differently 
from adults” ;7 he described tonsillectomy,
uvulotomy, and frenotomy, and the repair 
of harelip and nasal defects.6 At that time, 
surgical therapy of sore eyes by extirpation 
or cauterization of scalp vessels was prac­
tised in children; fingers were removed in 
cases of polydactyly, and hypospadias was 
repaired by plastic surgery.6 It was recom­
mended that castration, performed “in the 
cradle” by non-Jews to provide eunuchs, 
be done by excision rather than crushing.8 
Aretaeus, born in 81 AD, listed diseases to 
which children were specially subject;4 
Soranus (96-138 AD), whom some regard 
as history’s leading authority on pediatrics, 
was the first to describe rickets;3 Galen 
(131-201) forbad blood-letting of children 
under 14 years of age; and Oribasius (325- 
403) wrote treatises on the diet and diseases 
of children.4
Development of Pediatric Surgery
The concept of pediatric surgery as dis­
tinct from surgery in adults, at least in the 
Near East and Europe, appears to date from 
the Middle Ages. One of the earliest books 
on the subject that illustrates pediatric sur­
gical procedures —  entitled “Cerrahiyei 
Ilhaniye” — was written by A. Sharaphed- 
din Sabuncuoglu, in Turkey, in 1465.9 In 
1612 a new edition of Felix Wiirtz’s “Prac- 
tica der Wundartzney” (“An Experimental 
Treatise of Surgery”) appeared with a pedi­
atric appendix including reference to ortho­
pedic problems.2 The index catalogue of 
the American Surgeon General’s Office, 
series 1 (1811), records a translation pub­
lished in London in 1656 of a four-volume 
“History of Medicine”, to which was added 
a section on surgery, including an appendix 
on children’s surgery. William Cheselden 
(1688-1752), surgeon to St. Thomas’s Hos­
pital, London, performed iridotomy, restor­
ing sight to a blind boy by constructing an 
artificial pupil.3
Jacques Mathieu Delpech (1777-1832), 
professor of surgery at Montpellier, is con­
sidered the founder of modern orthopedic 
surgery,4 particularly pediatric. Earlier op­
erations to correct clubfoot had produced 
poor results, but Delpech perfected the 
procedure and applied it for other muscle 
contractures. At about the same time Du- 
puytren introduced division of the sterno-
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mastoid muscle to correct wryneck. The 
specialty was further developed in the early 
19th century by Georg Stromeyer, who also 
established a reputation for curing clubfeet. 
One of Stromeyer’s patients was William 
Little, who himself later specialized in ortho­
pedics; in 1838 he founded the Orthopaedic 
Hospital in London. In 1879 Macewen in­
troduced the method for performing osteo­
tomy that still bears his name, to correct 
severe leg deformities due to rickets (for 
which Daniel Whistler, in 1645, had pro­
posed the name “paedosplanchnosteocases”). 
In 1880 he transplanted tibial wedges from 
several boys with rachitic deformities into 
the humerus of a 5-year-old boy who had 
had most of the bone removed because of 
severe osteomyelitis; 30 years later the arm 
was useful and the humerus had almost 
doubled in length.4
Meanwhile, more publications were ap­
pearing that included pediatric surgery. 
Specific surgical conditions were discussed 
in J. M. Coley’s “A Practical Treatise on 
the Diseases of Children,” published in 
London in 1846, and between 1856 and 
1877 they were the subject of at least 15 
publications in English, French, or Italian. 
These included “The Surgical Diseases of 
Children” by J. C. Forster in 1860, and a 
compilation of 12 Lettsomian Lectures by 
Thomas Bryant in 1863.10 The first North 
American textbook devoted to this subject, 
by S. W. Kelley, was published in 1909;11 
and many more European publications ap­
peared about that time, notably by Barring- 
ton-Ward, Fraser, Ladd and Gross in Eng­
lish, Ombredanne in French, and Drachter 
and Gossmann in German.10
H o sp it a l s  fo r  C h il d r e n
The earliest known institution specifically 
for treating children was the Dispensary 
for the Infant Poor, in London; this was 
established by George Armstrong (who prac­
tised surgery) in 1769.12 Christ’s Hospital 
(a so-called Royal hospital founded by 
Henry VIII) had been opened in 1553 for the 
care of orphans,13 but the first European 
hospital for inpatient treatment of children 
was l’Hopital des Enfants Malades, in Pa­
ris, opened in 1802. The latter was originally 
the Maison de l’Enfant Jesu, opened in the 
late 1670s as a home for “foundlings” .3
T h e  M o d e r n  E ra
Modern Pediatric Surgeons
Most pediatric surgeons of the last 
century engaged mainly in orthopedic sur­
gery, particularly the correction of con­
genital anomalies and the management of 
osteomyelitis. The formal teaching of gen­
eral pediatric surgery probably began with 
the lectures delivered by M. P. Guersant, a 
surgeon at l’Hopital des Enfants Malades, 
from 1840 to I860.7 In 1867, Matejovsky, 
then associate professor of surgery at the 
University of Prague, began lecturing in 
pediatric surgery;14 and in 1901, Vaclav 
Kafka, the first Czech to devote himself 
entirely to the surgery of children, was ap­
pointed surgeon-in-chief of the children’s 
hospital. Jan Kossakowski was the first pro­
fessor of pediatric surgery in Poland.15 Such 
men laid the foundations of the specialty as 
we have come to know it.
What do we mean by “pediatric surgery”? 
According to H. E. Coe, one of North 
America’s founding pediatric surgeons, the 
first reference to pediatric surgery as a 
specialty was by J. S. Stone, chief of surgery 
at the Boston Children’s Hospital. In 1919 
Stone was asked by a former surgical resi­
dent if he might spend some time training 
with him, to prepare himself for a practice 
limited to the surgery of infants and chil­
dren. Stone replied that he had “never heard 
of such a specialty, but [that he] would 
gladly give all possible assistance” (Coe 
HE: Unpublished address to the ninth In­
ternational Congress of Paediatrics, Mont­
real, July 22, 1959). As late as 1952, when 
I was being interviewed by Robert Janes, 
professor of surgery at the University of 
Toronto, and cited “pediatric surgery” as 
my proposed specialty, this reply brought a 
quizzical look and the statement: “There 
isn’t such a thing.” In fact, some still define 
it as general surgery practised in the adult 
but applied to the infant and child. I think 
this description inadequate; the comments 
by Coe, in his address to the ninth Interna­
tional Congress of Paediatrics, are more ap­
propriate.
Pediatric surgery may be defined as the applica­
tion of sound surgical principles in the treatment 
of an organism which is in the most rapidly 
changing state of its entire life span. The prin-
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ciples are constant, but the application requires 
infinite adjustment. Pediatric surgery is the sur­
gery of evolution as contrasted with involution. 
It is, in the highest degree, physiologic surgery as 
contrasted with removal or excision surgery. It 
is the surgery of the transition period between 
the protected intrauterine existence and a world 
of an infinite number of more or less violent ex­
ternal stimuli —  the period of adjustment of 
neuromuscular mechanisms, of heat regulation, 
of nutrition, of fluid and electrolyte balance —  
when arithmetical computation of requirements 
based on those of 150-pound adults is completely 
fallacious. The patient frequently does not un­
derstand our language, cannot or will not co­
operate, and has emotional and mental reactions 
which are often unpredictable.
Modern pediatric surgery is largely the 
work of three generations of surgeons.16 
The founders, including Ladd in Boston and 
Barrington-Ward and Sir Dennis Browne in 
London, began their work in the 1920s. A 
middle generation comprised 50 to 60 sur­
geons who worked closely together and 
were responsible for founding the British 
Association of Paediatric Surgeons and the 
surgical section of the American Academy 
of Pediatrics. The third generation is the 
very large number of surgeons all over the 
world, now practising pediatric surgery.
Any study of the recent development of 
this specialty must begin with the father of 
pediatric surgery in North America, William 
E. Ladd (Fig. 1). In 1908 he was appointed 
to the staff of the Boston Children’s Hospi­
tal, where he served for 37 years. His ideals, 
keen insight, and technical excellence — all 
generously disseminated for the benefit of 
his many pupils —  made him the greatest 
stimulus to the improved surgical care of 
children in North America. It is said that 
some people grow under responsibility, 
whereas others only swell; of Ladd it can 
be said that he grew to phenomenal stature. 
In recognition of his service, the Harvard 
Medical School established a chair of pe­
diatric surgery, the Ladd professorship of 
child surgery and in 1954 the surgical sec­
tion of the American Academy of Pediatrics 
established the Ladd medal in his honour.
Following closely after Ladd, H. E. Coe 
began the practice of pediatric surgery in 
Seattle, in 1919; O. S. Wyatt, in Minnea­
polis, in 1928; and G. C. Penberthy, in 
Detroit, J. Fraser in Edinburgh, M. Grob in 
Switzerland and A. Oberniedermayr in Ger-
Fig. 1.—William Edwards Ladd (1880-1967), 
leader in pediatric surgery in North America 
(courtesy of Dr. William Clatworthy).
many.10 In Canada, the pioneers in this 
specialty were W. E. Gallie, A. B. LeMe- 
surier and D. E. Robertson at The Hospital 
for Sick Children, Toronto (Fig. 2), Dudley 
Ross and Alexis Favreau in Montreal and 
J. D. McEachern in Winnipeg (Canadian 
Association of Paediatric Surgeons: Unpub­
lished brief to the Royal College of Physi­
cians and Surgeons of Canada, 1973).
In the 1940s, Mexico was a leader in the 
organization of training programs in the 
specialty. These were developed by Federico 
Gomez, director of the Children’s Hospital 
in Mexico City, soon after the hospital was 
opened in 1943. Jesus Lozoya-Solis, who 
had trained under Ladd, became head of 
the department of surgery — and Mexico’s 
first pediatric surgeon. In 1954 the National 
University of Mexico started a formal course 
of training, under the direct supervision and 
control of pediatric surgeons.
Pediatric Surgery Organizations
In the stimulating environment of the 
American Academy of Pediatrics, surgical
- U  
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Fig. 2.-Operating room in The Hospital for Sick Children, Toronto, when it was located at 67 
College Street (circa 1901) (courtesy of The Hospital for Sick Children, Toronto).
subjects began to appear on the programs. 
Presentations by such eminent surgeons as 
Ladd, Gross, Swenson, Potts, Coe and 
Lozoya-Solis encouraged the formation of a 
surgical section in the Academy to further 
the improvements in the surgical care of 
children. Since its inception in 1948, mem­
bership in this section has been limited to 
surgeons whose practice is at least 90% 
pediatric surgery. There were 20 original 
members; now there are over 400.
The British Association of Paediatric Sur­
geons was founded in 1953, the Canadian 
Association of Paediatric Surgeons in 1967, 
and the American Pediatric Surgical Asso­
ciation 2 years later. The most recent addi­
tion is the South African. Association of 
Paediatric Surgeons, formed in 1976.
In 1974 the World Federation of Associa­
tions of Pediatric Surgeons was founded to 
unify efforts in the surgical care of infants 
and children throughout the world; Harvey 
E. Beardmore, of Montreal, became the 
first president. All of these associations 
recognize the need to consider neonatology 
and surgery of the newborn as the most im­
portant part of the specialty. The rapid in­
crease in knowledge, particularly of respira­
tory tract physiology, coupled with the de­
velopment of new techniques and micro­
methods, has pushed neonatology into the 
forefront. The most important aim is to 
prevent damage rather than to correct it.
In 1966, the Royal Australasian College 
of Surgeons approved pediatric surgery as 
a specialty, establishing a curriculum and 
examining candidates. In June 1972, the 
American Board of Surgery, after consider­
ing a brief from members of the American 
Pediatric Surgical Association, unanimously 
approved the establishment of a certificate 
of “special competence in Pediatric Surgery”; 
the first examination took place in Phila­
delphia on June 12, 1974. In February 
1973, the Canadian Association of Paedia­
tric Surgeons, through a small committee 
chaired by Colin Ferguson of Winnipeg, 
(then president of the association), ap­
proached the Royal College of Physicians 
and Surgeons of Canada, seeking special 
recognition for pediatric surgery in Canada. 
Approval of a suggested training program 
and the principle of recognition for this sub­
specialty was granted by the college at its
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1975 annual meeting, and the first examina­
tion was in the fall of 1976. Most recently, 
in 1976, pediatric surgery achieved official 
recognition as a specialty in Austria.
Pediatric Surgical Journals and
Subspecialties
There are now journals devoted entirely 
to this specialty; the Journal of Pediatric 
Surgery (in its 9th year) and Annales de 
Chirurgie Infantile are examples. Pediatric 
surgery once attracted surgeons who oper­
ated on diverse systems; they did a little 
of everything, including orthopedics, neuro­
surgery, cardiovascular surgery, plastic sur­
gery and general surgery. Now, in the larger 
pediatric hospitals, surgical departments 
comprise specialty divisions, a structure that 
undoubtedly increases the expertise with 
which problems can be managed. Today’s 
improved survival figures for major opera­
tions on newborn infants are largely attri­
butable to assistance given the surgeon by 
highly trained pediatric anesthetists, and by 
neonatologists (a new breed of specialist); 
improvements in intravenous and elemental 
diets and in radiology; the advent of bio­
medical engineering, and the availability of 
aids to respiration and circulation. (The first 
exchange transfusion was done in Toronto, 
at The Hospital for Sick Children, in 192517 
—  a far cry from the first transfusions, to 
a dog in 1665 and of lamb’s blood to a 16- 
year-old boy in June 1667.3) All of these 
disciplines, bringing vastly increased scien­
tific and physiologic knowledge, are helping 
to improve the monitoring of body func­
tions before, during and after surgery. The 
team approach has made possible surgical 
procedures that previously would have 
courted disaster.
The Future of Pediatric Surgery
The specialty of pediatric surgery has 
come of age in response to demand and is 
one of the most rapidly growing surgical 
disciplines. Departments are being estab­
lished in universities throughout the world:18 
“Paediatric surgery will advance and the 
care of its patients improve in those chil­
dren’s hospitals where there is overt evi­
dence of love of scholarship and of a con­
tinuing interest and emphasis on research.”1*1
But with acceptance comes responsibility.
There is need for continuing improvement in 
the surgical management of children and for 
increased awareness of the problems of 
trauma from all causes. Possibly the most 
pressing moral issue has to do with the 
place of surgery in the management of in­
fants with correctable congenital anomalies 
associated with serious disabling neurologic 
disorders.20- 21 This critical ethical and 
moral issue, recently reviewed by Wald- 
man,22 can be resolved only by the coop­
erative effort of medical, legal, religious and 
judicial leaders with the community.
The role of the pediatric surgeon will 
probably best be realized in centres that 
have special facilities for managing the com­
plex problems of the newborn. His dedica­
tion to the welfare of infants and children 
means that he will be interested in the edu­
cation of all surgeons coming in contact 
with these small patients.
The future of this specialty is indeed chal­
lenging. “The aim of the paediatric surgeon 
is not to create a monopoly but to set a 
standard” (Sir Dennis Browne, KCVO, 
1892-1967; quoted by Zachary RB: For- 
shall Lecture to British Association of 
Paediatric Surgeons, Sheffield, England, 
July 9, 1976).
The author is indebted to Miss U. Matthews, 
Ms. E. Golomb-Avramov and other staff of the 
medical publications department, who devoted 
many hours to collecting and correlating the his­
torical material in this paper.
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FIRST ANNUAL DAVIS & GECK SURGICAL ESSAY AWARD
Mr. T. D. Smith, president of Cyanamid of Canada Ltd., presents a cheque for $1000.00 to 
Dr. John B. Pietsch, resident in surgery at the Royal Victoria Hospital, Montreal. Dr. Pietsch 
won the first Davis & Geek award for his manuscript entitled “The Delayed Hypersensitivity 
Response: Clinical Application in Surgery”, which will be published in the January 1977 issue
of the Canadian Journal of Surgery.
The editorial board and the editors of the Journal wish to thank Davis & Geek for 
providing this award, and extend their congratulations to Dr. Pietsch and their thanks to all 
those who participated in the competition.
(Requirements for the 1977 award will appear in the January 1977 issue of the Canadian 
Journal of Surgery.)
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et al: Pediatric Surgery, vol. I, 2nd ed, Chi­
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Modern Treatise on Pediatric Surgery, New 
York, Treat, 1909
12. G uthrie D, editor: Royal Edinburgh Hos­
pital for Sick Children: 1860-1960, Edinburgh, 
Livingstone, 1960
13. Ives AG: British Hospitals, London, Collins, 
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Sheffield and Warsaw, July, 1976
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19. Wyllie GG: Paediatric surgeon — operating 
physician or surgeon? Ibid, p 79
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CRITIQUE OF ITEMS 41-43 (SESAP II)
41—This item deals with the complications of total parenteral alimentation or hyperali­
mentation. One might disagree with treating an obstructing carcinoma of the esophagus 
by preoperative irradiation; however, that has nothing to do with the question. The prob­
lem is that the patient becomes lethargic, her behavior is strange, and her urine output is 
greatly increased. This clinical complex is most commonly produced by a large glucose 
load exceeding the ability of the patient’s pancreas to respond with insulin that is adequate 
to maintain a normal blood glucose level. The resultant severe hyperglycemia produces 
lethargy and strange behavior; when the renal threshold of glucose is exceeded, a large in­
crease in urine output occurs. Thus, the correct response is measurement of blood glucose 
(E). None of the other measurements or responses would document problems producing 
this sequence of events, although one would likely find an elevated level of serum sodium.IT
42 The correct response is hyperosmolar, nonketotic coma (E). None of the other choices 
produce a clinical complex of lethargy, strange behavior, and polyuria. The presence of 
diabetes mellitus should have already been determined. Although diabetes mcllitus may 
produce a similar complex condition, hyperosmolar, nonketotic coma is far more com­
mon in a patient who receives intravenous nutrition.
E
43—The most appropriate treatment of hyperosmolar, nonketotic coma is administration 
of insulin and 5 per cent dextrose and water (E). Digitalis and diuretics (A) certainly 
would not be helpful. Administration of glucocorticoids (B) would be contraindicated 
and may actually exaggerate the hyperglycemia. Termination of all glucose infusions 
alone will not correct the situation rapidly enough. Termination is hazardous since 
eventually a rebound with hypoglycemia may occur. Insulin and hyperalimentation 
(D) is inappropriate because hyperalimentation, together with continued infusion of 
hypertonic glucose solutions, cannot be continued when there is marked hyperglycemia.
_E^
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B O O K  R E V I E W S
THE ADOLESCENT SPINE. Hugo A. Keim. 
219 pp. Illust. Grune & Stratton, Inc., New 
York; Longman Canada Limited, Toronto, 
1976. $21.25.
This monograph is an easily read, up-to-date 
review of spinal disease and deformity. The 
author is in charge of the Scoliosis Clinic at 
the Columbia-Presbyterian Medical Centre. 
The book can certainly be recommended to 
orthopedic residents, medical students inter­
ested in increasing their knowledge of the spine 
and practitioners who would like to learn 
about the present methods for the diagnosis 
and treatment of spinal abnormalities.
There are several minor criticisms. Perhaps 
insufficient attention is paid to the Boston 
orthosis; this is now widely used and is an 
extremely effective and readily accepted brace. 
The Boston orthosis is used in the treatment 
of patients with scoliosis where the apex of 
the curve is below the ninth thoracic level. 
In addition, the diagrams in the chapter on 
spinal injuries illustrating Holdsworth classi­
fications are not accurate.
This monograph fulfils a definite need and 
is therefore recommended.
G. W. D. A r m str o n g
Department of surgery,
Ottawa Civic Hospital,
Ottawa, ON.
MYOCARDIAL REVASCULARIZATION. 
A SURGICAL ATLAS. Quentin R. Stiles, 
Bernard L. Tucker, George G. Lindesmith 
and Bert W. Meyer. 165 pp. Illust. Little, 
Brown and Company (Inc.), Boston, 1976. 
Price not stated.
The authors have written about one type of 
myocardial revascularization procedure in 
which oxygenated blood is redirected into sur­
face coronary arteries beyond their point of 
obstruction. Their experience has been primari­
ly with aortocoronary (AC) vein bypass grafts 
and (to a lesser extent) mammary coronary 
artery grafts.
The anatomy section of this atlas is excellent, 
whereas the section dealing with the pathology 
of coronary artery disease is sketchy. The 
drawings based on cinecoronary angiographic 
studies are confusing; there is no demonstra­
tion of disease in the distal major coronary 
trunks and surface branches.
The section on cardiopulmonary bypass is 
excellent; the drawings of AC vein and mam­
mary coronary bypass techniques are clear. 
Unfortunately the new techniques to prevent
occlusion of vein or mammary artery grafts, 
resulting from adherence to midline sternal scar 
or displacement by lung, are not mentioned.
The authors report an average 2.5-year 
follow-up of 1521 patients treated by AC vein 
grafts. Of those operated upon, 93% were 
alive and 79.4% were considered improved. 
The operative mortality was 2.9% and the late 
mortality was 2% annually. After an average 
of 8 months, 458 patients were recatheterized; 
in 80% all grafts were patent, while in 92% 
at least one graft was patent. The total oper­
ative and late mortality was 27.3% for one 
graft and 5.3% for three or more grafts.
In cinecoronary angiograms of 1208 pa­
tients, Gensini recently showed that disease 
was present in the distal coronary trunks and 
their surface branches in 62% of right, 33% 
of left anterior descending, and 50% of cir­
cumflex coronary arteries. To my mind, three 
or more grafts are therefore unphysiologic in 
50% of patients with triple coronary disease. 
One of every two such patients needs revascu­
larization as recommended by Favaloro through 
nondiseased ventricular myocardial arterioles 
using mammary arterial ventricular implants 
alone or in combination (with AC bypass vein 
grafts).
The authors believe that doing a multiple 
graft procedure decreases mortality. On the 
basis of Gensini’s work I am inclined to believe 
that mortality is related to the high frequency 
of distal coronary artery disease.
The atlas is a useful reference for teaching 
purposes and a yardstick by which cardiovas­
cular surgeons may evaluate their experience.
A. M. VlNEBERG
Department of surgery,
Royal Victoria Hospital,
Montreal, PQ.
PRINCIPLES OF THYROID SURGERY.
John M. Beaugie. 225 pp. Illust. Grune &
Stratton, Inc., New York; Longman Canada
Limited, Toronto, 1975. $19.00.
As with most British-authored texts this mono­
graph is well written and easy to read. The 
deficiencies of single-author texts are apparent 
in areas where the subject matter lacks depth. 
Overall, the book is well produced with good 
illustrations and well-defined diagrams.
The organization is standard, beginning with 
an interesting chapter on history. The chapter 
on investigation of thyroid disease includes 
some of the newer tests such as radioimmuno-
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of shock, Solu-Medrol should be adjunctive to 
conventional supportive therapy such as fluid 
replacement, etc. Although adverse effects as­
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assay for T3; this section is well done and up 
to date. However, the author has retained some 
outdated material and has given undue em­
phasis to some tests such as the protein-bound- 
iodine determination. In addition, despite evi­
dence to the contrary, the author continues to 
consider the Achilles tendon reflex time 
response useful for the follow-up of thyroid 
function in patients after surgery. There is 
some confusion about the differentiation of 
Grave’s disease and other forms of hyperthy­
roidism. Although this is a surgical text, the 
author places too much emphasis on the place 
of surgery in the modern management of thyro­
toxicosis; he gives little recognition to the 
limitations of surgery.
Considering the frequency of thyroid nodules 
in clinical practice, the chapter on non-toxic 
and solitary nodules is underemphasized; the 
chapter on malignant disease is well balanced 
with proper emphasis on the more conserva­
tive management of differentiated carcinomas.
There are shortcomings in the chapters re­
lating to surgery. The section on anatomy is 
limited with few illustrations; little mention is 
made of vulnerability of the external laryngeal 
branch of the superior laryngeal nerve in dis­
section of the superior pole. It is also sur­
prising that surgeons are still not directed to 
identify the recurrent laryngeal nerve in all 
thyroidectomies. The lateral approach for 
second exposures of the thyroid and for sur­
gery on carcinoma-infiltrated strap muscles is 
unfortunately not mentioned. Similarly, tem­
porary detachment of the lower end of the 
sternomastoid muscle to aid exposure in modi­
fied block dissection of the neck is omitted.
Although monographs on special topics by 
experienced clinicians are always welcome, the 
contribution must be outstanding to warrant 
yet another text on a previously well-covered 
subject. This text has little new to offer to 
meet this requirement. However, it is a good 
guide to current references.
W . G. B e a t t i e
Department of Surgery,
Ottawa Civic Hospital,
Ottawa, ON.
The above book review was received in the Jour­
nal office 24 hours after Dr. Beattie’s sudden 
death, at age 56, of a myocardial infarction during 
a tennis match. Dr. Beattie was chief of surgery at 
the Ottawa Civic Hospital for many years; he 
lived to see the department expand from one 
oriented to general surgery to a highly sophisti­
cated department with all of the contemporary 
surgical specialties.
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NOTICE
ROYAL COLLEGE MEETING
The 46th annual meeting of the Royal 
College of Physicians and Surgeons will be 
held from Jan. 26 to 29, 1977 in Toronto, 
Ont. The scientific program will begin on 
Wednesday, Jan. 26 with a series of sym­
posia sponsored by the Canadian Society for 
Clinical Investigation. The scientific ses­
sions will continue until 12 a.m. on Satur­
day, Jan. 29.
The president’s reception and dinner will 
be held on Thursday, Jan. 27 in the ball­
room of the Sheraton Centre and the annual 
convocation ceremonies will take place at 
Hart House, University of Toronto on Friday, 
Jan. 28.
